Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,A1BG,Alpha-1B-glycoprotein,2143,83,8.59 [2.41-30.58],0.0009049271658342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AAMDC,Mth938 domain-containing protein,2096,83,1.02 [0.67-1.56],0.9317520842164646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AARSD1,Alanyl-tRNA editing protein Aarsd1,2475,101,1.14 [0.84-1.55],0.3839467399762557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABCA2,ATP-binding cassette sub-family A member 2,2068,81,2.09 [1.44-3.05],0.0001228823690364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABHD14B,Protein ABHD14B,2457,97,1.10 [0.79-1.54],0.5633738169294369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABL1,Tyrosine-protein kinase ABL1,2475,101,1.24 [0.97-1.59],0.0875456812854868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABO,Histo-blood group ABO system transferase,2148,83,0.94 [0.82-1.08],0.3949781320627813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABRAXAS2,BRISC complex subunit Abraxas 2,2068,81,1.12 [0.80-1.57],0.5000898075009774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",2418,95,1.01 [0.82-1.25],0.9335382733738448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",2114,81,1.14 [0.85-1.52],0.3897864508346867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",2138,84,1.00 [0.78-1.27],0.9797273592351836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACAN,Aggrecan core protein,2454,99,1.04 [0.58-1.88],0.8958120057386414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACE,Angiotensin-converting enzyme,2148,83,3.08 [1.52-6.21],0.0017108334447892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACE2,Angiotensin-converting enzyme 2,2437,97,1.11 [0.86-1.44],0.4121098406433947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACHE,Acetylcholinesterase,2109,80,1.26 [0.70-2.27],0.4380879544489587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACOT13,Acyl-coenzyme A thioesterase 13,2130,82,1.04 [0.86-1.27],0.6683980420160749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,2483,101,0.75 [0.51-1.10],0.1423697464692172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,2078,82,0.89 [0.55-1.45],0.6402390932157973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACP5,Tartrate-resistant acid phosphatase type 5,2491,102,1.72 [1.03-2.88],0.0373821046379529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACP6,Lysophosphatidic acid phosphatase type 6,2495,102,1.05 [0.80-1.38],0.7288987904952341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACRBP,Acrosin-binding protein,2133,83,1.06 [0.61-1.83],0.8378265313456738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACRV1,Acrosomal protein SP-10,2078,82,1.13 [0.92-1.39],0.2373345509033992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACSL1,Long-chain-fatty-acid--CoA ligase 1,2068,81,1.21 [0.69-2.12],0.5026362306037155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACTA2,"Actin, aortic smooth muscle",2437,97,1.84 [1.45-2.32],3.4199787238998024e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACTN2,Alpha-actinin-2,2068,81,1.23 [0.89-1.71],0.2075418972508346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACTN4,Alpha-actinin-4,2421,99,0.99 [0.57-1.72],0.9776402230489843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACVRL1,Serine/threonine-protein kinase receptor R3,2462,98,6.80 [4.50-10.27],8.998773963826963e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACY1,Aminoacylase-1,2483,101,0.83 [0.64-1.06],0.1343045108073808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,2068,81,1.08 [0.75-1.55],0.6889895859444684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACYP1,Acylphosphatase-1,2106,80,0.99 [0.71-1.39],0.9688483986531726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADA,Adenosine deaminase,2506,101,1.50 [0.94-2.39],0.0914367756023774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADA2,Adenosine deaminase 2,2461,99,2.82 [2.10-3.78],6.166898630289434e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,2078,82,2.41 [1.54-3.79],0.0001311551147226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,2437,97,1.28 [0.73-2.25],0.3926971852894523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,2463,98,2.70 [1.71-4.27],2.100988047937089e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,2506,101,2.89 [1.63-5.11],0.0002691133140091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,2502,102,2.63 [1.57-4.40],0.0002372525022963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,2130,82,3.14 [1.87-5.28],1.5096240367526106e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,2078,82,2.95 [1.42-6.13],0.003695323640557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,2510,102,1.14 [0.57-2.27],0.7099869393147218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,2475,101,1.50 [1.03-2.18],0.0346395352951606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,2437,97,1.64 [1.15-2.36],0.0068067251208075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,2078,82,1.36 [0.76-2.44],0.3057495959543437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,2489,101,0.90 [0.61-1.31],0.5736930185370157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTSL2,ADAMTS-like protein 2,2147,82,2.43 [1.57-3.79],7.703841071565104e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTSL4,ADAMTS-like protein 4,2096,83,1.49 [0.63-3.55],0.3621244697708972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTSL5,ADAMTS-like protein 5,2138,84,1.80 [1.18-2.76],0.0064045678906449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,2418,95,0.63 [0.32-1.24],0.1840989730539786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADD1,Alpha-adducin,2109,80,1.06 [0.77-1.45],0.7234586501170222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRB3,Adhesion G protein-coupled receptor B3,2462,98,3.27 [2.29-4.67],8.559137005211861e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRD1,Adhesion G-protein coupled receptor D1,2109,80,2.14 [1.36-3.37],0.0010062880504232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRE1,Adhesion G protein-coupled receptor E1,2130,82,1.27 [0.89-1.82],0.1875559465780172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRE2,Adhesion G protein-coupled receptor E2,2496,99,2.99 [1.76-5.10],5.48326778965294e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRE5,Adhesion G protein-coupled receptor E5,2497,102,3.05 [2.02-4.59],9.876826147534337e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRF5,Adhesion G protein-coupled receptor F5,2138,84,1.36 [0.60-3.06],0.4618201463423022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRG1,Adhesion G-protein coupled receptor G1,2475,101,1.42 [1.23-1.63],1.0238635231993524e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRG2,Adhesion G-protein coupled receptor G2,2483,101,0.40 [0.22-0.73],0.0026553504569259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRV1,Adhesion G-protein coupled receptor V1,2071,82,0.89 [0.63-1.26],0.522438545187928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADH1B,All-trans-retinol dehydrogenase,2109,80,0.76 [0.59-0.99],0.0447080539434621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,2437,97,0.71 [0.57-0.87],0.0013461646887029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADIPOQ,Adiponectin,2143,83,1.00 [0.75-1.32],0.9999064195515353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADM,Pro-adrenomedullin,2500,102,10.15 [5.25-19.60],5.342846356455976e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADRA2A,Alpha-2A adrenergic receptor,2068,81,0.98 [0.70-1.36],0.8959823142890623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AFAP1,Actin filament-associated protein 1,2109,80,0.73 [0.53-0.99],0.0436243052839072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AFM,Afamin,2143,83,0.29 [0.13-0.66],0.0032690383049513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AFP,Alpha-fetoprotein,2456,98,0.59 [0.44-0.79],0.0004353525632125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGBL2,Cytosolic carboxypeptidase 2,2071,82,1.15 [0.92-1.45],0.2179553043276069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGER,Advanced glycosylation end product-specific receptor,2479,99,1.46 [0.98-2.18],0.0626803161842349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGR2,Anterior gradient protein 2 homolog,2399,92,1.41 [1.20-1.67],4.267351612522956e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGR3,Anterior gradient protein 3,2413,95,1.45 [1.07-1.96],0.0157625528036737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGRN,Agrin,2496,99,3.64 [2.63-5.04],5.316940193606927e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGRP,Agouti-related protein,2506,101,1.99 [1.43-2.78],4.880452792805167e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGT,Angiotensinogen,2148,83,1.86 [0.92-3.76],0.0835572405289527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGXT,Serine--pyruvate aminotransferase,2483,101,0.94 [0.76-1.17],0.602235257351992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHCY,Adenosylhomocysteinase,2483,101,1.00 [0.76-1.31],0.9844834751540282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHNAK,Neuroblast differentiation-associated protein AHNAK,2096,83,0.99 [0.50-1.95],0.9718545596151672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHNAK2,Protein AHNAK2,2096,83,1.80 [1.10-2.95],0.0192914085165898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,2133,83,1.14 [0.85-1.55],0.3796640866424726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHSG,Alpha-2-HS-glycoprotein,2148,83,1.88 [0.85-4.16],0.1197273264709833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHSP,Alpha-hemoglobin-stabilizing protein,2485,100,0.93 [0.75-1.14],0.4724894409124496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AIDA,"Axin interactor, dorsalization-associated protein",2095,81,1.02 [0.80-1.31],0.8683085500245895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AIF1,Allograft inflammatory factor 1,2418,95,0.90 [0.63-1.29],0.5594816401705468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AIF1L,Allograft inflammatory factor 1-like,2096,83,1.45 [1.10-1.92],0.007803993560809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",2474,101,1.04 [0.88-1.23],0.6094710643870496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AK1,Adenylate kinase isoenzyme 1,2483,101,0.83 [0.62-1.10],0.1846405825969859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AK2,"Adenylate kinase 2, mitochondrial",2140,84,1.02 [0.83-1.25],0.8662078988155558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKAP12,A-kinase anchor protein 12,2109,80,1.08 [0.36-3.22],0.8862569322765683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKR1B1,Aldo-keto reductase family 1 member B1,2418,95,1.03 [0.80-1.31],0.8448735537277734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKR1B10,Aldo-keto reductase family 1 member B10,2095,81,0.99 [0.77-1.28],0.9681187221755492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKR1C4,Aldo-keto reductase family 1 member C4,2437,97,0.85 [0.58-1.25],0.4137033379271636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,2078,82,1.00 [0.76-1.32],0.9858319451348478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKT1S1,Proline-rich AKT1 substrate 1,2414,94,1.25 [0.94-1.66],0.1310384630359488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKT2,RAC-beta serine/threonine-protein kinase,2136,83,1.00 [0.84-1.19],0.9609816587686032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKT3,RAC-gamma serine/threonine-protein kinase,2407,94,0.99 [0.71-1.39],0.9542247576480352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALCAM,CD166 antigen,2510,102,3.53 [1.68-7.43],0.0009054573149124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALDH1A1,Retinal dehydrogenase 1,2490,100,0.75 [0.55-1.00],0.0516836596660181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALDH2,"Aldehyde dehydrogenase, mitochondrial",2133,83,1.32 [1.06-1.65],0.0139684523719272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",2473,100,0.88 [0.70-1.10],0.2513821009116391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",2136,83,1.30 [0.84-2.01],0.2345289635548358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALMS1,Alstrom syndrome protein 1,2114,81,1.24 [0.81-1.88],0.3178404429890378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALPI,Intestinal-type alkaline phosphatase,2078,82,1.13 [0.96-1.33],0.1514836014643193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALPP,"Alkaline phosphatase, placental type",2475,101,1.03 [0.87-1.22],0.7389382696398854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMBN,Ameloblastin,2421,99,1.11 [0.64-1.91],0.7083696207114627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMBP,Protein AMBP,2499,102,18.47 [8.97-38.03],2.5029266337719964e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,2147,82,1.20 [0.50-2.86],0.6836627155516499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMFR,E3 ubiquitin-protein ligase AMFR,2414,94,1.22 [0.93-1.59],0.1584834004687352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMIGO1,Amphoterin-induced protein 1,2095,81,0.87 [0.55-1.39],0.5707851605299399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMIGO2,Amphoterin-induced protein 2,2475,101,1.77 [0.90-3.48],0.0978217391798439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMN,Protein amnionless,2421,99,1.33 [0.93-1.91],0.1183472140538789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMOT,Angiomotin,2109,80,0.94 [0.55-1.61],0.830827861541019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMOTL2,Angiomotin-like protein 2,2122,81,1.33 [0.87-2.02],0.1837647472075402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMPD3,AMP deaminase 3,2140,84,1.03 [0.77-1.37],0.8639179958897274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,2020,76,1.01 [0.66-1.56],0.9562023705470604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMY2A,Pancreatic alpha-amylase,2388,94,0.96 [0.68-1.34],0.7939138395763705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMY2B,Alpha-amylase 2B,2315,92,0.94 [0.66-1.32],0.7170220752449878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANG,Angiogenin,2476,99,2.41 [1.54-3.79],0.00013337234689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPT1,Angiopoietin-1,2475,99,0.89 [0.72-1.10],0.2759234700130248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPT2,Angiopoietin-2,2500,102,3.47 [2.41-5.01],2.9184323933407913e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL1,Angiopoietin-related protein 1,2441,100,1.56 [0.87-2.79],0.1397460256720514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL2,Angiopoietin-related protein 2,2489,99,1.47 [0.96-2.25],0.0762026520473666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL3,Angiopoietin-related protein 3,2484,99,0.86 [0.55-1.36],0.5270467955405005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL4,Angiopoietin-related protein 4,2492,99,3.92 [2.73-5.63],1.484779255358949e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL7,Angiopoietin-related protein 7,2500,102,1.83 [1.20-2.80],0.0049782140486976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANK2,Ankyrin-2,2068,81,0.94 [0.68-1.29],0.7100443662029321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,2078,82,1.12 [0.86-1.47],0.4037763417509868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANKRA2,Ankyrin repeat family A protein 2,2063,81,0.85 [0.56-1.30],0.4571923716769728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANKRD54,Ankyrin repeat domain-containing protein 54,2418,95,0.88 [0.64-1.22],0.4574121396829843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,2096,83,0.76 [0.42-1.39],0.3770525323072962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANPEP,Aminopeptidase N,2481,99,1.49 [0.84-2.64],0.1704395617320133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA1,Annexin A1,2101,80,0.80 [0.45-1.42],0.444924398470453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA10,Annexin A10,2414,94,1.04 [0.85-1.27],0.6954047454469914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA11,Annexin A11,2474,100,0.86 [0.66-1.13],0.2769500180119278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA2,Annexin A2,2068,83,0.93 [0.69-1.27],0.6660545020304197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA3,Annexin A3,2502,102,0.97 [0.75-1.25],0.8140458608979612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA4,Annexin A4,2472,99,0.84 [0.64-1.10],0.2009098122351889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA5,Annexin A5,2410,94,2.30 [1.58-3.35],1.4552834544324057e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AOC1,Amiloride-sensitive amine oxidase [copper-containing],2421,99,0.87 [0.61-1.25],0.4627249901057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AOC3,Membrane primary amine oxidase,2486,99,6.08 [3.58-10.34],2.4939271571952308e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AP1G2,AP-1 complex subunit gamma-like 2,2133,83,1.05 [0.80-1.38],0.7346917967301461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AP2B1,AP-2 complex subunit beta,2095,81,1.14 [0.72-1.79],0.5825535562533453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AP3B1,AP-3 complex subunit beta-1,2130,82,1.21 [0.91-1.62],0.1930596401211166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AP3S2,AP-3 complex subunit sigma-2,2140,84,1.18 [0.76-1.83],0.4503710843557992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,2475,101,1.23 [0.85-1.77],0.269056760913836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APCS,Serum amyloid P-component,2118,83,0.54 [0.29-0.98],0.0422867413375132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,2491,102,0.89 [0.65-1.21],0.4571018394557093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APLP1,Amyloid-like protein 1,2483,101,0.86 [0.61-1.20],0.3643943957098481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA1,Apolipoprotein A-I,2143,83,0.30 [0.15-0.61],0.0009129422174539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA2,Apolipoprotein A-II,2148,83,1.70 [1.17-2.49],0.0059265280172663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA4,Apolipoprotein A-IV,2143,83,4.06 [2.57-6.43],2.215827811055547e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOB,Apolipoprotein B-100,2148,83,1.42 [0.55-3.66],0.4642615122009438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOBR,Apolipoprotein B receptor,2096,83,0.94 [0.57-1.56],0.8227152531665238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOC1,Apolipoprotein C-I,2139,83,0.59 [0.34-1.06],0.0760146820519682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOD,Apolipoprotein D,2045,80,0.50 [0.27-0.93],0.0281008981097851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOE,Apolipoprotein E,2143,83,0.75 [0.51-1.12],0.1640748616534489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOF,Apolipoprotein F,2148,83,0.79 [0.43-1.45],0.4508179829926996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOH,Beta-2-glycoprotein 1,2490,100,1.63 [1.10-2.42],0.0160059386157975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOL1,Apolipoprotein L1,2148,83,1.05 [0.73-1.51],0.7944363964061391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOM,Apolipoprotein M,2485,99,0.43 [0.25-0.76],0.0033767693880998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APP,Amyloid-beta precursor protein,2485,99,0.99 [0.76-1.30],0.9436313224520416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APPL2,DCC-interacting protein 13-beta,2109,80,0.96 [0.78-1.17],0.6654737517981233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APRT,Adenine phosphoribosyltransferase,2461,98,1.71 [1.13-2.59],0.0113729743840407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARAF,Serine/threonine-protein kinase A-Raf,2114,81,1.09 [0.80-1.50],0.5804732649047435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AREG,Amphiregulin,2475,101,2.60 [1.93-3.49],2.5381333508306816e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARF6,ADP-ribosylation factor 6,2130,82,1.04 [0.84-1.29],0.7120286069511552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARFIP1,Arfaptin-1,2136,83,0.98 [0.71-1.36],0.92436643744847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARG1,Arginase-1,2449,100,0.75 [0.54-1.04],0.0811878021959863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARG2,"Arginase-2, mitochondrial",2133,83,1.57 [1.05-2.33],0.0262795711508499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP1,Rho GTPase-activating protein 1,2418,95,0.74 [0.49-1.13],0.1648256392017833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP25,Rho GTPase-activating protein 25,2418,95,1.18 [0.86-1.60],0.3045872237768387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP30,Rho GTPase-activating protein 30,2114,81,1.17 [0.68-2.02],0.5616461557522755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP45,Rho GTPase-activating protein 45,2109,80,1.07 [0.81-1.41],0.643697529459249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP5,Rho GTPase-activating protein 5,2063,81,0.88 [0.66-1.17],0.365955168882097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGEF1,Rho guanine nucleotide exchange factor 1,2140,84,1.05 [0.82-1.34],0.7156238821185843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGEF10,Rho guanine nucleotide exchange factor 10,2136,83,1.09 [0.87-1.36],0.4413432658715046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGEF12,Rho guanine nucleotide exchange factor 12,2477,100,1.07 [0.90-1.28],0.4302556869591839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,2071,82,1.30 [1.00-1.70],0.0524262924767379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARID3A,AT-rich interactive domain-containing protein 3A,2071,82,1.18 [0.67-2.08],0.5615700099911626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARID4B,AT-rich interactive domain-containing protein 4B,2414,94,0.87 [0.54-1.41],0.5708673384604279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARL13B,ADP-ribosylation factor-like protein 13B,2068,81,1.01 [0.74-1.37],0.970847370597632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,2068,81,1.17 [0.66-2.05],0.5901389755180837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARMCX2,Armadillo repeat-containing X-linked protein 2,2071,82,0.89 [0.59-1.33],0.5560161208998669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARNT,Aryl hydrocarbon receptor nuclear translocator,2421,99,1.42 [0.94-2.14],0.0985230642432271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,2068,81,0.86 [0.55-1.35],0.5154333847288234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARSA,Arylsulfatase A,2490,100,1.13 [0.78-1.63],0.5221765553469472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARSB,Arylsulfatase B,2475,101,0.97 [0.71-1.35],0.8765256050598437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ART3,Ecto-ADP-ribosyltransferase 3,2486,99,2.12 [1.38-3.27],0.0006578813207748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ART5,Ecto-ADP-ribosyltransferase 5,2071,82,1.07 [0.77-1.48],0.7005356666608449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARTN,Artemin,2421,99,0.96 [0.64-1.45],0.8515240118064195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASAH1,Acid ceramidase,2133,82,0.84 [0.54-1.32],0.4492238267530098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASAH2,Neutral ceramidase,2463,98,0.98 [0.70-1.36],0.9023452746443512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASGR1,Asialoglycoprotein receptor 1,2463,98,4.28 [2.70-6.80],6.764879221341634e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASGR2,Asialoglycoprotein receptor 2,2148,83,6.23 [3.40-11.40],3.033091081070457e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASPN,Asporin,2138,84,1.93 [1.00-3.71],0.0486058594335002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASPSCR1,Tether containing UBX domain for GLUT4,2136,83,1.08 [0.77-1.51],0.660387454799455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASRGL1,Isoaspartyl peptidase/L-asparaginase,2096,83,0.96 [0.77-1.20],0.7364720091761106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASS1,Argininosuccinate synthase,2068,81,0.89 [0.68-1.15],0.3642162625114836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATF2,Cyclic AMP-dependent transcription factor ATF-2,2414,94,1.14 [0.91-1.45],0.2581970887483527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATF4,Cyclic AMP-dependent transcription factor ATF-4,2063,81,1.17 [0.65-2.08],0.6051953089229634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATG16L1,Autophagy-related protein 16-1,2130,82,1.15 [0.88-1.48],0.3032002251052068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATG4A,Cysteine protease ATG4A,2418,95,1.00 [0.74-1.34],0.9759197032622696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATOX1,Copper transport protein ATOX1,2489,101,1.30 [0.99-1.71],0.0553757216347712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,2068,81,1.43 [1.00-2.03],0.0469286583642158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,2068,81,1.04 [0.55-1.98],0.9033374460385948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,2068,81,1.18 [0.67-2.08],0.5592233476014072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP1B4,Protein ATP1B4,2063,81,0.92 [0.55-1.54],0.7464325461656962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP2B4,Plasma membrane calcium-transporting ATPase 4,2068,81,0.77 [0.49-1.21],0.2534042847547193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP5F1D,"ATP synthase subunit delta, mitochondrial",2068,81,1.11 [0.70-1.74],0.6573951906402804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP5IF1,"ATPase inhibitor, mitochondrial",2496,99,1.00 [0.84-1.18],0.9672022787628032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP5PO,"ATP synthase subunit O, mitochondrial",2414,94,1.04 [0.68-1.59],0.8651526216154608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6AP2,Renin receptor,2418,95,1.40 [0.94-2.10],0.1000857462140339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6V1D,V-type proton ATPase subunit D,2475,101,1.01 [0.54-1.87],0.9764712555411028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6V1F,V-type proton ATPase subunit F,2411,93,1.02 [0.77-1.36],0.8687240185099178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6V1G1,V-type proton ATPase subunit G 1,2096,83,1.18 [0.87-1.60],0.2779368859544198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6V1G2,V-type proton ATPase subunit G 2,2068,81,0.89 [0.68-1.15],0.3594777872502309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATRAID,All-trans retinoic acid-induced differentiation factor,2130,82,3.91 [2.45-6.26],1.247526457865548e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATRN,"Attractin, Isoform 2",2143,83,1.89 [0.58-6.22],0.2922190505658977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATXN10,Ataxin-10,2414,94,1.08 [0.83-1.40],0.5761833209260364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATXN2,Ataxin-2,2071,82,0.84 [0.67-1.06],0.1449409621170646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATXN2L,Ataxin-2-like protein,2136,83,1.03 [0.65-1.61],0.9135254750059836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATXN3,Ataxin-3,2140,84,1.04 [0.74-1.45],0.8261476679597348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AXIN1,Axin-1,2477,100,1.04 [0.86-1.26],0.6629567946913879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AXL,Tyrosine-protein kinase receptor UFO,2486,99,2.03 [1.15-3.58],0.0143620819865827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AZI2,5-azacytidine-induced protein 2,2136,83,1.10 [0.75-1.64],0.6192153604982393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AZU1,Azurocidin,2414,100,1.00 [0.80-1.26],0.9820303265033148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B2M,Beta-2-microglobulin,2143,83,4.04 [2.46-6.66],3.8982069842513176e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,2068,81,2.43 [0.93-6.32],0.0691496898050761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",2096,83,3.00 [1.74-5.16],7.634332495072388e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",2496,99,5.87 [3.27-10.54],2.958568257043593e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B4GAT1,"Beta-1,4-glucuronyltransferase 1",2490,100,1.56 [0.75-3.25],0.2376459321737564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BABAM1,BRISC and BRCA1-A complex member 1,2078,82,0.92 [0.40-2.10],0.8416666239052477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BACH1,Transcription regulator protein BACH1,2477,100,0.95 [0.73-1.22],0.6631198755548554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAG3,BAG family molecular chaperone regulator 3,2462,98,0.83 [0.55-1.25],0.3753700095753433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAG4,BAG family molecular chaperone regulator 4,2078,82,1.15 [0.74-1.81],0.5360399371980711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAG6,Large proline-rich protein BAG6,2437,97,1.17 [0.71-1.92],0.5337107259691378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,2418,95,1.24 [0.98-1.58],0.073661692087157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,2418,95,2.73 [1.85-4.02],3.962145479270346e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BANK1,B-cell scaffold protein with ankyrin repeats,2477,100,0.96 [0.81-1.14],0.6434408940414017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAP18,Chromatin complexes subunit BAP18,2140,84,0.90 [0.65-1.25],0.529431671602574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BATF,Basic leucine zipper transcriptional factor ATF-like,2095,81,1.04 [0.81-1.34],0.759167300117257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAX,Apoptosis regulator BAX,2410,94,1.21 [0.98-1.48],0.0706175128545889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAM,Basal cell adhesion molecule,2490,100,3.23 [1.66-6.30],0.0005853419947863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAN,Brevican core protein,2463,98,0.60 [0.37-0.98],0.0398731502353492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",2138,84,1.50 [0.81-2.80],0.1986829970480159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",2071,82,0.66 [0.38-1.15],0.1423348961352465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCHE,Cholinesterase,2109,82,0.68 [0.31-1.49],0.3389793152060397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL2,Apoptosis regulator Bcl-2,2130,82,1.30 [0.95-1.79],0.1021400416931241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL2L1,Bcl-2-like protein 1,2140,84,0.97 [0.78-1.22],0.8052482819330583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",2477,100,1.58 [0.98-2.54],0.061535000734108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL2L15,Bcl-2-like protein 15,2078,82,1.13 [0.80-1.60],0.4786849281679027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL7A,B-cell CLL/lymphoma 7 protein family member A,2063,81,0.95 [0.67-1.34],0.7517799814097449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL7B,B-cell CLL/lymphoma 7 protein family member B,2133,83,0.98 [0.60-1.63],0.950996965543909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCR,Breakpoint cluster region protein,2477,100,1.03 [0.84-1.26],0.7712370191030606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BDNF,Brain-derived neurotrophic factor,2147,82,0.84 [0.66-1.09],0.1882703910129246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BECN1,Beclin-1,2096,83,1.16 [0.80-1.67],0.4293697452169074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BEX3,Protein BEX3,2063,81,1.08 [0.74-1.57],0.6969208326629854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BGLAP,Osteocalcin,2147,82,1.02 [0.83-1.27],0.8320853755648641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BGN,Biglycan,2417,95,0.97 [0.83-1.12],0.6458489095270242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BHLHE40,Class E basic helix-loop-helix protein 40,2071,82,0.95 [0.69-1.31],0.7640590905985891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,2068,81,1.68 [0.70-4.05],0.2481189944665751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BID,BH3-interacting domain death agonist,2477,100,0.89 [0.67-1.18],0.4078627250852282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BIN2,Bridging integrator 2,2490,100,0.95 [0.78-1.17],0.6510696988488198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BIRC2,Baculoviral IAP repeat-containing protein 2,2418,95,1.12 [0.83-1.52],0.4514825942144171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLMH,Bleomycin hydrolase,2510,102,0.92 [0.54-1.58],0.7737744094564446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLNK,B-cell linker protein,2078,82,0.72 [0.39-1.34],0.2972844350639607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,2071,82,0.93 [0.69-1.25],0.6339399051388908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,2140,84,1.03 [0.59-1.79],0.9179862364683288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLVRB,Flavin reductase,2490,100,0.91 [0.70-1.19],0.4849049477295611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMP10,Bone morphogenetic protein 10,2109,80,2.63 [1.55-4.48],0.0003434697742103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMP4,Bone morphogenetic protein 4,2462,98,1.14 [0.79-1.63],0.4816762014634096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMP6,Bone morphogenetic protein 6,2434,97,1.17 [0.74-1.85],0.4954057046458543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMPER,BMP-binding endothelial regulator protein,2109,80,2.94 [1.64-5.27],0.000292335105998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,2138,84,1.13 [0.60-2.14],0.7033270073279484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,2078,82,1.84 [1.20-2.83],0.0052232418969177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BOC,Brother of CDO,2437,97,3.40 [1.68-6.86],0.0006577556219014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BOLA1,BolA-like protein 1,2071,82,1.40 [1.07-1.83],0.0154689281666494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BOLA2_BOLA2B,BolA-like protein 2,2096,83,1.09 [0.73-1.62],0.6787528490848124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BPIFA2,BPI fold-containing family A member 2,2025,78,0.87 [0.72-1.06],0.1691518884575622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BPIFB1,BPI fold-containing family B member 1,2470,101,0.80 [0.62-1.04],0.1017506102649931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BPIFB2,BPI fold-containing family B member 2,2134,84,0.95 [0.72-1.26],0.7404905980954991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRAP,BRCA1-associated protein,2107,81,1.10 [0.89-1.35],0.365435320605227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRD1,Bromodomain-containing protein 1,2114,81,0.80 [0.37-1.72],0.5657404800671005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRD2,Bromodomain-containing protein 2,2071,82,1.01 [0.53-1.93],0.9763334493232496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRD3,Bromodomain-containing protein 3,2068,81,1.01 [0.65-1.57],0.9699338054391808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRDT,Bromodomain testis-specific protein,2068,81,0.94 [0.52-1.70],0.8321368628186335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRK1,Protein BRICK1,2414,94,1.61 [1.09-2.36],0.0159937698859382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRME1,Break repair meiotic recombinase recruitment factor 1,2071,82,0.88 [0.50-1.53],0.6481741715775176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRSK2,Serine/threonine-protein kinase BRSK2,2136,83,1.08 [0.60-1.94],0.7999506631763613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BSG,Basigin,2501,101,6.63 [3.46-12.71],1.2535080394036473e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BSND,Barttin,2063,81,0.93 [0.46-1.85],0.8257850739001109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,2505,102,2.11 [1.23-3.63],0.0067448043271996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BST2,Bone marrow stromal antigen 2,2505,102,1.19 [0.87-1.61],0.2708757167116707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTC,Probetacellulin,2418,95,0.98 [0.76-1.26],0.8658203300333491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTD,Biotinidase,2143,83,2.24 [0.79-6.35],0.1301667132174457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTLA,B- and T-lymphocyte attenuator,2063,81,0.84 [0.63-1.12],0.2380539920637705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN1A1,Butyrophilin subfamily 1 member A1,2130,83,1.16 [0.70-1.93],0.56693206864129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN2A1,Butyrophilin subfamily 2 member A1,2496,99,4.83 [3.18-7.34],1.3930974926290134e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN3A2,Butyrophilin subfamily 3 member A2,2477,100,2.19 [1.46-3.28],0.0001646465418516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTNL10,Butyrophilin-like protein 10,2063,81,1.20 [0.72-1.99],0.4840732032209581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C19orf12,Protein C19orf12,2414,94,0.76 [0.58-0.99],0.0403721171326297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1GALT1C1,C1GALT1-specific chaperone 1,2068,81,1.52 [1.03-2.23],0.0330870882081969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QA,Complement C1q subcomponent subunit A,2495,101,3.84 [2.12-6.93],8.26157598852016e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",2136,83,0.88 [0.61-1.27],0.5008646609474434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QL2,Complement C1q-like protein 2,2078,82,0.87 [0.54-1.42],0.5832302644979703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,2486,99,1.56 [1.16-2.10],0.0034320598749304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,2109,80,1.11 [0.61-2.04],0.7306049980440887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,2136,83,1.69 [1.02-2.81],0.0422994019011615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,2107,80,0.77 [0.51-1.16],0.2100902349499596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1R,Complement C1r subcomponent,2143,83,0.67 [0.17-2.57],0.5556684011373538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1RL,Complement C1r subcomponent-like protein,2138,83,1.84 [0.65-5.27],0.2534704085261233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1S,Complement C1s subcomponent,2143,83,1.10 [0.39-3.11],0.8569025713030961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C2,Complement C2,2485,99,1.50 [0.65-3.50],0.3439108481322955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C2CD2L,Phospholipid transfer protein C2CD2L,2411,93,1.34 [0.90-2.00],0.1477232565401087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C2orf69,UPF0565 protein C2orf69,2095,81,0.97 [0.64-1.47],0.8810899635443876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C3,Complement C3,2028,76,0.86 [0.50-1.51],0.6084772801142551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C4BPB,C4b-binding protein beta chain,2489,101,0.86 [0.56-1.32],0.49420255692052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C5,Complement C5,2143,83,1.65 [0.45-6.01],0.4454176556044112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C7,Complement component C7,2086,82,2.94 [1.77-4.88],3.128623383941763e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C7orf50,Uncharacterized protein C7orf50,2140,84,0.47 [0.13-1.71],0.2505196590446171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C8B,Complement component C8 beta chain,2143,83,1.13 [0.56-2.30],0.7284857737403937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C9,Complement component C9,2148,83,1.46 [1.02-2.09],0.0386501381519824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C9orf40,Uncharacterized protein C9orf40,2130,82,1.05 [0.81-1.35],0.724242023604061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA1,Carbonic anhydrase 1,2440,98,0.89 [0.66-1.20],0.443670819819938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA11,Carbonic anhydrase-related protein 11,2418,95,1.02 [0.59-1.78],0.933054186906655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA12,Carbonic anhydrase 12,2475,101,5.16 [3.46-7.71],8.935621271862618e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA13,Carbonic anhydrase 13,2460,98,0.96 [0.80-1.14],0.6319046216129809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA14,Carbonic anhydrase 14,2500,102,2.55 [1.69-3.85],8.913807870937501e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA2,Carbonic anhydrase 2,2483,100,1.01 [0.79-1.29],0.953118871093114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA3,Carbonic anhydrase 3,2509,102,1.66 [1.28-2.14],0.0001224388820467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA4,Carbonic anhydrase 4,2510,102,2.27 [1.23-4.20],0.0085630255819485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",2437,97,0.98 [0.82-1.18],0.8411640783236289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA6,Carbonic anhydrase 6,2482,99,0.77 [0.58-1.02],0.0642180729819448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA7,Carbonic anhydrase 7,2114,81,1.26 [0.77-2.05],0.3532278082729643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA8,Carbonic anhydrase-related protein,2078,82,1.00 [0.41-2.39],0.99285508853507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA9,Carbonic anhydrase 9,2500,102,1.40 [1.04-1.88],0.0267234092683876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CABP2,Calcium-binding protein 2,2095,81,0.90 [0.62-1.30],0.5649663184388328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,2071,82,0.86 [0.44-1.69],0.6679665598031967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,2068,81,1.04 [0.75-1.43],0.8310859444135558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,2071,82,0.90 [0.62-1.31],0.5835011802566854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,2136,83,1.03 [0.80-1.33],0.8159856578549354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACYBP,Calcyclin-binding protein,2108,80,1.03 [0.82-1.28],0.8241670246656863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CADPS,Calcium-dependent secretion activator 1,2095,81,0.87 [0.52-1.47],0.6080770351236086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALB1,Calbindin,2475,101,2.22 [1.59-3.11],3.125498423326141e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALB2,Calretinin,2414,94,2.11 [1.29-3.45],0.0029959516746579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCA,Calcitonin,2460,97,1.39 [1.11-1.75],0.0042565653058045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCB,Calcitonin gene-related peptide 2,2140,84,1.76 [1.34-2.32],5.3698340678018415e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,2491,102,1.03 [0.87-1.22],0.7419771178375811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,2096,83,1.03 [0.77-1.38],0.8481356528232922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALY,Neuron-specific vesicular protein calcyon,2068,81,1.41 [0.84-2.35],0.188763157297789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,2418,95,1.50 [1.03-2.19],0.0343000696877898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,2095,81,1.21 [0.82-1.77],0.3398415245644429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,2136,83,1.09 [0.89-1.34],0.4001959205654075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CANT1,Soluble calcium-activated nucleotidase 1,2475,99,1.53 [0.67-3.47],0.3125786671718187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAPG,Macrophage-capping protein,2462,102,1.24 [0.92-1.66],0.1524234463345049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAPN3,Calpain-3,2133,83,1.40 [0.88-2.22],0.1544427307244717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAPS,Calcyphosin,2140,84,1.07 [0.89-1.28],0.4595607585735743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CARHSP1,Calcium-regulated heat-stable protein 1,2414,94,0.90 [0.62-1.29],0.5494385586133139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASC3,Protein CASC3,2095,81,0.90 [0.53-1.54],0.7085644418107688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP1,Caspase-1,2414,94,0.82 [0.62-1.07],0.1466129606537987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP10,Caspase-10,2414,94,1.13 [0.87-1.46],0.3714994695048381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP2,Caspase-2,2477,100,1.04 [0.80-1.35],0.7663463120892736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP3,Caspase-3,2510,102,1.02 [0.83-1.25],0.8749909333923263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP4,Caspase-4,2114,81,0.99 [0.87-1.13],0.8790954098766998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP7,Caspase-7,2140,84,1.02 [0.78-1.34],0.8803038046846019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP8,Caspase-8,2494,102,0.98 [0.74-1.31],0.913385887760938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP9,Caspase-9,2078,82,0.96 [0.66-1.40],0.8393545663630096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASQ2,Calsequestrin-2,2068,81,0.98 [0.58-1.65],0.9438528743019526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAT,Catalase,2111,83,1.05 [0.72-1.55],0.7974344806666156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBLIF,Cobalamin binding intrinsic factor,2483,101,1.29 [1.07-1.57],0.0087678715797224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBLN1,Cerebellin-1,2071,82,0.89 [0.68-1.16],0.3870025946964949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBLN4,Cerebellin-4,2500,102,0.58 [0.35-0.97],0.036541922841925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBS,Cystathionine beta-synthase,2096,83,0.72 [0.47-1.08],0.110652202555466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBX2,Chromobox protein homolog 2,2068,81,1.10 [0.63-1.91],0.7490610306992045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,2463,98,1.13 [0.88-1.44],0.3307621999857419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCAR2,Cell cycle and apoptosis regulator protein 2,2140,84,1.03 [0.72-1.48],0.8681677471757238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC134,Coiled-coil domain-containing protein 134,2133,83,1.21 [0.78-1.88],0.4009108276593971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC28A,Coiled-coil domain-containing protein 28A,2095,81,0.51 [0.26-1.02],0.0562370941067204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC50,Coiled-coil domain-containing protein 50,2136,83,0.80 [0.57-1.12],0.1915289641875525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC80,Coiled-coil domain-containing protein 80,2483,101,1.77 [1.19-2.64],0.0048623964391668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,2096,83,1.40 [1.05-1.86],0.0206566248242295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL11,Eotaxin,2506,101,2.20 [1.36-3.56],0.0012499755944253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL13,C-C motif chemokine 13,2503,101,1.02 [0.79-1.33],0.8730827523797824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL14,C-C motif chemokine 14,2476,99,2.46 [1.74-3.50],4.258870384759271e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL15,C-C motif chemokine 15,2510,102,2.67 [1.94-3.68],2.1758348887408198e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL16,C-C motif chemokine 16,2510,102,1.55 [1.11-2.15],0.0094593402948223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL17,C-C motif chemokine 17,2480,99,1.03 [0.85-1.24],0.7844812781109077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL18,C-C motif chemokine 18,2452,99,1.20 [0.96-1.51],0.1139755305151657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL19,C-C motif chemokine 19,2505,102,1.05 [0.94-1.18],0.3682601754160053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL2,C-C motif chemokine 2,2462,98,1.10 [0.78-1.55],0.5868480071936417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL20,C-C motif chemokine 20,2506,101,1.00 [0.83-1.21],0.9691253138370006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL21,C-C motif chemokine 21,2496,99,1.56 [1.23-1.99],0.0002919999231165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL22,C-C motif chemokine 22,2461,98,1.27 [0.92-1.74],0.1446371938061373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL23,C-C motif chemokine 23,2496,99,1.69 [1.14-2.48],0.0082849837862694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL24,C-C motif chemokine 24,2492,99,1.07 [0.87-1.32],0.5274454887956789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL25,C-C motif chemokine 25,2506,101,2.35 [1.61-3.41],7.908113460696612e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL26,C-C motif chemokine 26,2477,100,0.83 [0.67-1.02],0.0758464548125205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL27,C-C motif chemokine 27,2483,101,0.92 [0.69-1.23],0.5743466412294895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL28,C-C motif chemokine 28,2469,99,1.13 [0.84-1.51],0.4120812363837773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL3,C-C motif chemokine 3,2477,100,1.41 [1.16-1.71],0.0006401679177332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL4,C-C motif chemokine 4,2488,99,0.98 [0.75-1.29],0.9026598193160394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL5,C-C motif chemokine 5,2486,99,1.08 [0.91-1.29],0.3826625287254629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL7,C-C motif chemokine 7,2477,100,1.43 [1.06-1.93],0.0175471927438755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL8,C-C motif chemokine 8,2499,102,1.22 [0.89-1.65],0.211440530248795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN1,CCN family member 1,2474,101,1.02 [0.79-1.31],0.9069656394676572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN2,CCN family member 2,2484,99,1.02 [0.74-1.42],0.8963357316520614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN3,CCN family member 3,2503,102,3.52 [2.48-5.01],2.700984892206589e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN4,CCN family member 4,2500,102,3.22 [2.23-4.67],5.821293089332316e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN5,CCN family member 5,2490,100,3.67 [2.53-5.34],9.837934055502807e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCND2,G1/S-specific cyclin-D2,2114,81,0.95 [0.54-1.66],0.8582942501692872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCNE1,G1/S-specific cyclin-E1,2078,82,1.20 [0.98-1.46],0.0758598271007015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCS,Copper chaperone for superoxide dismutase,2463,98,0.73 [0.50-1.08],0.1129325547983221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCT5,T-complex protein 1 subunit epsilon,2418,95,0.90 [0.58-1.40],0.6397356450818799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD101,Immunoglobulin superfamily member 2,2130,82,1.26 [0.82-1.92],0.2890530695652169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD109,CD109 antigen,2490,100,1.77 [1.09-2.89],0.0211563861529109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD14,Monocyte differentiation antigen CD14,2442,97,2.25 [1.55-3.25],1.7237401261235713e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD160,CD160 antigen,2506,101,2.43 [1.80-3.28],6.465916069789131e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,2486,99,1.49 [1.02-2.17],0.0387927347922835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD164,Sialomucin core protein 24,2490,100,2.26 [1.50-3.41],8.962531293124538e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD164L2,CD164 sialomucin-like 2 protein,2095,81,0.93 [0.51-1.71],0.825561853270937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD177,CD177 antigen,2482,100,0.94 [0.83-1.07],0.3350177747316535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD1C,T-cell surface glycoprotein CD1c,2489,101,0.47 [0.24-0.90],0.0232830246606494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD2,T-cell surface antigen CD2,2068,81,1.36 [0.95-1.95],0.0929660754095379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD200,OX-2 membrane glycoprotein,2477,100,2.08 [1.28-3.40],0.0033841970362245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD200R1,Cell surface glycoprotein CD200 receptor 1,2471,100,1.20 [0.73-1.96],0.4789555103760249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD207,C-type lectin domain family 4 member K,2434,100,2.47 [1.63-3.74],2.0409273312635897e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD209,CD209 antigen,2491,100,1.13 [0.70-1.82],0.620377710064123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD22,B-cell receptor CD22,2506,101,1.03 [0.70-1.51],0.8802583158654746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD226,CD226 antigen,2078,82,1.53 [0.93-2.52],0.0921547689245979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD244,Natural killer cell receptor 2B4,2506,101,2.97 [1.72-5.13],9.96623232276458e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD248,Endosialin,2147,82,1.05 [0.64-1.72],0.8560085737224108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD27,CD27 antigen,2489,101,3.71 [2.74-5.03],3.286279790396033e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD274,Programmed cell death 1 ligand 1,2463,98,2.31 [1.67-3.19],3.772195716421474e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD276,CD276 antigen,2481,99,6.36 [4.33-9.33],3.5103952173127794e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD28,T-cell-specific surface glycoprotein CD28,2418,95,2.03 [1.32-3.11],0.001190922564911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD2AP,CD2-associated protein,2483,101,0.96 [0.73-1.26],0.7612288446027704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300A,CMRF35-like molecule 8,2109,80,3.07 [1.61-5.89],0.0007016760729341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300C,CMRF35-like molecule 6,2505,102,4.31 [2.81-6.61],2.4221516533384862e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300E,CMRF35-like molecule 2,2493,102,3.24 [2.33-4.51],2.379431298090672e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300LF,CMRF35-like molecule 1,2500,102,1.74 [1.31-2.32],0.0001553339119103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300LG,CMRF35-like molecule 9,2490,100,2.41 [1.63-3.55],9.524959225622744e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD302,CD302 antigen,2475,101,4.49 [3.10-6.50],2.0299102984069863e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD33,Myeloid cell surface antigen CD33,2489,101,0.92 [0.74-1.14],0.4572173477255506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD34,Hematopoietic progenitor cell antigen CD34,2500,101,1.87 [0.94-3.71],0.0729252523663102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD36,Platelet glycoprotein 4,2078,82,1.44 [0.91-2.26],0.1157512669786487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,2475,101,3.74 [2.42-5.77],2.662208309019029e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD3D,T-cell surface glycoprotein CD3 delta chain,2071,82,1.19 [0.60-2.36],0.6236516351916812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD3E,T-cell surface glycoprotein CD3 epsilon chain,2114,81,1.02 [0.54-1.94],0.9473041435312256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD3G,T-cell surface glycoprotein CD3 gamma chain,2078,82,1.07 [0.87-1.32],0.5317406331335004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD4,T-cell surface glycoprotein CD4,2473,99,2.13 [1.42-3.21],0.0002617904408024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD40,Tumor necrosis factor receptor superfamily member 5,2484,99,1.66 [1.23-2.23],0.000921783238148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD40LG,CD40 ligand,2506,101,0.90 [0.72-1.13],0.3703865505682445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD46,Membrane cofactor protein,2467,99,3.26 [2.10-5.05],1.2543074974800397e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD48,CD48 antigen,2492,99,2.81 [1.65-4.79],0.0001463347655236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD5,T-cell surface glycoprotein CD5,2499,102,2.40 [1.69-3.40],9.373037889871372e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD55,Complement decay-accelerating factor,2388,95,3.14 [2.03-4.84],2.413712010939519e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD58,Lymphocyte function-associated antigen 3,2476,99,2.15 [0.79-5.88],0.1348197499950036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD59,CD59 glycoprotein,2375,100,5.32 [3.32-8.53],3.9325617667885055e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD5L,CD5 antigen-like,2132,83,1.48 [0.97-2.24],0.0656980462091625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD6,T-cell differentiation antigen CD6,2501,101,1.05 [0.75-1.48],0.7731378460692463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD63,CD63 antigen,2462,98,0.95 [0.66-1.38],0.8021416412537403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD69,Early activation antigen CD69,2469,100,0.97 [0.79-1.19],0.7731658687559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD7,T-cell antigen CD7,2073,82,2.36 [1.65-3.38],2.672471838862508e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD70,CD70 antigen,2477,100,1.55 [1.05-2.28],0.0268717494037381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD72,B-cell differentiation antigen CD72,2109,80,1.89 [1.19-2.99],0.0068144489313296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD74,HLA class II histocompatibility antigen gamma chain,2505,102,5.70 [3.77-8.62],1.5242843495882995e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,2506,101,2.44 [1.78-3.34],2.413185811640444e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD80,T-lymphocyte activation antigen CD80,2138,84,2.42 [1.47-3.98],0.0005365730236027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD82,CD82 antigen,2114,81,1.01 [0.63-1.61],0.969948492065617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD83,CD83 antigen,2477,100,2.87 [1.90-4.35],6.365361017399799e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD84,SLAM family member 5,2477,100,1.25 [0.71-2.22],0.4360459502108867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD86,T-lymphocyte activation antigen CD86,2130,82,0.97 [0.47-2.02],0.9380500033897256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,2505,102,1.38 [1.02-1.85],0.0337357376034882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD93,Complement component C1q receptor,2404,93,2.91 [1.84-4.61],5.49681734967032e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD99,CD99 antigen,2490,100,5.90 [2.87-12.15],1.424839659891796e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD99L2,CD99 antigen-like protein 2,2490,100,4.12 [2.16-7.87],1.7729707491589953e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDA,Cytidine deaminase,2136,84,0.94 [0.62-1.44],0.7900742243875359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDAN1,Codanin-1,2140,84,0.56 [0.20-1.56],0.2655076088144658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC123,Cell division cycle protein 123 homolog,2063,81,0.73 [0.49-1.09],0.1241278325854924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC25A,M-phase inducer phosphatase 1,2063,81,1.05 [0.59-1.87],0.8753379828019457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC26,Anaphase-promoting complex subunit CDC26,2125,81,1.29 [0.93-1.79],0.1231364895868288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC27,Cell division cycle protein 27 homolog,2418,95,1.00 [0.75-1.34],0.9907099931763584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC37,Hsp90 co-chaperone Cdc37,2489,101,0.99 [0.80-1.23],0.926759238593338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC42BPB,Serine/threonine-protein kinase MRCK beta,2130,82,1.18 [0.96-1.46],0.1172498861413774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDCP1,CUB domain-containing protein 1,2463,98,1.23 [0.92-1.65],0.1610276714595372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH1,Cadherin-1,2385,94,2.27 [1.71-3.00],1.024698173752615e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH15,Cadherin-15,2502,101,1.35 [1.11-1.64],0.0022111809184177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH17,Cadherin-17,2483,101,1.46 [1.18-1.82],0.0005253304395843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH2,Cadherin-2,2483,101,1.28 [0.82-1.98],0.2795086438622637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH22,Cadherin-22,2114,81,0.98 [0.45-2.15],0.9665230590979468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH23,Cadherin-23,2140,84,0.92 [0.40-2.12],0.8503942194729497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH3,Cadherin-3,2505,102,3.32 [2.33-4.72],3.017565409840615e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH4,Cadherin-4,2071,82,1.32 [0.90-1.93],0.1524323557183472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH5,Cadherin-5,2510,102,1.98 [1.16-3.40],0.012852446974051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH6,Cadherin-6,2483,101,1.89 [1.27-2.82],0.0017606600213775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDHR1,Cadherin-related family member 1,2414,94,1.17 [0.80-1.73],0.4220282138925278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDHR2,Cadherin-related family member 2,2475,101,0.83 [0.65-1.07],0.1493598803618546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDHR5,Cadherin-related family member 5,2483,101,1.04 [0.66-1.64],0.8546371322081443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDK1,Cyclin-dependent kinase 1,2063,81,1.40 [0.82-2.39],0.2237711613726848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,2136,83,1.04 [0.71-1.51],0.849375983179847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDKL5,Cyclin-dependent kinase-like 5,2071,82,0.98 [0.65-1.49],0.9397119693328604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDKN1A,Cyclin-dependent kinase inhibitor 1,2475,101,1.11 [0.94-1.31],0.2372320675863969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,2475,101,0.99 [0.81-1.20],0.8950184172638852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDNF,Cerebral dopamine neurotrophic factor,2475,101,1.72 [1.38-2.16],2.099575186972289e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,2488,99,2.66 [1.37-5.18],0.0040092079720821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDSN,Corneodesmosin,2495,101,1.69 [1.16-2.45],0.0061556109324186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,2480,100,0.73 [0.40-1.34],0.3118870509737535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,2130,82,0.95 [0.72-1.24],0.6862968730961332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,2114,81,0.92 [0.67-1.25],0.5906453201512922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,2130,82,1.47 [0.95-2.28],0.0817625247019701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,2114,81,1.08 [0.71-1.64],0.7121420369727984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,2477,100,1.19 [0.99-1.45],0.0706916350136288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,2418,95,1.36 [0.96-1.91],0.0837028882788393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,2390,92,1.34 [1.04-1.74],0.0258346700372949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,2147,82,1.54 [0.93-2.55],0.0960126804292619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,2437,97,1.48 [1.03-2.12],0.0320859021594974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEBPA,CCAAT/enhancer-binding protein alpha,2078,82,1.01 [0.54-1.89],0.96510223532835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEBPB,CCAAT/enhancer-binding protein beta,2437,97,0.71 [0.43-1.18],0.1899419434277014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CELA2A,Chymotrypsin-like elastase family member 2A,2147,82,0.83 [0.63-1.09],0.1813219639838405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CELA3A,Chymotrypsin-like elastase family member 3A,2506,102,0.88 [0.68-1.12],0.299141983419661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,2109,80,2.45 [1.30-4.63],0.0056241001143659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEMIP2,Cell surface hyaluronidase,2078,82,1.66 [1.07-2.57],0.0227066244388674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEND1,Cell cycle exit and neuronal differentiation protein 1,2071,82,1.08 [0.77-1.52],0.651081915742924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CENPF,Centromere protein F,2114,81,1.07 [0.73-1.58],0.7149336594021962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CENPJ,Centromere protein J,2114,81,1.10 [0.82-1.48],0.5276202693044758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP112,Centrosomal protein of 112 kDa,2068,81,0.91 [0.53-1.57],0.7298454404572823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP152,Centrosomal protein of 152 kDa,2063,81,1.75 [1.21-2.54],0.0030999212682505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP164,Centrosomal protein of 164 kDa,2421,99,1.09 [0.86-1.37],0.4848109304378544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP170,Centrosomal protein of 170 kDa,2096,83,1.22 [0.91-1.64],0.1784559192803587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP20,Centrosomal protein 20,2418,95,1.06 [0.83-1.35],0.6228634215589159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP290,Centrosomal protein of 290 kDa,2114,81,1.11 [0.79-1.57],0.5524461954214568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP350,Centrosome-associated protein 350,2063,81,1.51 [1.08-2.11],0.0163992785086825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP43,Centrosomal protein 43,2420,94,0.94 [0.71-1.24],0.6573066298936914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP85,Centrosomal protein of 85 kDa,2418,95,1.03 [0.78-1.36],0.8501986981414219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CERT,Ceramide transfer protein,2414,94,1.01 [0.74-1.39],0.9274468640898912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CES1,Liver carboxylesterase 1,2489,100,0.88 [0.74-1.05],0.1663297932724163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CES2,Cocaine esterase,2475,101,1.56 [1.18-2.05],0.0015374274971573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CES3,Carboxylesterase 3,2475,101,0.86 [0.64-1.14],0.2928852786966406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CETN2,Centrin-2,2414,94,1.10 [0.84-1.44],0.4981905753747542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CETN3,Centrin-3,2130,82,0.92 [0.67-1.24],0.5721544303889312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFB,Complement factor B,2099,81,1.61 [0.84-3.10],0.1514600542226072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFC1,Cryptic protein,2418,95,1.50 [1.14-1.98],0.0039389273034717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFD,Complement factor D,2143,83,4.37 [2.55-7.48],7.655358351171483e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFH,Complement factor H,2003,77,1.70 [0.64-4.53],0.2914871834357767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFHR2,Complement factor H-related protein 2,2125,81,1.37 [0.92-2.05],0.1212912634418027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFHR4,Complement factor H-related protein 4,2140,83,0.79 [0.60-1.04],0.0886458368387839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFHR5,Complement factor H-related protein 5,2115,81,1.43 [0.85-2.39],0.1742987850390865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFI,Complement factor I,2143,83,1.82 [0.62-5.35],0.2774350092417913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFP,Properdin,2143,83,0.36 [0.13-0.99],0.0480240986679857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGA,Glycoprotein hormones alpha chain,2490,100,1.46 [1.14-1.87],0.0026227898040709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,2148,83,1.33 [0.75-2.34],0.3291233552294724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGN,Cingulin,2095,81,0.75 [0.40-1.40],0.3701160529128711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGREF1,Cell growth regulator with EF hand domain protein 1,2483,101,2.63 [1.89-3.65],7.498562871334767e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,2418,95,1.19 [0.89-1.59],0.2467450035080565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHAD,Chondroadherin,2109,80,0.49 [0.34-0.72],0.0002175683656017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",2140,84,3.14 [2.14-4.59],4.2600696309852225e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHCHD6,MICOS complex subunit MIC25,2133,83,2.32 [1.37-3.95],0.0018751489519936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHEK2,Serine/threonine-protein kinase Chk2,2437,97,0.81 [0.47-1.39],0.4371228803702577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHGA,Chromogranin-A,2147,82,1.38 [1.19-1.60],2.3980995275625764e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHGB,Secretogranin-1,2497,101,3.10 [2.29-4.20],2.569512390386373e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHI3L1,Chitinase-3-like protein 1,2425,98,1.61 [1.35-1.92],9.693792219967293e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHIT1,Chitotriosidase-1,2486,100,1.01 [0.90-1.15],0.8223577410170164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHL1,Neural cell adhesion molecule L1-like protein,2480,97,1.42 [0.84-2.42],0.1935554018061327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHM,Rab proteins geranylgeranyltransferase component A 1,2095,81,1.01 [0.70-1.45],0.9577868435675584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHMP1A,Charged multivesicular body protein 1a,2463,98,1.08 [0.84-1.38],0.5505334453397732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHMP6,Charged multivesicular body protein 6,2138,84,1.01 [0.70-1.48],0.9440751168981532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHP1,Calcineurin B homologous protein 1,2071,82,0.87 [0.62-1.21],0.4001693151391958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHRDL1,Chordin-like protein 1,2492,99,4.20 [2.69-6.55],2.4353564906940183e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHRDL2,Chordin-like protein 2,2483,101,0.71 [0.50-1.02],0.0624870751514367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHRM1,Muscarinic acetylcholine receptor M1,2095,81,1.02 [0.59-1.78],0.931391403270866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CIAPIN1,Anamorsin,2489,101,1.14 [0.85-1.54],0.3772756378618643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CILP,Cartilage intermediate layer protein 1,2147,82,2.01 [1.43-2.85],7.223970313262151e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CINP,Cyclin-dependent kinase 2-interacting protein,2114,81,0.96 [0.59-1.56],0.8565432070406616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CIRBP,Cold-inducible RNA-binding protein,2130,82,1.06 [0.84-1.35],0.6101325911829154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CIT,Citron Rho-interacting kinase,2095,81,1.19 [0.77-1.82],0.4350504453157544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKAP4,Cytoskeleton-associated protein 4,2494,101,3.70 [2.76-4.97],2.365404741561504e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKB,Creatine kinase B-type,2147,82,2.07 [1.54-2.77],1.112807956322156e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",2472,99,1.17 [0.88-1.54],0.2756520239613446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLASP1,CLIP-associating protein 1,2063,81,0.93 [0.68-1.26],0.6296913246459159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLC,Galectin-10,2480,101,1.29 [1.00-1.66],0.047939814308972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC10A,C-type lectin domain family 10 member A,2463,98,2.21 [1.37-3.56],0.0011700691503705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC11A,C-type lectin domain family 11 member A,2487,99,1.34 [0.94-1.92],0.1086838411527166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC12A,C-type lectin domain family 12 member A,2078,82,2.14 [0.76-6.04],0.1516973972619636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC14A,C-type lectin domain family 14 member A,2490,100,3.13 [2.02-4.85],3.520246708844133e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC1A,C-type lectin domain family 1 member A,2437,97,2.31 [1.50-3.57],0.000162716785228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC1B,C-type lectin domain family 1 member B,2505,102,1.02 [0.85-1.23],0.8002514106052966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC2L,C-type lectin domain family 2 member L,2095,81,0.90 [0.56-1.46],0.6669103445671858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC3B,Tetranectin,2087,81,0.24 [0.10-0.55],0.0007383492900918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4A,C-type lectin domain family 4 member A,2477,100,0.51 [0.32-0.79],0.0026224769078902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4C,C-type lectin domain family 4 member C,2477,100,0.68 [0.48-0.97],0.0349513566003465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4D,C-type lectin domain family 4 member D,2477,100,1.60 [1.25-2.05],0.0002115583598759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4G,C-type lectin domain family 4 member G,2477,100,1.49 [0.88-2.52],0.1379268266587197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4M,C-type lectin domain family 4 member M,2144,82,0.77 [0.49-1.22],0.264051701190017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC5A,C-type lectin domain family 5 member A,2476,101,3.08 [1.88-5.02],6.896070501591904e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC6A,C-type lectin domain family 6 member A,2418,95,1.68 [1.18-2.40],0.0037229111289831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC7A,C-type lectin domain family 7 member A,2506,101,2.28 [1.59-3.26],6.773104740414088e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLGN,Calmegin,2095,81,1.14 [0.71-1.81],0.590502389539538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLIC5,Chloride intracellular channel protein 5,2095,81,1.16 [0.66-2.05],0.6021158404600713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLINT1,Clathrin interactor 1,2063,81,0.78 [0.44-1.38],0.3956260289106749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLIP2,CAP-Gly domain-containing linker protein 2,2477,100,1.10 [0.93-1.30],0.2624123700291408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLMP,CXADR-like membrane protein,2500,102,7.60 [4.12-14.02],8.761544540853205e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLNS1A,Methylosome subunit pICln,2095,81,0.85 [0.43-1.66],0.6364323872886741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",2460,97,1.18 [0.98-1.43],0.0859787875879554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLPS,Colipase,2485,100,0.94 [0.75-1.16],0.5582215918298111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSPN,Claspin,2411,93,0.85 [0.46-1.55],0.5952819775379681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSTN1,Calsyntenin-1,2414,94,1.10 [0.79-1.52],0.5760984625339538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSTN2,Calsyntenin-2,2506,101,1.60 [1.13-2.27],0.008134351425023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSTN3,Calsyntenin-3,2140,84,1.42 [0.74-2.69],0.2899066271992802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLTA,Clathrin light chain A,2437,97,0.90 [0.59-1.36],0.6029690016661385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLU,Clusterin,2143,83,1.63 [0.74-3.60],0.2290151378048011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLUL1,Clusterin-like protein 1,2481,101,1.14 [0.79-1.64],0.4995546222429428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CMC1,COX assembly mitochondrial protein homolog,2138,84,1.04 [0.81-1.32],0.7778502433186327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CMIP,C-Maf-inducing protein,2133,83,1.11 [0.86-1.44],0.4175375283477273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNDP1,Beta-Ala-His dipeptidase,2486,99,1.23 [0.85-1.78],0.2797016040647017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNGB3,Cyclic nucleotide-gated cation channel beta-3,2071,82,1.25 [0.94-1.67],0.1277283158501205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",2089,83,1.05 [0.79-1.39],0.7489722729796451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNPY2,Protein canopy homolog 2,2437,97,0.92 [0.67-1.26],0.5930641202113647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNPY4,Protein canopy homolog 4,2475,101,1.09 [0.85-1.38],0.5004763629228189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNST,Consortin,2483,101,0.94 [0.80-1.11],0.4698404092533164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTF,Ciliary neurotrophic factor,2071,82,0.76 [0.40-1.44],0.4045749335319062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN1,Contactin-1,2510,102,1.98 [1.06-3.68],0.031131965826524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN2,Contactin-2,2500,102,1.41 [0.98-2.03],0.0667903484656129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN3,Contactin-3,2490,100,1.50 [0.84-2.66],0.1703478127321263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN4,Contactin-4,2490,100,2.06 [1.03-4.14],0.0413589564339511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN5,Contactin-5,2491,100,0.78 [0.49-1.23],0.2777958938546345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTNAP2,Contactin-associated protein-like 2,2477,100,1.51 [1.07-2.13],0.0204950758305037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTNAP4,Contactin-associated protein-like 4,2095,81,0.93 [0.74-1.17],0.5411333113282244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COCH,Cochlin,2138,84,0.86 [0.55-1.35],0.5196661784697076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL15A1,Collagen alpha-1(XV) chain,2147,82,1.94 [1.03-3.66],0.0413379553009379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL18A1,Collagen alpha-1(XVIII) chain,2483,101,9.69 [5.41-17.37],2.3785860018338352e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL1A1,Collagen alpha-1(I) chain,2510,102,0.83 [0.41-1.67],0.6019435653648579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL24A1,Collagen alpha-1(XXIV) chain,2130,82,1.58 [1.07-2.34],0.0229252990085094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL28A1,Collagen alpha-1(XXVIII) chain,2095,81,1.12 [0.87-1.44],0.370511123048998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL2A1,Collagen alpha-1(II) chain,2096,83,0.96 [0.73-1.25],0.739318510596903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL3A1,Collagen alpha-1(III) chain,2147,82,1.31 [0.54-3.17],0.549376426195292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL4A1,Collagen alpha-1(IV) chain,2483,101,1.98 [1.45-2.71],1.8877828576626008e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL4A4,Collagen alpha-4(IV) chain,2111,81,0.76 [0.52-1.12],0.1645708366751216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL5A1,Collagen alpha-1(V) chain,2109,80,1.55 [1.03-2.35],0.0377935501237436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL6A3,Collagen alpha-3(VI) chain,2510,102,4.24 [3.07-5.84],1.4635789591903342e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL9A1,Collagen alpha-1(IX) chain,2477,100,0.94 [0.67-1.32],0.7200182496548989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL9A2,Collagen alpha-2(IX) chain,2114,81,1.19 [0.74-1.91],0.4795823289145856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COLEC12,Collectin-12,2481,99,7.14 [4.55-11.20],1.1729851105086457e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COMMD1,COMM domain-containing protein 1,2096,83,1.28 [0.88-1.84],0.1919404081154778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COMMD9,COMM domain-containing protein 9,2133,83,1.15 [0.76-1.75],0.5031623896762805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COMP,Cartilage oligomeric matrix protein,2444,98,0.88 [0.54-1.43],0.6000390790460437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COMT,Catechol O-methyltransferase,2415,93,0.96 [0.75-1.21],0.7163137449735507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COPB2,Coatomer subunit beta',2068,81,0.99 [0.59-1.68],0.9762044968224752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COPE,Coatomer subunit epsilon,2414,94,0.92 [0.61-1.40],0.7049174402862777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",2096,83,1.01 [0.59-1.75],0.957733328349126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CORO1A,Coronin-1A,2434,99,1.04 [0.85-1.28],0.7066670640608634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CORO6,Coronin-6,2071,82,1.41 [0.89-2.24],0.1414464027535619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",2475,101,1.37 [1.07-1.75],0.0124236292758004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COX6B1,Cytochrome c oxidase subunit 6B1,2138,84,1.35 [0.70-2.58],0.3683444935352555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPA1,Carboxypeptidase A1,2510,102,0.86 [0.68-1.08],0.1812835403994251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPA2,Carboxypeptidase A2,2500,100,1.46 [1.17-1.81],0.0006467722764971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPA4,Carboxypeptidase A4,2053,78,1.12 [0.68-1.86],0.6495568245630611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPB1,Carboxypeptidase B,2510,102,0.86 [0.66-1.11],0.2445819084522715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPB2,Carboxypeptidase B2,2139,83,1.24 [0.48-3.20],0.6497496432420937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPE,Carboxypeptidase E,2476,101,0.77 [0.50-1.19],0.2439264715972466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPLX2,Complexin-2,2063,81,0.74 [0.35-1.55],0.4247847930125393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPM,Carboxypeptidase M,2493,102,2.31 [1.46-3.67],0.0003831960697932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",2078,82,0.70 [0.31-1.57],0.380380669205686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPPED1,Serine/threonine-protein phosphatase CPPED1,2505,102,0.84 [0.64-1.11],0.2221982077116629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPQ,Carboxypeptidase Q,2145,82,2.33 [1.36-4.00],0.0021103264076613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPTP,Ceramide-1-phosphate transfer protein,2068,81,1.17 [0.69-1.99],0.5513381723611268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPVL,Probable serine carboxypeptidase CPVL,2497,102,2.55 [1.61-4.03],6.371506510250036e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPXM1,Probable carboxypeptidase X1,2489,101,0.93 [0.72-1.20],0.5794609172924281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPXM2,Inactive carboxypeptidase-like protein X2,2138,84,4.53 [2.31-8.89],1.1236622277734789e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CR1,Complement receptor type 1,2143,83,1.99 [1.17-3.38],0.0105620388340911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CR2,Complement receptor type 2,2486,99,1.50 [1.07-2.09],0.0183308800837654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,2418,95,1.10 [0.89-1.35],0.3792891684194944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRADD,Death domain-containing protein CRADD,2460,97,1.07 [0.83-1.39],0.6089759307811347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CREB3,Cyclic AMP-responsive element-binding protein 3,2063,81,1.06 [0.73-1.53],0.771911325063227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CREBZF,CREB/ATF bZIP transcription factor,2063,81,1.25 [0.53-2.96],0.6063223460506921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CREG1,Protein CREG1,2460,101,0.78 [0.51-1.20],0.26679386648041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRELD1,Protein disulfide isomerase CRELD1,2109,80,2.25 [1.31-3.86],0.0032676379928533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRELD2,Protein disulfide isomerase CRELD2,2492,99,1.42 [1.04-1.96],0.028952132585471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRH,Corticoliberin,2415,94,0.78 [0.62-0.98],0.0313071540378385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRHBP,Corticotropin-releasing factor-binding protein,2481,99,2.27 [1.21-4.24],0.0104032557904214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRHR1,Corticotropin-releasing factor receptor 1,2437,97,0.84 [0.62-1.15],0.2878434502285542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRIM1,Cysteine-rich motor neuron 1 protein,2496,99,10.03 [4.95-20.31],1.5351476025897076e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRIP2,Cysteine-rich protein 2,2463,98,2.36 [1.58-3.51],2.5353190777749707e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRISP2,Cysteine-rich secretory protein 2,2500,102,0.95 [0.72-1.26],0.7361453496801151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRISP3,Cysteine-rich secretory protein 3,2133,83,0.80 [0.36-1.79],0.5888724747190182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRKL,Crk-like protein,2487,99,1.03 [0.86-1.23],0.7355658720290374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRLF1,Cytokine receptor-like factor 1,2496,99,2.26 [1.14-4.49],0.0201623420389719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRNN,Cornulin,2411,98,1.03 [0.80-1.31],0.843741103585657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRTAC1,Cartilage acidic protein 1,2510,102,0.82 [0.47-1.42],0.4755520755152425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRTAM,Cytotoxic and regulatory T-cell molecule,2463,98,1.77 [1.26-2.48],0.0009336610765343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRTAP,Cartilage-associated protein,2095,81,1.02 [0.65-1.62],0.9190216503529092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRX,Cone-rod homeobox protein,2437,97,0.80 [0.62-1.02],0.0659771517458685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYBB1,Beta-crystallin B1,2138,84,1.19 [0.85-1.67],0.3093799329438978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYBB2,Beta-crystallin B2,2140,84,1.09 [0.88-1.35],0.4419184610758817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYGD,Gamma-crystallin D,2140,84,0.98 [0.79-1.22],0.8488915689678199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYM,Ketimine reductase mu-crystallin,2071,82,1.09 [0.81-1.47],0.5629410871289429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYZL1,Quinone oxidoreductase-like protein 1,2096,83,1.03 [0.80-1.32],0.8297156472421593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSDE1,Cold shock domain-containing protein E1,2068,81,1.01 [0.83-1.23],0.9387395218568146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF1,Macrophage colony-stimulating factor 1,2496,99,5.13 [3.00-8.78],2.299093661814625e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,2148,83,1.59 [1.00-2.53],0.0496183834898674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF2,Granulocyte-macrophage colony-stimulating factor,2068,81,0.88 [0.48-1.63],0.6874209065927193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,2463,98,1.40 [1.08-1.82],0.0117241944454708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF2RB,Cytokine receptor common subunit beta,2078,82,1.07 [0.64-1.80],0.7997520171999976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF3,Granulocyte colony-stimulating factor,2421,99,0.92 [0.64-1.33],0.6541322806736509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF3R,Granulocyte colony-stimulating factor receptor,2078,82,1.41 [0.73-2.72],0.3110947673918882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSH1,Chorionic somatomammotropin hormone 1,2148,83,1.66 [0.77-3.55],0.1955184393266962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSNK1D,Casein kinase I isoform delta,2078,82,1.25 [0.90-1.74],0.1772290768721195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSNK2A1,Casein kinase II subunit alpha,2136,83,1.33 [0.82-2.16],0.2419621912927692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSPG4,Chondroitin sulfate proteoglycan 4,2147,82,2.78 [1.55-4.98],0.000575411345091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSPG5,Chondroitin sulfate proteoglycan 5,2071,82,1.68 [1.19-2.38],0.003457426356615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSRP3,Cysteine and glycine-rich protein 3,2068,81,1.29 [1.06-1.56],0.0100016459754404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST1,Cystatin-SN,1882,68,0.80 [0.63-1.02],0.0687641381696267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST3,Cystatin-C,2478,98,4.39 [2.89-6.68],4.508939575656818e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST5,Cystatin-D,2440,97,1.44 [1.07-1.94],0.0149578368986402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST6,Cystatin-M,2412,100,1.45 [1.04-2.01],0.0275040216022128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST7,Cystatin-F,2488,99,1.08 [0.91-1.29],0.3642968327232881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSTB,Cystatin-B,2448,96,2.09 [1.40-3.12],0.0003397565669787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTAG1A_CTAG1B,Cancer/testis antigen 1,2112,81,1.05 [0.68-1.62],0.8396810822905239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTBS,Di-N-acetylchitobiase,2115,82,1.81 [0.80-4.07],0.1519503431791505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTF1,Cardiotrophin-1,2437,97,0.98 [0.78-1.22],0.850854136073474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTHRC1,Collagen triple helix repeat-containing protein 1,2147,82,2.25 [1.27-3.97],0.0052904842473407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTLA4,Cytotoxic T-lymphocyte protein 4,2147,82,1.02 [0.54-1.91],0.9541397622398108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTNNA1,Catenin alpha-1,2071,82,0.81 [0.36-1.80],0.5986076037496352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTRB1,Chymotrypsinogen B,2490,100,0.85 [0.67-1.09],0.2029783363801383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTRC,Chymotrypsin-C,2487,99,0.78 [0.62-0.98],0.0309779698422004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTRL,Chymotrypsin-like protease CTRL-1,2140,84,0.82 [0.64-1.05],0.122627107082536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSB,Cathepsin B,2479,102,2.05 [1.53-2.75],1.7897407084503266e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSC,Dipeptidyl peptidase 1,2482,99,0.86 [0.57-1.28],0.4468235918551706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSD,Cathepsin D,2323,88,1.58 [1.10-2.26],0.0134150099651506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSE,Cathepsin E,2109,80,1.97 [1.35-2.87],0.0004200474536415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSF,Cathepsin F,2489,101,1.93 [1.27-2.92],0.0019576817429313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSH,Pro-cathepsin H,2433,97,1.22 [0.95-1.55],0.1171573605284479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSL,Cathepsin L1,2483,101,2.61 [1.48-4.60],0.0009080846074486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSO,Cathepsin O,2506,101,2.71 [1.69-4.34],3.314106960564964e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSS,Cathepsin S,1967,81,4.81 [2.07-11.21],0.0002720807125684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSV,Cathepsin L2,2492,102,0.76 [0.51-1.13],0.1701861948023801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSZ,Cathepsin Z,2479,99,3.32 [2.11-5.23],2.17703126226923e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,2095,81,1.14 [0.75-1.72],0.545320564145984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CWC15,Spliceosome-associated protein CWC15 homolog,2120,82,1.11 [0.78-1.56],0.5671065995186836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CX3CL1,Fractalkine,2463,98,2.55 [1.69-3.83],7.122223043446451e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXADR,Coxsackievirus and adenovirus receptor,2477,100,1.87 [1.37-2.55],9.03483012261746e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL1,Growth-regulated alpha protein,2484,99,1.12 [0.93-1.35],0.2303715929534357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL10,C-X-C motif chemokine 10,2496,99,1.28 [1.00-1.64],0.0530101336439971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL11,C-X-C motif chemokine 11,2505,102,1.14 [0.92-1.42],0.22565482611694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL12,Stromal cell-derived factor 1,2421,99,0.96 [0.61-1.50],0.854455402229637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL13,C-X-C motif chemokine 13,2505,102,1.26 [1.01-1.57],0.0387632350285304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL14,C-X-C motif chemokine 14,2421,99,1.13 [0.86-1.49],0.3726894683298571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL16,C-X-C motif chemokine 16,2507,102,3.71 [1.93-7.13],8.631398433191998e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL17,C-X-C motif chemokine 17,2506,101,1.43 [0.95-2.16],0.089635599325568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL3,C-X-C motif chemokine 3,2484,99,1.00 [0.82-1.21],0.9750698195371854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL5,C-X-C motif chemokine 5,2474,100,0.96 [0.82-1.12],0.6018993795947748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL6,C-X-C motif chemokine 6,2506,101,1.17 [0.93-1.48],0.1770224827984376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL8,Interleukin-8,2459,102,1.15 [0.91-1.45],0.2530617091844751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL9,C-X-C motif chemokine 9,2496,99,1.62 [1.29-2.03],3.127115639960649e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYB5A,Cytochrome b5,2063,81,1.12 [0.83-1.53],0.4558051602256173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYB5R2,NADH-cytochrome b5 reductase 2,2112,81,1.48 [1.02-2.16],0.0407453325298803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",2068,81,0.69 [0.49-0.97],0.0304221801308609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYTH3,Cytohesin-3,2063,81,1.13 [0.85-1.50],0.4053436770575774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYTL1,Cytokine-like protein 1,2147,82,2.44 [1.16-5.13],0.018741871531298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAAM1,Disheveled-associated activator of morphogenesis 1,2109,80,0.91 [0.69-1.20],0.4965573168096595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAB2,Disabled homolog 2,2500,102,1.06 [0.90-1.25],0.505627789641204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAG1,Dystroglycan,2496,99,1.50 [1.00-2.23],0.0477140100059534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAND5,DAN domain family member 5,2078,82,1.06 [0.77-1.46],0.7158243335420428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAPK2,Death-associated protein kinase 2,2078,82,0.98 [0.66-1.45],0.9029419165772944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,2477,100,0.95 [0.82-1.10],0.5250614105058791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DARS1,"Aspartate--tRNA ligase, cytoplasmic",2460,97,1.00 [0.77-1.29],0.9868053298115868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DBH,Dopamine beta-hydroxylase,2146,83,1.08 [0.89-1.32],0.4325453710941535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DBI,Acyl-CoA-binding protein,2474,99,1.28 [1.00-1.63],0.0532042248147796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DBN1,Drebrin,2078,82,1.52 [1.00-2.30],0.0508924592972232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DBNL,Drebrin-like protein,2496,99,1.03 [0.84-1.26],0.791475406035582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",2489,101,3.45 [2.20-5.41],7.460724266754435e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCC,Netrin receptor DCC,2095,81,1.79 [0.82-3.91],0.1457445436003804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCDC2C,Doublecortin domain-containing protein 2C,2063,81,0.90 [0.63-1.31],0.5928373507660043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCLRE1C,Protein artemis,2063,81,0.73 [0.35-1.54],0.411323806807234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCN,Decorin,2437,97,4.46 [2.49-7.97],4.67823337901617e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTD,Deoxycytidylate deaminase,2109,80,0.97 [0.76-1.23],0.7866890505427749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTN1,Dynactin subunit 1,2500,102,1.11 [0.83-1.48],0.4740407733431523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTN2,Dynactin subunit 2,2475,101,1.10 [0.91-1.33],0.32558795628489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTN6,Dynactin subunit 6,2414,94,1.17 [0.95-1.44],0.1469314275773078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTPP1,dCTP pyrophosphatase 1,2483,101,1.18 [0.68-2.03],0.555768282738287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCUN1D1,DCN1-like protein 1,2071,82,0.97 [0.72-1.31],0.8471661044102086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCUN1D2,DCN1-like protein 2,2063,81,0.91 [0.67-1.22],0.5173464364198356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCXR,L-xylulose reductase,2489,101,0.75 [0.55-1.02],0.0673595079538844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDA1,DET1- and DDB1-associated protein 1,2068,81,1.16 [0.73-1.86],0.5297689799311474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",2475,101,1.45 [0.98-2.14],0.0599855710259478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDC,Aromatic-L-amino-acid decarboxylase,2483,101,0.55 [0.39-0.77],0.0005807032080059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDHD2,Phospholipase DDHD2,2136,83,1.14 [0.82-1.59],0.4429472616297202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDI2,Protein DDI1 homolog 2,2109,80,1.04 [0.80-1.35],0.771935411981678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDR1,Epithelial discoidin domain-containing receptor 1,2505,102,4.06 [2.21-7.47],6.35949591407961e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDT,D-dopachrome decarboxylase,2147,82,0.90 [0.54-1.48],0.6706092915271964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX1,ATP-dependent RNA helicase DDX1,2130,82,1.25 [0.82-1.90],0.3038225539816287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX25,ATP-dependent RNA helicase DDX25,2095,81,1.27 [0.74-2.19],0.3863728841919535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX39A,ATP-dependent RNA helicase DDX39A,2078,82,1.16 [0.49-2.75],0.7295589215855125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX4,Probable ATP-dependent RNA helicase DDX4,2078,82,0.91 [0.57-1.45],0.6864847002206247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX53,Probable ATP-dependent RNA helicase DDX53,2095,81,0.77 [0.40-1.47],0.4294638389516727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX58,Antiviral innate immune response receptor RIG-I,2418,95,0.80 [0.56-1.14],0.2120766136864593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",2477,100,1.00 [0.83-1.22],0.9631818630219324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFA1_DEFA1B,Neutrophil defensin 1,2419,96,1.90 [1.49-2.42],2.38537918889891e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB103A_DEFB103B,Beta-defensin 103,2065,82,1.14 [0.75-1.73],0.5334109304613167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB104A_DEFB104B,Beta-defensin 104,2071,82,0.99 [0.65-1.50],0.9635657217432748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB116,Beta-defensin 116,2071,82,0.91 [0.66-1.26],0.5857920695682859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB118,Beta-defensin 118,2071,82,1.01 [0.71-1.45],0.9384508538989292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB4A_DEFB4B,Beta-defensin 4A,2460,101,1.05 [0.94-1.18],0.4128563884426565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DENND2B,DENN domain-containing protein 2B,2068,81,1.20 [0.85-1.69],0.3064465650067369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DENR,Density-regulated protein,2078,82,1.14 [0.79-1.63],0.4803573649860772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DFFA,DNA fragmentation factor subunit alpha,2506,101,1.05 [0.79-1.39],0.7561849225803814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DGCR6,Protein DGCR6,2071,82,1.37 [0.83-2.27],0.2157048123266349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DGKA,Diacylglycerol kinase alpha,2078,82,1.25 [0.84-1.87],0.2707822031050598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DGKZ,Diacylglycerol kinase zeta,2421,99,0.88 [0.52-1.49],0.6309803961123296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DHODH,Dihydroorotate dehydrogenase,2068,81,0.88 [0.53-1.45],0.6045934778208407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DHPS,Deoxyhypusine synthase,2133,83,0.86 [0.50-1.49],0.5916150188470553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,2140,84,1.01 [0.64-1.60],0.955557558217563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DIABLO,"Diablo homolog, mitochondrial",2476,101,0.87 [0.74-1.03],0.1014395881688377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DIPK1C,Divergent protein kinase domain 1C,2095,81,0.61 [0.32-1.16],0.1323442154528979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DIPK2B,Divergent protein kinase domain 2B,2109,80,1.58 [0.75-3.30],0.2275440527810706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK1,Dickkopf-related protein 1,2505,102,0.98 [0.73-1.33],0.9124256728497918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK3,Dickkopf-related protein 3,2510,102,3.16 [1.85-5.41],2.673070382065487e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK4,Dickkopf-related protein 4,2460,98,3.28 [2.47-4.35],1.6842869331019195e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKKL1,Dickkopf-like protein 1,2475,101,1.03 [0.84-1.27],0.7545345159139762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLG4,Disks large homolog 4,2140,84,1.06 [0.78-1.43],0.7105558353095365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLGAP5,Disks large-associated protein 5,2136,83,1.32 [0.95-1.84],0.1026700193404296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLK1,Protein delta homolog 1,2510,102,1.03 [0.77-1.39],0.8320968849727904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLL1,Delta-like protein 1,2489,101,5.39 [3.49-8.32],3.124779614707723e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLL4,Delta-like protein 4,2096,83,0.99 [0.75-1.30],0.9501288686299572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DMD,Dystrophin,2096,83,1.85 [1.30-2.63],0.0006148505746718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DMP1,Dentin matrix acidic phosphoprotein 1,2096,83,0.50 [0.37-0.68],1.1854504090299456e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJA1,DnaJ homolog subfamily A member 1,2063,81,1.04 [0.61-1.77],0.8810421572101689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJA2,DnaJ homolog subfamily A member 2,2499,101,1.06 [0.85-1.33],0.6050191291118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJA4,DnaJ homolog subfamily A member 4,2140,84,1.03 [0.77-1.37],0.8472360316399223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB1,DnaJ homolog subfamily B member 1,2475,101,1.01 [0.82-1.25],0.915355593399795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB14,DnaJ homolog subfamily B member 14,2130,82,1.21 [0.87-1.69],0.2609205072472867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB2,DnaJ homolog subfamily B member 2,2109,80,0.96 [0.64-1.44],0.8459425504868381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB6,DnaJ homolog subfamily B member 6,2091,80,1.01 [0.77-1.34],0.935689785822694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB8,DnaJ homolog subfamily B member 8,2437,97,1.18 [0.87-1.59],0.2932992938120741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJC21,DnaJ homolog subfamily C member 21,2140,84,0.78 [0.43-1.40],0.4000884855631834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJC6,Putative tyrosine-protein phosphatase auxilin,2096,83,1.16 [0.90-1.51],0.2566850737477313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJC9,DnaJ homolog subfamily C member 9,2130,82,1.19 [0.89-1.58],0.2397709090039358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,2484,99,0.72 [0.38-1.37],0.3190897989261099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNLZ,DNL-type zinc finger protein,2071,82,0.86 [0.65-1.16],0.3257184592106297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNM1,Dynamin-1,2130,82,1.00 [0.82-1.22],0.9836594950786434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNM3,Dynamin-3,2136,83,1.42 [0.99-2.03],0.0595406614051049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNMBP,Dynamin-binding protein,2463,98,1.28 [0.96-1.72],0.0920733339286899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNPEP,Aspartyl aminopeptidase,2140,84,0.85 [0.61-1.17],0.3169836684229791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,2491,99,1.03 [0.73-1.45],0.8859061378477852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DOC2B,Double C2-like domain-containing protein beta,2095,81,0.55 [0.25-1.17],0.1192363824484189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DOCK9,Dedicator of cytokinesis protein 9,2071,82,0.87 [0.69-1.09],0.218264996095519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DOK1,Docking protein 1,2140,84,1.05 [0.89-1.23],0.5631361387815934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DOK2,Docking protein 2,2483,101,1.00 [0.86-1.16],0.9949106374481336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPEP1,Dipeptidase 1,2460,97,0.93 [0.65-1.34],0.7037049182007287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPEP2,Dipeptidase 2,2475,101,2.10 [1.22-3.62],0.0078102758450285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP10,Inactive dipeptidyl peptidase 10,2477,100,1.23 [0.82-1.86],0.3167320838039874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP4,Dipeptidyl peptidase 4,2441,97,0.61 [0.36-1.05],0.0759795036548808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,2475,101,2.31 [1.52-3.50],8.418245728587316e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP7,Dipeptidyl peptidase 2,2469,101,1.12 [0.84-1.50],0.4422908842175453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPT,Dermatopontin,2510,102,2.09 [1.03-4.26],0.04209470107409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPY30,Protein dpy-30 homolog,2491,102,1.59 [1.22-2.07],0.0005786354704245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DRAXIN,Draxin,2463,98,1.64 [1.13-2.39],0.0099079750663613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DRG2,Developmentally-regulated GTP-binding protein 2,2475,101,0.99 [0.71-1.37],0.933448848997011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSC2,Desmocollin-2,2467,99,4.29 [2.80-6.57],2.2550098315909104e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSCAM,Down syndrome cell adhesion molecule,2136,83,1.33 [0.79-2.23],0.2792844473708964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSG2,Desmoglein-2,2490,100,2.29 [1.39-3.78],0.0011412261399303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSG3,Desmoglein-3,2492,102,1.31 [0.82-2.09],0.2571895962255823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSG4,Desmoglein-4,2469,101,0.51 [0.36-0.73],0.0001765536388545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTD1,D-aminoacyl-tRNA deacylase 1,2109,80,0.97 [0.75-1.26],0.8035497235019045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTNB,Dystrobrevin beta,2128,82,2.33 [1.59-3.42],1.4062301345851005e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTX2,Probable E3 ubiquitin-protein ligase DTX2,2095,81,0.82 [0.53-1.28],0.3854240474114555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,2475,101,4.02 [2.18-7.39],7.777024541747547e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTYMK,Thymidylate kinase,2138,84,1.12 [0.82-1.54],0.4789796047643888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUOX2,Dual oxidase 2,2437,97,1.05 [0.81-1.35],0.7289423433785155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUSP13,Dual specificity protein phosphatase 13 isoform A,2133,83,0.69 [0.41-1.15],0.1580365198762963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUSP29,Dual specificity phosphatase 29,2095,81,0.97 [0.69-1.36],0.842013967309558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUSP3,Dual specificity protein phosphatase 3,2414,94,0.88 [0.69-1.12],0.3123062604455983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",2130,82,1.04 [0.84-1.29],0.6881050716341091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DXO,Decapping and exoribonuclease protein,2140,84,1.16 [0.71-1.90],0.5494450505039223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,2133,83,1.24 [0.78-1.96],0.3591760327398516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DYNLT1,Dynein light chain Tctex-type 1,2095,81,0.99 [0.75-1.32],0.961088985380292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DYNLT3,Dynein light chain Tctex-type 3,2133,83,0.71 [0.43-1.17],0.1739698580052637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,2463,98,1.02 [0.84-1.24],0.8638223755575261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EBI3_IL27,Interleukin-27,2495,102,3.00 [1.77-5.06],4.137774339121625e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECE1,Endothelin-converting enzyme 1,2414,94,1.06 [0.64-1.76],0.8262040532819115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",2138,84,0.88 [0.67-1.14],0.3299062818987875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",2096,83,1.04 [0.84-1.29],0.7432943524114906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECI2,Enoyl-CoA delta isomerase 2,2068,81,0.93 [0.67-1.31],0.6920964720625331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECM1,Extracellular matrix protein 1,2082,82,0.86 [0.47-1.56],0.6101775396530136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECSCR,Endothelial cell-specific chemotaxis regulator,2071,82,1.09 [0.74-1.60],0.6616537579209607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,2500,102,3.90 [3.02-5.04],1.7630912822822289e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDAR,Tumor necrosis factor receptor superfamily member EDAR,2477,100,0.96 [0.77-1.19],0.7029114194976216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDDM3B,Epididymal secretory protein E3-beta,2133,83,1.09 [0.74-1.60],0.6600166157600509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,2068,81,1.25 [0.68-2.30],0.476223207992804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDF1,Endothelial differentiation-related factor 1,2136,83,0.93 [0.65-1.33],0.6998227149512293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,2437,97,1.33 [0.81-2.18],0.2640046937344368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDN1,Endothelin-1,2096,83,4.78 [2.58-8.83],6.346715120077718e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDNRB,Endothelin receptor type B,2078,82,1.47 [0.90-2.42],0.1240387448492495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EEF1D,Elongation factor 1-delta,2138,84,1.14 [0.90-1.45],0.264245032022765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,2130,82,3.78 [2.25-6.35],5.369764513725204e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFCAB2,Dynein regulatory complex protein 8,2114,81,1.06 [0.57-1.98],0.8569592261653212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,2483,99,3.51 [2.28-5.43],1.4371486880728632e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFHD1,EF-hand domain-containing protein D1,2136,83,2.03 [1.27-3.23],0.0030198978570187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA1,Ephrin-A1,2488,100,5.28 [3.60-7.75],1.822964839640929e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA4,Ephrin-A4,2462,98,4.99 [3.55-7.01],1.7713349051704418e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNB2,Ephrin-B2,2095,81,1.40 [1.05-1.85],0.0203922960766047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGF,Pro-epidermal growth factor,2482,98,0.95 [0.80-1.13],0.5928594071338534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGFL7,Epidermal growth factor-like protein 7,2418,95,1.77 [1.15-2.70],0.0086832482632373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGFLAM,Pikachurin,2130,82,1.50 [0.80-2.81],0.2039964175153824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGFR,Epidermal growth factor receptor,2510,102,1.18 [0.44-3.17],0.7388112200930025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGLN1,Egl nine homolog 1,2477,100,0.95 [0.68-1.33],0.769162752522625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EHBP1,EH domain-binding protein 1,2138,84,1.17 [0.87-1.57],0.3069554536566266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EHD3,EH domain-containing protein 3,2096,83,0.95 [0.79-1.15],0.6156908425696175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",2140,84,0.87 [0.56-1.34],0.5215069358584641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",2118,81,1.05 [0.85-1.29],0.6760348393344704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,2068,81,0.92 [0.66-1.30],0.6468745586438482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,2096,83,0.71 [0.39-1.29],0.2585889041888097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4B,Eukaryotic translation initiation factor 4B,2463,98,0.91 [0.66-1.26],0.576816032666936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4E,Eukaryotic translation initiation factor 4E,2078,82,1.11 [0.86-1.42],0.4218685878475797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,2483,101,1.14 [0.88-1.49],0.3165364828825963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,2506,101,1.01 [0.84-1.22],0.911345058504228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,2136,83,1.14 [0.82-1.58],0.4514088606352681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF5,Eukaryotic translation initiation factor 5,2068,81,1.57 [1.11-2.24],0.0114987565912366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF5A,Eukaryotic translation initiation factor 5A-1,2421,99,0.98 [0.56-1.73],0.9516924454205692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELAC1,Zinc phosphodiesterase ELAC protein 1,2136,83,1.05 [0.80-1.37],0.741394865472107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELAVL4,ELAV-like protein 4,2071,82,1.03 [0.81-1.31],0.7997994840887939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELN,Elastin,2138,84,3.08 [1.86-5.09],1.1316500210704276e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELOA,Elongin-A,2475,101,0.71 [0.48-1.04],0.077566241556858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELOB,Elongin-B,2068,81,1.16 [0.69-1.95],0.5724667760310032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENAH,Protein enabled homolog,2421,99,1.22 [0.86-1.72],0.2687188862549916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENDOU,Poly(U)-specific endoribonuclease,1984,74,1.64 [1.11-2.42],0.0127182369303676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENG,Endoglin,2510,102,4.03 [1.64-9.90],0.0023549406805739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENO1,Alpha-enolase,2487,99,1.04 [0.82-1.32],0.7392884088449982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENO2,Gamma-enolase,2505,102,1.08 [0.81-1.43],0.6023494891613081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENO3,Beta-enolase,2096,83,0.66 [0.46-0.95],0.0261626538402153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENOPH1,Enolase-phosphatase E1,2133,83,0.70 [0.47-1.02],0.0655790871658916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,2068,81,1.32 [0.67-2.58],0.4216276366786534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPEP,Glutamyl aminopeptidase,2068,81,1.02 [0.69-1.51],0.9317878432017352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,2510,102,1.76 [1.00-3.10],0.0483134282671702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,2496,99,0.86 [0.57-1.29],0.4630682524309123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,2096,83,1.56 [0.86-2.84],0.1433534401096096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,2396,95,1.00 [0.82-1.23],0.9943900867945552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENSA,Alpha-endosulfine,2133,83,0.75 [0.47-1.20],0.229323427259181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,2418,95,1.10 [0.74-1.63],0.6260801974058876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,2437,97,0.46 [0.20-1.04],0.0631247741983825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,2437,97,2.47 [1.16-5.23],0.0185284426096673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENTR1,Endosome-associated-trafficking regulator 1,2096,83,0.89 [0.62-1.26],0.5101148330144021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EP300,Histone acetyltransferase p300,2078,82,1.23 [0.64-2.38],0.5327745668946627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPB41L5,Band 4.1-like protein 5,2095,81,1.42 [1.08-1.85],0.0117009009190543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPCAM,Epithelial cell adhesion molecule,2481,97,0.95 [0.77-1.16],0.6040810917766457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPGN,Epigen,2133,83,1.09 [0.67-1.79],0.7250240049191565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA1,Ephrin type-A receptor 1,2491,99,2.67 [1.58-4.51],0.0002407586821534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA10,Ephrin type-A receptor 10,2414,94,0.96 [0.72-1.27],0.7553235483043441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA2,Ephrin type-A receptor 2,2393,97,4.24 [3.03-5.93],3.020817239312816e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA4,Ephrin type-A receptor 4,2109,80,2.90 [1.42-5.90],0.0034088250475919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHB4,Ephrin type-B receptor 4,2510,102,4.98 [3.28-7.56],4.932102633927022e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHB6,Ephrin type-B receptor 6,2460,97,2.95 [1.88-4.63],2.667281422370831e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHX2,Bifunctional epoxide hydrolase 2,2437,97,0.72 [0.50-1.03],0.0704073846118364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPN1,Epsin-1,2114,81,0.75 [0.42-1.35],0.3347188851239608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPO,Erythropoietin,2477,100,1.28 [1.04-1.56],0.0178249131177388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPPK1,Epiplakin,2096,83,1.30 [0.98-1.71],0.0648497578779785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,2496,102,1.60 [0.96-2.67],0.0707161888166681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,2489,101,0.71 [0.36-1.40],0.3271475325969388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,2475,99,1.42 [0.59-3.42],0.4286772070876458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,2489,101,1.81 [1.00-3.27],0.0492562642120876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERBIN,Erbin,2475,101,1.00 [0.84-1.20],0.997523778372179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERC2,ERC protein 2,2095,81,1.11 [0.83-1.47],0.4876059905693625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERCC1,DNA excision repair protein ERCC-1,2063,81,1.34 [0.74-2.44],0.3316325608817136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EREG,Proepiregulin,2460,97,1.01 [0.80-1.27],0.959950174098972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERI1,3'-5' exoribonuclease 1,2114,81,0.78 [0.41-1.52],0.4717013712662673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERMAP,Erythroid membrane-associated protein,2078,82,2.33 [1.45-3.74],0.000439421856255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,2133,83,1.07 [0.62-1.83],0.8053748125038847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERP29,Endoplasmic reticulum resident protein 29,2109,80,0.96 [0.79-1.16],0.6594198807115803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERP44,Endoplasmic reticulum resident protein 44,2474,101,1.24 [0.63-2.46],0.5353310816775447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,2068,81,0.83 [0.47-1.46],0.5163793055145565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESAM,Endothelial cell-selective adhesion molecule,2510,102,3.60 [2.31-5.63],1.7958421734477554e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESM1,Endothelial cell-specific molecule 1,2481,99,0.98 [0.59-1.62],0.9255348219123264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESPL1,Separin,2063,81,0.88 [0.60-1.28],0.4932098962818682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESR1,Estrogen receptor,2078,82,1.10 [0.73-1.66],0.6342572360388607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESYT2,Extended synaptotagmin-2,2140,84,1.13 [0.87-1.47],0.3613194786849312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EVI2B,Protein EVI2B,2063,81,0.66 [0.32-1.37],0.2690162092622181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EVI5,Ecotropic viral integration site 5 protein homolog,2078,82,1.11 [0.87-1.42],0.4090319904194797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EVPL,Envoplakin,2114,81,1.17 [0.61-2.21],0.6400599580765909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EXOSC10,Exosome component 10,2068,81,1.13 [0.81-1.58],0.4581638294497169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EXTL1,Exostosin-like 1,2068,81,1.56 [1.17-2.07],0.002140551463018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EZR,Ezrin,2505,102,0.69 [0.33-1.44],0.321195484142466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F10,Coagulation factor X,2148,83,0.59 [0.31-1.11],0.1025447737077381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F11,Coagulation factor XI,2116,82,1.50 [0.75-3.02],0.2553831533389547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F11R,Junctional adhesion molecule A,2490,100,1.29 [0.93-1.77],0.1217207017829403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F12,Coagulation factor XII,2143,83,0.98 [0.58-1.64],0.9375113921557238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F13B,Coagulation factor XIII B chain,2132,83,1.13 [0.51-2.49],0.7601436830883789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F2,Prothrombin,2143,83,0.90 [0.23-3.48],0.8769486827771065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F2R,Proteinase-activated receptor 1,2492,99,1.68 [1.22-2.32],0.0016249053903852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F3,Tissue factor,2486,102,2.36 [1.32-4.21],0.0036255736835962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F7,Coagulation factor VII,2481,99,0.75 [0.45-1.24],0.2616019403649451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F9,Coagulation factor IX,2485,99,0.88 [0.33-2.34],0.7960377724702827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP1,"Fatty acid-binding protein, liver",2481,99,1.54 [1.30-1.82],3.846401143309141e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP2,"Fatty acid-binding protein, intestinal",2483,101,1.42 [1.17-1.71],0.0003235289766072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP3,"Fatty acid-binding protein, heart",2138,84,2.28 [1.73-3.00],4.9760288873546405e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP4,"Fatty acid-binding protein, adipocyte",2510,102,2.04 [1.60-2.61],1.0348639647924464e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP5,Fatty acid-binding protein 5,2498,101,1.51 [1.18-1.92],0.0010696054217406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP6,Gastrotropin,2434,96,1.11 [0.82-1.50],0.4979000868207259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP9,Fatty acid-binding protein 9,2477,100,1.05 [0.77-1.42],0.7668811137439648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FADD,FAS-associated death domain protein,2483,101,0.92 [0.71-1.18],0.4969795508095598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM13A,Protein FAM13A,2130,82,1.10 [0.79-1.52],0.5681370461631714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM171A2,Protein FAM171A2,2136,83,1.02 [0.89-1.16],0.7894180136001333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM171B,Protein FAM171B,2133,83,1.47 [0.69-3.15],0.3200446979156716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM172A,Cotranscriptional regulator FAM172A,2096,83,0.92 [0.64-1.34],0.680294063843098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM20A,Pseudokinase FAM20A,2138,84,2.75 [1.32-5.73],0.0069015009187442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3B,Protein FAM3B,2475,101,4.75 [2.85-7.93],2.372258746160104e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3C,Protein FAM3C,2483,101,6.23 [4.02-9.65],2.715744279651428e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3D,Protein FAM3D,2130,82,1.58 [1.24-2.01],0.0002043446969764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAP,Prolyl endopeptidase FAP,2510,102,1.26 [0.70-2.25],0.4380212731039761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FARSA,Phenylalanine--tRNA ligase alpha subunit,2095,81,0.91 [0.65-1.26],0.5654173588745119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAS,Tumor necrosis factor receptor superfamily member 6,2502,102,1.93 [1.45-2.57],7.686466658968894e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FASLG,Tumor necrosis factor ligand superfamily member 6,2506,101,1.61 [1.02-2.56],0.0428350242637801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FBLN2,Fibulin-2,2147,82,2.48 [1.45-4.26],0.0009547617732348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FBN2,Fibrillin-2,2095,81,1.29 [0.87-1.93],0.2043863105699886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FBP1,"Fructose-1,6-bisphosphatase 1",2483,101,0.76 [0.60-0.96],0.01992199042957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,2138,84,1.21 [0.92-1.61],0.1727162651021892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCAR,Immunoglobulin alpha Fc receptor,2477,100,1.46 [1.06-2.01],0.0206383009978789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,2136,83,1.42 [0.67-2.99],0.359826646911092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,2490,100,1.49 [1.14-1.96],0.0038324370765991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,2473,98,1.41 [1.00-2.00],0.0519436310665356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,2418,95,0.90 [0.65-1.24],0.5156598167247903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,2479,99,1.27 [0.89-1.83],0.1889322121168436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCN1,Ficolin-1,2146,83,2.26 [1.45-3.53],0.0003136123057124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCN2,Ficolin-2,2467,99,0.95 [0.60-1.48],0.8052167505984974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL1,Fc receptor-like protein 1,2483,101,0.95 [0.65-1.39],0.7777218879081368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL2,Fc receptor-like protein 2,2498,99,1.14 [0.83-1.55],0.4214727952478675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL3,Fc receptor-like protein 3,2421,99,0.98 [0.72-1.32],0.8870139300433496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL5,Fc receptor-like protein 5,2490,100,1.12 [0.84-1.50],0.4275213790588076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL6,Fc receptor-like protein 6,2477,100,1.31 [1.01-1.69],0.0411270762880058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRLB,Fc receptor-like B,2418,95,1.48 [1.15-1.91],0.0021284392878808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FDX1,"Adrenodoxin, mitochondrial",2068,81,1.11 [0.80-1.53],0.5319381060494994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FDX2,"Ferredoxin-2, mitochondrial",2068,81,1.25 [0.83-1.88],0.2951668169199326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FEN1,Flap endonuclease 1,2418,95,0.90 [0.67-1.19],0.4481274002607078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FES,Tyrosine-protein kinase Fes/Fps,2418,95,0.76 [0.50-1.14],0.1807247867111535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FETUB,Fetuin-B,2485,99,0.91 [0.61-1.37],0.6540339524159815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGA,Fibrinogen alpha chain,2085,80,1.52 [0.77-3.04],0.2304152768064236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",2136,83,1.06 [0.81-1.39],0.6716794264642987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF12,Fibroblast growth factor 12,2078,82,0.80 [0.44-1.47],0.480355221284239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF16,Fibroblast growth factor 16,2078,82,0.49 [0.29-0.83],0.0077892992565822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF19,Fibroblast growth factor 19,2496,99,0.90 [0.72-1.12],0.3540415560229112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF2,Fibroblast growth factor 2,2477,100,1.25 [0.98-1.59],0.0776437440468549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF20,Fibroblast growth factor 20,2078,82,1.18 [0.78-1.79],0.4354343270248818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF21,Fibroblast growth factor 21,2495,102,1.13 [0.98-1.29],0.0865995597644867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF23,Fibroblast growth factor 23,2495,102,1.73 [1.42-2.11],8.441017732629552e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF3,Fibroblast growth factor 3,2078,82,0.72 [0.30-1.75],0.4669328678027596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF5,Fibroblast growth factor 5,2421,99,3.99 [2.63-6.05],6.827349788813819e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF6,Fibroblast growth factor 6,2078,82,1.24 [0.89-1.75],0.2073797232102142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF7,Fibroblast growth factor 7,2063,81,1.07 [0.84-1.37],0.5774246350872202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF9,Fibroblast growth factor 9,2061,81,0.86 [0.50-1.47],0.5831943660104353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFBP1,Fibroblast growth factor-binding protein 1,2489,101,0.33 [0.21-0.53],5.592816217519544e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFBP2,Fibroblast growth factor-binding protein 2,2147,82,0.42 [0.28-0.64],3.6118876618131047e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFBP3,Fibroblast growth factor-binding protein 3,2140,84,0.70 [0.40-1.22],0.2070085676043496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFR2,Fibroblast growth factor receptor 2,2489,101,3.82 [2.10-6.94],1.091303890724474e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFR4,Fibroblast growth factor receptor 4,2109,80,0.82 [0.55-1.24],0.350804907232548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGL1,Fibrinogen-like protein 1,2148,83,1.71 [1.26-2.33],0.0005987901621387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGR,Tyrosine-protein kinase Fgr,2414,94,0.95 [0.70-1.28],0.7334998550298852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FH,"Fumarate hydratase, mitochondrial",2071,82,1.12 [0.91-1.39],0.2903715294528222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FHIP2A,FHF complex subunit HOOK interacting protein 2A,2068,81,0.84 [0.53-1.32],0.4531172962158438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FHIT,Bis(5'-adenosyl)-triphosphatase,2414,94,1.01 [0.78-1.32],0.9308479060700926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FIS1,Mitochondrial fission 1 protein,2483,99,0.96 [0.76-1.23],0.7700400640545645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,2136,83,1.00 [0.80-1.25],0.9993786664276222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,2487,99,1.00 [0.85-1.18],0.9787805535488112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,2463,98,1.51 [0.95-2.38],0.0787310741115251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,2463,98,1.09 [0.89-1.35],0.3908834550770381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,2411,93,1.10 [0.75-1.61],0.6337311309822085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBPL,FK506-binding protein-like,2130,82,1.16 [0.79-1.70],0.4579977244883696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLI1,Friend leukemia integration 1 transcription factor,2418,95,1.07 [0.91-1.27],0.4048911342496805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,2463,98,4.04 [2.61-6.25],3.630743804037799e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT1,Vascular endothelial growth factor receptor 1,2471,101,1.99 [1.30-3.06],0.0016068902554647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT3,Receptor-type tyrosine-protein kinase FLT3,2418,95,0.94 [0.51-1.73],0.8359118115908357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,2506,101,1.70 [1.03-2.79],0.0361229694428485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT4,Vascular endothelial growth factor receptor 3,2489,101,0.61 [0.37-0.99],0.0433240339878437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FMNL1,Formin-like protein 1,2414,94,0.93 [0.71-1.23],0.6221182883807328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FMR1,Synaptic functional regulator FMR1,2418,95,0.99 [0.59-1.66],0.9815773289633348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FN1,Fibronectin,2143,83,0.73 [0.33-1.63],0.4474649986481752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FNDC1,Fibronectin type III domain-containing protein 1,2140,84,1.31 [0.85-2.01],0.2146933121866652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,2133,83,0.91 [0.45-1.84],0.7855135789222332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLH1,Glutamate carboxypeptidase 2,2078,82,1.21 [1.02-1.44],0.0260369926702978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLR1,Folate receptor alpha,2476,101,3.07 [1.86-5.05],1.0629208267628117e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLR2,Folate receptor beta,2505,102,2.07 [1.17-3.65],0.0125315486384014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLR3,Folate receptor gamma,2477,100,1.04 [0.96-1.13],0.3113957538841911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOS,Proto-oncogene c-Fos,2061,81,1.02 [0.53-1.95],0.9544503529653828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOSB,Protein fosB,2414,94,1.17 [0.72-1.90],0.5320204496022322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOXJ3,Forkhead box protein J3,2078,82,1.04 [0.66-1.66],0.8561472148732723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOXO1,Forkhead box protein O1,2477,100,1.09 [0.88-1.36],0.4221676371835494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOXO3,Forkhead box protein O3,2418,95,1.14 [0.95-1.37],0.1686249252293316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FRMD4B,FERM domain-containing protein 4B,2068,81,1.21 [0.89-1.66],0.2179809367125213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FRMD7,FERM domain-containing protein 7,2095,81,1.19 [0.62-2.28],0.6109464341563731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FRZB,Secreted frizzled-related protein 3,2459,98,1.43 [0.69-2.96],0.3328736761884296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSHB,Follitropin subunit beta,2096,83,1.47 [0.99-2.18],0.0567433119842945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FST,Follistatin,2492,99,1.29 [0.89-1.89],0.1791981656339361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSTL1,Follistatin-related protein 1,2096,83,6.93 [2.86-16.75],1.738906677797592e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSTL3,Follistatin-related protein 3,2482,99,3.78 [2.57-5.56],1.5426027583710574e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FTCD,Formimidoyltransferase-cyclodeaminase,2135,83,0.84 [0.68-1.04],0.1098413172084293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUCA1,Tissue alpha-L-fucosidase,2499,102,1.11 [0.90-1.38],0.3228233929576847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUOM,Fucose mutarotase,2109,80,0.74 [0.54-1.01],0.0560691803372639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FURIN,Furin,2489,101,0.72 [0.43-1.22],0.2259160947783463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUS,RNA-binding protein FUS,2413,95,0.84 [0.50-1.40],0.5033251469747073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",2110,81,0.87 [0.62-1.24],0.4536402405844609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,2505,102,1.86 [1.31-2.64],0.0005125924487335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUT8,"Alpha-(1,6)-fucosyltransferase",2463,98,0.99 [0.73-1.34],0.9346654607915956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FXN,"Frataxin, mitochondrial",2500,102,1.08 [0.84-1.38],0.5539148648608805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FXYD5,FXYD domain-containing ion transport regulator 5,2421,99,1.14 [0.87-1.49],0.3459904068849341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FYB1,FYN-binding protein 1,2485,100,0.99 [0.81-1.20],0.8856819560116076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FZD10,Frizzled-10,2095,81,0.82 [0.53-1.27],0.3730087343263187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FZD8,Frizzled-8,2071,82,1.28 [0.87-1.89],0.206565933579245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GABARAP,Gamma-aminobutyric acid receptor-associated protein,2133,83,1.24 [0.84-1.82],0.2748102973852305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,2114,81,1.04 [0.77-1.41],0.776488030649092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,2071,82,1.23 [0.90-1.67],0.19509165825475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAD1,Glutamate decarboxylase 1,2063,81,1.36 [0.59-3.17],0.4726711972128381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAD2,Glutamate decarboxylase 2,2078,82,0.86 [0.48-1.52],0.593688079747108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,2114,81,0.99 [0.63-1.54],0.9598194937607204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,2096,83,1.01 [0.66-1.53],0.9741492864907644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAGE2A,G antigen 2A,2063,81,0.77 [0.52-1.13],0.1768708761960712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAL,Galanin peptides,2496,99,0.96 [0.74-1.25],0.7752405662165257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,2475,101,2.39 [1.35-4.22],0.0027218827612602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,2500,102,0.58 [0.31-1.09],0.0903026865629856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,2421,99,1.68 [1.15-2.47],0.0078404885422322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,2138,84,1.68 [0.86-3.27],0.1274229630258337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT7,N-acetylgalactosaminyltransferase 7,2475,101,1.64 [0.74-3.65],0.2254673512961755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAMT,Guanidinoacetate N-methyltransferase,2068,81,1.14 [0.62-2.09],0.6759876373504079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,2049,77,0.75 [0.36-1.57],0.4478128794529252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GART,Trifunctional purine biosynthetic protein adenosine-3,2136,83,1.28 [0.60-2.72],0.5163187205893984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAS2,Growth arrest-specific protein 2,2114,81,0.62 [0.38-1.03],0.065490756345976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAS6,Growth arrest-specific protein 6,2494,102,2.12 [1.08-4.18],0.0300525013938877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GASK1A,Golgi-associated kinase 1A,2068,81,0.93 [0.59-1.45],0.7457532536773781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAST,Gastrin,2140,84,1.14 [1.02-1.28],0.0259205955561779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,2063,81,0.93 [0.40-2.14],0.8597224269894324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",2096,83,0.95 [0.71-1.28],0.7481733739459713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBA,Lysosomal acid glucosylceramidase,2095,81,1.20 [0.88-1.63],0.2581384832588216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBP1,Guanylate-binding protein 1,2138,84,1.16 [0.83-1.63],0.3837844296173889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBP2,Guanylate-binding protein 2,2421,99,1.13 [0.86-1.50],0.3791991176921064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBP4,Guanylate-binding protein 4,2414,94,0.98 [0.66-1.45],0.9018140489191075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBP6,Guanylate-binding protein 6,2068,81,0.95 [0.57-1.59],0.85058545450054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GC,Vitamin D-binding protein,2143,83,1.49 [0.67-3.30],0.3301621371780943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCC1,GRIP and coiled-coil domain-containing protein 1,2140,84,1.01 [0.82-1.24],0.9497236631001436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCG,Pro-glucagon,2418,95,1.23 [1.08-1.42],0.0026569365347377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,2050,79,1.64 [1.19-2.24],0.0022044020438596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCLM,Glutamate--cysteine ligase regulatory subunit,2068,81,1.21 [0.77-1.90],0.4007267847277466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",2475,101,2.44 [1.53-3.92],0.0002022143642049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDF15,Growth/differentiation factor 15,2510,102,2.50 [2.03-3.07],2.7921190499074226e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDF2,Growth/differentiation factor 2,2483,101,1.22 [0.77-1.95],0.3983502094465985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDNF,Glial cell line-derived neurotrophic factor,2414,94,1.87 [1.24-2.82],0.0026597956699219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GET3,ATPase GET3,2138,84,1.02 [0.70-1.51],0.9010771221106642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFAP,Glial fibrillary acidic protein,2414,94,1.01 [0.69-1.48],0.9517517263925588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFER,FAD-linked sulfhydryl oxidase ALR,2418,95,1.16 [0.86-1.56],0.3231515689538045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,2418,95,1.14 [1.01-1.30],0.0377361865901752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA1,GDNF family receptor alpha-1,2495,102,6.84 [4.39-10.67],2.021447047214652e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA2,GDNF family receptor alpha-2,2475,101,1.50 [0.67-3.32],0.3238528049679028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA3,GDNF family receptor alpha-3,2455,97,2.53 [1.43-4.48],0.0014703353753465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRAL,GDNF family receptor alpha-like,2069,84,0.88 [0.63-1.22],0.4323006596307381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGA1,ADP-ribosylation factor-binding protein GGA1,2414,94,1.06 [0.81-1.39],0.6884998811542363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGACT,Gamma-glutamylaminecyclotransferase,2138,84,1.10 [0.80-1.50],0.5602252362238629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGCT,Gamma-glutamylcyclotransferase,2136,84,1.18 [0.74-1.90],0.483039475359307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGH,Gamma-glutamyl hydrolase,2430,97,0.90 [0.53-1.55],0.7083351741566415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGT1,Glutathione hydrolase 1 proenzyme,2488,100,1.01 [0.74-1.40],0.9312469922719095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGT5,Glutathione hydrolase 5 proenzyme,2463,98,6.65 [3.83-11.54],1.7013029850563398e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GH1,Somatotropin,2483,101,1.13 [1.02-1.25],0.0196762749166451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GH2,Growth hormone variant,2418,95,0.98 [0.87-1.10],0.6958193753264637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GHR,Growth hormone receptor,2109,80,0.36 [0.18-0.71],0.0034289002865104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GHRHR,Growth hormone-releasing hormone receptor,2414,94,1.23 [0.90-1.67],0.1985284279238516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GHRL,Appetite-regulating hormone,2483,101,1.21 [0.99-1.49],0.0664367818316714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GID8,Glucose-induced degradation protein 8 homolog,2136,83,0.84 [0.40-1.77],0.6538001829996762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIGYF2,GRB10-interacting GYF protein 2,2136,83,1.31 [0.99-1.74],0.055851950614489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIMAP7,GTPase IMAP family member 7,2109,80,0.66 [0.30-1.46],0.3037332157678056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIMAP8,GTPase IMAP family member 8,2063,81,0.66 [0.40-1.10],0.1131565331726231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIP,Gastric inhibitory polypeptide,2096,83,1.32 [0.94-1.86],0.1105950285156769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIPC2,PDZ domain-containing protein GIPC2,2140,84,2.79 [1.63-4.78],0.0001762728838721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIPC3,PDZ domain-containing protein GIPC3,2130,82,1.06 [0.84-1.33],0.6510908781627647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIPR,Gastric inhibitory polypeptide receptor,2078,82,0.61 [0.34-1.10],0.0986354036374661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIT1,ARF GTPase-activating protein GIT1,2078,82,1.06 [0.84-1.33],0.6329922030840935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GJA8,Gap junction alpha-8 protein,2063,81,1.09 [0.80-1.49],0.5826589565641049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GKN1,Gastrokine-1,2378,90,1.65 [0.86-3.16],0.1335097853948507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLA,Alpha-galactosidase A,2108,80,1.48 [0.86-2.54],0.1563199162878638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLB1,Beta-galactosidase,2463,98,1.10 [0.71-1.69],0.6662556263849434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLI2,Zinc finger protein GLI2,2078,82,1.23 [0.62-2.47],0.5558146268719719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLO1,Lactoylglutathione lyase,2437,97,1.27 [0.93-1.73],0.1314029670477231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLOD4,Glyoxalase domain-containing protein 4,2479,99,1.10 [0.64-1.88],0.7352650916330529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLP1R,Glucagon-like peptide 1 receptor,2071,82,1.32 [0.82-2.14],0.2508750114796604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLRX,Glutaredoxin-1,2472,101,0.94 [0.69-1.28],0.6905350156187727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",2109,80,0.87 [0.66-1.14],0.3087224518398157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,2414,94,0.89 [0.56-1.41],0.6241890152498168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLYR1,Putative oxidoreductase GLYR1,2133,83,0.99 [0.66-1.48],0.9547981724855998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GM2A,Ganglioside GM2 activator,2097,81,2.67 [1.89-3.76],2.1949736447797e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GMFG,Glia maturation factor gamma,2138,84,1.09 [0.80-1.49],0.5894744112431058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GMPR,GMP reductase 1,2506,101,0.91 [0.64-1.31],0.6184050143676407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GMPR2,GMP reductase 2,2109,80,0.96 [0.69-1.36],0.8340100881496741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNAS,Neuroendocrine secretory protein 55,2136,83,1.11 [0.88-1.39],0.3957677357316295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,2418,95,0.89 [0.67-1.19],0.4392744798777711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,2095,81,0.86 [0.54-1.35],0.4985009782445168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNLY,Granulysin,2490,100,1.04 [0.75-1.45],0.8007289981774595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNPDA1,Glucosamine-6-phosphate isomerase 1,2096,83,0.96 [0.53-1.74],0.8984734985758179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,2109,80,0.56 [0.30-1.02],0.0566291873975269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GOLGA3,Golgin subfamily A member 3,2136,83,1.19 [0.91-1.56],0.2041132203037091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GOLM2,Protein GOLM2,2505,102,2.06 [1.40-3.03],0.0002319281426803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,2477,100,0.95 [0.79-1.14],0.5991366146514373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GORASP2,Golgi reassembly-stacking protein 2,2130,82,1.29 [0.81-2.06],0.2833938607240585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GOT1,"Aspartate aminotransferase, cytoplasmic",2147,82,0.67 [0.42-1.08],0.0974921041759607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP1BA,Platelet glycoprotein Ib alpha chain,2472,99,1.73 [1.06-2.82],0.0285392318278156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP1BB,Platelet glycoprotein Ib beta chain,2068,81,1.11 [0.81-1.52],0.5019958947775499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,2408,95,0.83 [0.67-1.03],0.0880194293129619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP5,Platelet glycoprotein V,2109,80,1.00 [0.54-1.86],0.995784601759154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP6,Platelet glycoprotein VI,2485,100,1.08 [0.88-1.33],0.460850282650769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPA33,Cell surface A33 antigen,2475,101,0.88 [0.77-1.01],0.062525828505066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPC1,Glypican-1,2500,102,2.00 [1.14-3.49],0.0148754664412966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPC5,Glypican-5,2463,98,0.80 [0.58-1.10],0.1643939401191929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPD1,Glycerol-3-phosphate dehydrogenase,2133,83,0.87 [0.61-1.24],0.449399157391962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPHA2,Glycoprotein hormone alpha-2,2130,82,1.35 [0.94-1.95],0.1090014749017378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPI,Glucose-6-phosphate isomerase,2148,83,1.10 [0.68-1.76],0.7075130911049701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,2130,82,1.16 [0.85-1.58],0.3394751354156311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPKOW,G-patch domain and KOW motifs-containing protein,2414,94,1.18 [0.70-2.00],0.5334081543183546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPNMB,Transmembrane glycoprotein NMB,2427,98,2.88 [1.62-5.10],0.0002942627012176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR101,Probable G-protein coupled receptor 101,2071,82,1.07 [0.70-1.62],0.7575233239466372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR158,Probable G-protein coupled receptor 158,2136,83,1.38 [0.80-2.39],0.2471647163336807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR15L,Protein GPR15L,2130,82,1.28 [0.94-1.74],0.1201738475283612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR37,Prosaposin receptor GPR37,2437,97,2.22 [1.73-2.84],3.3992839501825285e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPRC5C,G-protein coupled receptor family C group 5 member C,2133,83,1.44 [1.07-1.93],0.0149830397478439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRAP2,GRB2-related adapter protein 2,2483,101,0.99 [0.86-1.14],0.880498343190069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,2138,84,1.10 [0.78-1.56],0.5913195295445164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRIK2,"Glutamate receptor ionotropic, kainate 2",2136,83,1.02 [0.63-1.66],0.9205419319469992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",2071,82,1.25 [0.85-1.84],0.2467302999529679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRK5,G protein-coupled receptor kinase 5,2437,97,0.64 [0.41-1.00],0.0502906427252088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRN,Progranulin,2477,100,3.44 [1.83-6.48],0.0001281677684598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRP,Gastrin-releasing peptide,2096,83,1.34 [0.98-1.85],0.0699060732977572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",2475,101,1.38 [1.06-1.79],0.016958848253832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRSF1,G-rich sequence factor 1,2052,81,1.00 [0.76-1.31],0.9866392451131656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSAP,Gamma-secretase-activating protein,2418,95,0.93 [0.73-1.17],0.5229760463158768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSN,Gelsolin,2143,83,0.48 [0.18-1.32],0.1565278855333681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSR,"Glutathione reductase, mitochondrial",2140,83,0.85 [0.35-2.03],0.7123181834172619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTA1,Glutathione S-transferase A1,2480,101,0.76 [0.62-0.93],0.0090263449948412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTA3,Glutathione S-transferase A3,2418,95,0.82 [0.65-1.03],0.0914091747506545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTM4,Glutathione S-transferase Mu 4,2068,81,1.05 [0.79-1.38],0.7540788788794105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTP1,Glutathione S-transferase P,2399,94,0.90 [0.67-1.21],0.488872493447209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTT2B,Glutathione S-transferase theta-2B,2140,84,0.98 [0.90-1.07],0.6701191968447071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,2114,81,0.89 [0.61-1.28],0.5245374219394502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GTPBP2,GTP-binding protein 2,2095,81,0.98 [0.74-1.30],0.8939232872104238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUCA2A,Guanylin,2482,100,2.99 [2.14-4.17],1.0267790928830764e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUCY2C,Heat-stable enterotoxin receptor,2114,81,0.94 [0.70-1.26],0.6576913704488564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUK1,Guanylate kinase,2068,81,1.45 [0.88-2.40],0.1428791973469519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUSB,Beta-glucuronidase,2491,102,0.92 [0.72-1.17],0.4845347533637366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GYS1,"Glycogen [starch] synthase, muscle",2437,97,0.93 [0.75-1.16],0.5285825278806271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GZMA,Granzyme A,2506,101,1.43 [0.86-2.39],0.170174388804912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GZMB,Granzyme B,2477,100,0.88 [0.65-1.19],0.4175365120477301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GZMH,Granzyme H,2437,97,1.15 [0.90-1.48],0.2511221432184399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,H2AP,Huntingtin-interacting protein M,2063,81,0.72 [0.41-1.26],0.2474442877385239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",2068,81,0.94 [0.68-1.30],0.7043136966257619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",2494,102,0.93 [0.73-1.18],0.5358198496666744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAO1,Hydroxyacid oxidase 1,2500,102,0.94 [0.82-1.07],0.3531831172117878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HARS1,"Histidine--tRNA ligase, cytoplasmic",2490,100,1.02 [0.80-1.30],0.8573007254946086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAVCR1,Hepatitis A virus cellular receptor 1,2499,102,2.13 [1.78-2.56],3.955742888759083e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAVCR2,Hepatitis A virus cellular receptor 2,2490,100,2.80 [1.86-4.20],6.980202177667755e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HBEGF,Proheparin-binding EGF-like growth factor,2494,102,0.97 [0.76-1.23],0.785030739221273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HBQ1,Hemoglobin subunit theta-1,2500,102,0.81 [0.60-1.09],0.1549695868822962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HBZ,Hemoglobin subunit zeta,2138,84,0.83 [0.68-1.03],0.0876965921479353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HCG22,Protein PBMUCL2,2068,81,0.96 [0.68-1.37],0.8372671253821986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HCLS1,Hematopoietic lineage cell-specific protein,2506,101,0.90 [0.65-1.26],0.5361822839604524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDAC8,Histone deacetylase 8,2078,82,0.99 [0.65-1.53],0.980353227846218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDAC9,Histone deacetylase 9,2071,82,0.79 [0.52-1.18],0.2498118807543751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDDC2,5'-deoxynucleotidase HDDC2,2130,82,1.09 [0.67-1.77],0.7197798805545348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDGF,Hepatoma-derived growth factor,2495,102,1.00 [0.83-1.21],0.9707676722295208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDGFL2,Hepatoma-derived growth factor-related protein 2,2140,84,1.14 [0.81-1.60],0.4486869659602097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEBP1,Heme-binding protein 1,2437,97,0.93 [0.65-1.32],0.6886285340532533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEG1,Protein HEG homolog 1,2109,80,1.23 [0.60-2.53],0.5673303404380616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEPACAM2,HEPACAM family member 2,2140,84,0.84 [0.53-1.33],0.4612462712750287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEPH,Hephaestin,2138,84,5.47 [2.49-12.00],2.263694898163511e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEXIM1,Protein HEXIM1,2477,100,1.11 [0.88-1.39],0.3752487856611306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HGF,Hepatocyte growth factor,2506,101,1.59 [1.01-2.49],0.0430311644299147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HGFAC,Hepatocyte growth factor activator,2130,82,2.49 [1.10-5.65],0.0294559070492634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,2418,95,0.98 [0.77-1.26],0.8815499359602631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HHEX,Hematopoietically-expressed homeobox protein HHEX,2140,84,1.11 [0.82-1.49],0.4981700656356937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HIF1A,Hypoxia-inducible factor 1-alpha,2078,82,0.93 [0.64-1.33],0.6828542203464275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HIP1,Huntingtin-interacting protein 1,2068,81,1.19 [0.60-2.37],0.6167872490107658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HIP1R,Huntingtin-interacting protein 1-related protein,2136,84,1.22 [0.84-1.78],0.3038548179845103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HJV,Hemojuvelin,2136,83,1.69 [1.23-2.31],0.0011171858422871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HK2,Hexokinase-2,2437,97,1.00 [0.53-1.90],0.9944178805080016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",2136,83,2.09 [1.10-3.98],0.0241209802232401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",2468,98,1.33 [0.85-2.08],0.2174451578663403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",2477,100,3.57 [2.48-5.15],9.612551522426072e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMBS,Porphobilinogen deaminase,2500,102,0.85 [0.57-1.27],0.4343400968070986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMCN2,Hemicentin-2,2105,80,1.40 [0.95-2.06],0.08496869710273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",2096,83,1.07 [0.67-1.71],0.7676265374421348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",2068,81,0.88 [0.50-1.54],0.6517413088637285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMMR,Hyaluronan mediated motility receptor,2058,80,1.25 [0.87-1.80],0.2334221187352673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMOX1,Heme oxygenase 1,2467,101,0.68 [0.48-0.97],0.0344129856532387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMOX2,Heme oxygenase 2,2414,94,1.24 [0.85-1.80],0.2692033192151588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HNF1A,Hepatocyte nuclear factor 1-alpha,2095,81,1.05 [0.81-1.36],0.7285772394977307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HNMT,Histamine N-methyltransferase,2457,97,1.24 [0.89-1.72],0.2076100692730244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,2432,97,0.93 [0.72-1.19],0.5431824677277337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,2136,83,1.44 [0.98-2.12],0.0641352649844316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HPCAL1,Hippocalcin-like protein 1,2506,101,1.06 [0.83-1.37],0.6332499010649753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HPGDS,Hematopoietic prostaglandin D synthase,2418,95,0.74 [0.45-1.23],0.2445206405692283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HPSE,Heparanase,2121,81,0.98 [0.77-1.23],0.8494885599744251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HRAS,GTPase Hras,2107,81,1.11 [0.93-1.32],0.2605749680634024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,2096,83,1.93 [1.35-2.75],0.0003272973760504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HRG,Histidine-rich glycoprotein,2132,83,1.15 [0.61-2.18],0.6698332821112256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HS1BP3,HCLS1-binding protein 3,2096,83,1.11 [0.86-1.42],0.4307595966412554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,2475,101,1.66 [1.07-2.57],0.0229400551608942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,2500,102,0.99 [0.63-1.54],0.9529611965926594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,2078,82,1.91 [1.20-3.03],0.0061386452998539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSBP1,Heat shock factor-binding protein 1,2096,83,0.94 [0.74-1.20],0.6137673420459613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,2477,100,1.03 [0.68-1.55],0.9011401421222224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,2140,84,1.01 [0.74-1.39],0.9400169476882002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSD17B3,Testosterone 17-beta-dehydrogenase 3,2068,81,0.99 [0.64-1.53],0.9541971782450672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,2096,83,1.12 [0.71-1.75],0.6327825583498042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSP90B1,Endoplasmin,2404,94,1.35 [1.06-1.71],0.0135601819821758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPA1A,Heat shock 70 kDa protein 1A,2491,99,0.94 [0.72-1.23],0.6650456771796233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPA2,Heat shock-related 70 kDa protein 2,2133,83,3.31 [2.22-4.93],4.211726551307218e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPB1,Heat shock protein beta-1,2448,99,0.97 [0.74-1.26],0.8109557735333804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPB6,Heat shock protein beta-6,2500,102,3.52 [2.53-4.90],6.598386147041975e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,2461,98,4.31 [2.88-6.45],1.3443132694288356e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HTR1A,5-hydroxytryptamine receptor 1A,2071,82,1.15 [0.93-1.42],0.1970835347961936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HTR1B,5-hydroxytryptamine receptor 1B,2071,82,0.70 [0.39-1.26],0.2373072502290207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HTRA2,"Serine protease HTRA2, mitochondrial",2489,101,1.06 [0.78-1.43],0.7227021146774198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HYAL1,Hyaluronidase-1,2460,95,3.34 [1.93-5.77],1.5238065612952966e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HYOU1,Hypoxia up-regulated protein 1,2510,102,5.79 [3.03-11.04],1.0069777296948477e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICA1,Islet cell autoantigen 1,2421,99,1.03 [0.82-1.30],0.7947197416118924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM1,Intercellular adhesion molecule 1,2466,99,1.75 [1.05-2.93],0.0323621192612435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM2,Intercellular adhesion molecule 2,2510,102,3.18 [1.86-5.44],2.307602834291622e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM3,Intercellular adhesion molecule 3,2510,102,1.97 [1.10-3.55],0.0232917070610747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM4,Intercellular adhesion molecule 4,2477,100,0.92 [0.65-1.28],0.6100416196261055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM5,Intercellular adhesion molecule 5,2483,101,1.33 [0.92-1.94],0.1342674401132683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICOSLG,ICOS ligand,2475,101,2.96 [1.27-6.88],0.0119604505790245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ID4,DNA-binding protein inhibitor ID-4,2114,81,0.89 [0.51-1.56],0.6840065631249426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDI2,Isopentenyl-diphosphate delta-isomerase 2,2414,94,1.48 [1.12-1.95],0.0060742277847882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDO1,"Indoleamine 2,3-dioxygenase 1",2096,83,0.83 [0.59-1.18],0.3037993651635112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDS,Iduronate 2-sulfatase,2506,101,1.33 [0.18-9.62],0.7791787223759885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDUA,Alpha-L-iduronidase,2500,102,1.77 [1.19-2.63],0.0048425778153978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,2081,77,2.28 [1.30-4.00],0.0041116581704312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,2114,81,0.82 [0.52-1.29],0.3910106720032604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,2114,81,0.88 [0.49-1.60],0.6785263153572205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNAR1,Interferon alpha/beta receptor 1,2130,82,2.06 [1.09-3.89],0.0256870827037969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNG,Interferon gamma,2421,99,1.07 [0.90-1.26],0.4343295849609672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNGR1,Interferon gamma receptor 1,2496,99,5.86 [3.05-11.28],1.1780068418749e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNGR2,Interferon gamma receptor 2,2463,98,1.22 [0.89-1.68],0.2077467686337678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNL1,Interferon lambda-1,2414,94,1.68 [1.25-2.26],0.0006293715671251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNL2,Interferon lambda-2,2071,82,1.18 [0.88-1.59],0.2656206282945308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNLR1,Interferon lambda receptor 1,2477,100,1.12 [0.69-1.83],0.6400897037775705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNW1,Interferon omega-1,2068,81,0.72 [0.34-1.50],0.3765935423466802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFT20,Intraflagellar transport protein 20 homolog,2095,81,1.05 [0.62-1.78],0.8580624622143318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGBP1,Immunoglobulin-binding protein 1,2136,83,1.14 [0.80-1.61],0.4752804176919107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,2071,82,1.16 [0.78-1.74],0.4560534041616261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,2147,82,1.63 [0.78-3.43],0.1949640556099345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGF1R,Insulin-like growth factor 1 receptor,2475,101,6.33 [3.74-10.74],6.924597337391313e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,2068,81,1.10 [0.68-1.78],0.7010564793937615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGF2R,Cation-independent mannose-6-phosphate receptor,2490,100,2.13 [1.01-4.50],0.048392902691155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP1,Insulin-like growth factor-binding protein 1,2509,102,1.34 [1.16-1.54],6.741950148213236e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP2,Insulin-like growth factor-binding protein 2,2505,102,2.11 [1.66-2.69],1.0774600257491015e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP3,Insulin-like growth factor-binding protein 3,2486,99,0.46 [0.32-0.66],1.5748209568703993e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP4,Insulin-like growth factor-binding protein 4,2463,96,2.65 [2.10-3.34],1.519322818141671e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP6,Insulin-like growth factor-binding protein 6,2471,99,2.97 [2.13-4.16],1.8829694574923567e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP7,Insulin-like growth factor-binding protein 7,2510,102,2.77 [2.03-3.79],1.5915115140329694e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,2483,101,2.12 [1.46-3.07],7.061445158382221e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFL4,Insulin growth factor-like family member 4,2078,82,0.90 [0.65-1.25],0.5170861340678687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGHMBP2,DNA-binding protein SMUBP-2,2068,81,1.17 [0.78-1.75],0.456378657549224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGLC2,Immunoglobulin lambda constant 2,2138,83,1.65 [0.76-3.59],0.2063811269103565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGLON5,IgLON family member 5,2063,81,1.22 [1.02-1.46],0.0336848144357007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF21,Immunoglobulin superfamily member 21,2096,83,0.62 [0.34-1.13],0.1190432922736232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF3,Immunoglobulin superfamily member 3,2475,101,1.39 [0.97-1.99],0.0705494907075475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF8,Immunoglobulin superfamily member 8,2483,101,2.01 [1.38-2.93],0.000294663246036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF9,Protein turtle homolog A,2138,84,1.01 [0.81-1.25],0.955053316415527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IKBKG,NF-kappa-B essential modulator,2477,100,0.99 [0.81-1.21],0.934169344616734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IKZF2,Zinc finger protein Helios,2418,95,1.12 [0.94-1.34],0.1962532248448483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL10,Interleukin-10,2421,99,1.34 [1.13-1.60],0.0010008052607423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL10RA,Interleukin-10 receptor subunit alpha,2421,99,1.16 [0.85-1.57],0.3496069938932029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL10RB,Interleukin-10 receptor subunit beta,2496,99,3.55 [2.19-5.73],2.419082250205771e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL11,Interleukin-11,2421,99,1.12 [0.86-1.46],0.3892508591550656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12A_IL12B,Interleukin-12,2475,101,1.40 [1.15-1.71],0.0007688209702227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12B,Interleukin-12 subunit beta,2506,101,1.65 [1.23-2.22],0.0009190651812044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12RB1,Interleukin-12 receptor subunit beta-1,2421,99,1.72 [1.11-2.67],0.015497369190246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12RB2,Interleukin-12 receptor subunit beta-2,2078,82,1.03 [0.58-1.84],0.9099906842082928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL13,Interleukin-13,2421,99,0.88 [0.58-1.32],0.5239534980116893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL13RA1,Interleukin-13 receptor subunit alpha-1,2453,98,1.43 [0.68-3.00],0.3400962014572921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL13RA2,Interleukin-13 receptor subunit alpha-2,2071,82,1.42 [0.66-3.04],0.372575113920265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL15,Interleukin-15,2477,100,1.99 [1.21-3.28],0.0067790415780741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL15RA,Interleukin-15 receptor subunit alpha,2421,99,2.45 [1.53-3.93],0.0001862537143143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL16,Pro-interleukin-16,2506,101,1.38 [0.96-1.97],0.080967280980255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17A,Interleukin-17A,2415,98,0.76 [0.49-1.17],0.2126405543467005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17C,Interleukin-17C,2421,99,1.28 [1.06-1.56],0.0118505663630591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17D,Interleukin-17D,2421,99,1.45 [1.06-1.97],0.0184234003023941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17F,Interleukin-17F,2421,99,1.17 [0.93-1.48],0.1768209231712282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17RA,Interleukin-17 receptor A,2490,100,1.32 [0.92-1.91],0.1342169042449052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17RB,Interleukin-17 receptor B,2454,99,1.36 [0.99-1.88],0.0615524887614549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18,Interleukin-18,2474,99,2.08 [1.44-2.99],8.959832723772356e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18BP,Interleukin-18-binding protein,2486,99,3.17 [2.03-4.93],3.53914876787644e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18R1,Interleukin-18 receptor 1,2506,101,2.69 [1.71-4.23],1.8637260277000315e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18RAP,Interleukin-18 receptor accessory protein,2450,96,1.05 [0.94-1.17],0.3699965516429425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL19,Interleukin-19,2434,97,1.26 [1.04-1.52],0.015495373741087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1A,Interleukin-1 alpha,2421,99,1.21 [0.93-1.57],0.1556113271859914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1B,Interleukin-1 beta,2407,99,0.93 [0.68-1.28],0.6604444209522189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1R1,Interleukin-1 receptor type 1,2488,100,6.91 [4.05-11.81],1.4616521223965604e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1R2,Interleukin-1 receptor type 2,2476,99,1.30 [0.59-2.86],0.5225825823736152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RAP,Interleukin-1 receptor accessory protein,2490,100,1.07 [0.75-1.55],0.7020333353557173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RL1,Interleukin-1 receptor-like 1,2502,102,2.26 [1.53-3.32],3.666121098288082e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RL2,Interleukin-1 receptor-like 2,2421,99,0.70 [0.44-1.12],0.1349959933429687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RN,Interleukin-1 receptor antagonist protein,2480,99,1.17 [0.89-1.54],0.2580545436815553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2,Interleukin-2,2421,99,1.22 [0.69-2.15],0.4965322187693133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL20,Interleukin-20,2421,99,1.07 [0.77-1.48],0.6991648633505052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL20RA,Interleukin-20 receptor subunit alpha,2421,99,1.02 [0.67-1.55],0.9181303424251066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL20RB,Interleukin-20 receptor subunit beta,2078,82,1.12 [0.68-1.83],0.6541843218665725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL21R,Interleukin-21 receptor,2078,82,0.94 [0.63-1.39],0.7568564871095365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL22,Interleukin-22,2133,83,1.25 [0.94-1.67],0.1208368907094333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL22RA1,Interleukin-22 receptor subunit alpha-1,2421,99,1.29 [0.90-1.83],0.160867719953205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL24,Interleukin-24,2421,99,1.03 [0.75-1.43],0.8412344003868074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL25,Interleukin-25,2058,81,1.22 [0.64-2.33],0.545272725408553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2RA,Interleukin-2 receptor subunit alpha,2460,100,2.38 [1.73-3.27],8.338753651338062e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2RB,Interleukin-2 receptor subunit beta,2421,99,1.21 [0.84-1.76],0.3102384588914384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2RG,Cytokine receptor common subunit gamma,2133,83,1.73 [1.10-2.72],0.0180833993010187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL3,Interleukin-3,2063,81,0.72 [0.54-0.94],0.0182667076616099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL31,Interleukin-31,2078,82,0.89 [0.57-1.37],0.5845503876744162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL31RA,Interleukin-31 receptor subunit alpha,2069,82,1.00 [0.58-1.73],0.9984442479093488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL32,Interleukin-32,2477,100,0.94 [0.66-1.33],0.724950485475981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL33,Interleukin-33,2421,99,1.41 [0.90-2.21],0.1340974427421605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL34,Interleukin-34,2410,94,1.05 [0.64-1.71],0.857294479495176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL36A,Interleukin-36 alpha,2078,82,1.04 [0.71-1.53],0.837066216213078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL36G,Interleukin-36 gamma,2073,82,1.07 [0.80-1.43],0.6550268957240766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL3RA,Interleukin-3 receptor subunit alpha,2421,99,1.43 [0.85-2.40],0.1743613502882716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL4,Interleukin-4,2421,99,1.04 [0.86-1.25],0.6798915332138199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL4R,Interleukin-4 receptor subunit alpha,2477,100,2.37 [1.65-3.39],2.8675326428304816e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL5,Interleukin-5,2421,99,1.00 [0.87-1.15],0.9750609755257976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL5RA,Interleukin-5 receptor subunit alpha,2477,100,1.35 [1.02-1.80],0.0384261094798343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL6,Interleukin-6,2475,101,1.07 [0.88-1.32],0.4838993845339826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL6R,Interleukin-6 receptor subunit alpha,2465,99,1.12 [0.68-1.84],0.6647414279931432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL6ST,Interleukin-6 receptor subunit beta,2483,101,4.47 [1.79-11.16],0.0013491204514221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL7,Interleukin-7,2477,100,0.97 [0.72-1.30],0.8306497613556197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL7R,Interleukin-7 receptor subunit alpha,2490,100,1.23 [0.87-1.74],0.2461650665164227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL9,Interleukin-9,2114,81,0.99 [0.69-1.43],0.9721167234317748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,2408,94,1.17 [0.88-1.57],0.2866584855377392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IMMT,MICOS complex subunit MIC60,2133,83,1.44 [0.98-2.13],0.0663680115180757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IMPA1,Inositol monophosphatase 1,2463,98,0.95 [0.69-1.30],0.745132590553995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IMPACT,Protein IMPACT,2140,84,1.16 [0.79-1.70],0.4527446275457629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IMPG1,Interphotoreceptor matrix proteoglycan 1,2071,82,1.64 [0.82-3.28],0.1595671265107534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ING1,Inhibitor of growth protein 1,2411,93,1.04 [0.72-1.49],0.8370039149144767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INHBB,Inhibin beta B chain,2109,80,2.61 [1.87-3.64],1.7024172991805783e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INHBC,Inhibin beta C chain,2490,100,1.44 [0.89-2.34],0.1394551131215136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INPP1,Inositol polyphosphate 1-phosphatase,2475,101,0.94 [0.67-1.32],0.7347660084584984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",2096,83,1.15 [0.79-1.67],0.4673012780405221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",2136,83,0.86 [0.50-1.51],0.6052496613570677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",2475,101,1.04 [0.86-1.25],0.7039842537959564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSL3,Insulin-like 3,2140,84,1.00 [0.79-1.26],0.9771700296064296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSL4,Early placenta insulin-like peptide,2133,83,1.98 [1.51-2.61],9.910769909760216e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSL5,Insulin-like peptide INSL5,2130,82,1.24 [1.02-1.50],0.034685479569405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSR,Insulin receptor,2078,82,5.86 [1.89-18.20],0.0022068120396671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IPCEF1,Interactor protein for cytohesin exchange factors 1,2462,98,0.98 [0.79-1.22],0.8670992575158916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,2475,101,1.06 [0.77-1.45],0.7243411256081794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",2437,97,1.11 [0.91-1.35],0.3214850848104107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IRAK1,Interleukin-1 receptor-associated kinase 1,2421,99,1.14 [0.87-1.49],0.3362967648469411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IRAK4,Interleukin-1 receptor-associated kinase 4,2477,100,1.05 [0.88-1.25],0.6069760102153823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,2383,89,0.86 [0.52-1.40],0.537515433724988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ISM1,Isthmin-1,2477,100,1.24 [0.83-1.83],0.291872082442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ISM2,Isthmin-2,2147,82,1.08 [0.65-1.78],0.7673243295150263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IST1,IST1 homolog,2115,82,1.05 [0.83-1.33],0.6842708787448603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGA11,Integrin alpha-11,2477,100,0.64 [0.40-1.03],0.0647230740841913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGA2,Integrin alpha-2,2109,80,0.59 [0.33-1.05],0.0741417227651841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGA5,Integrin alpha-5,2490,100,1.94 [1.06-3.56],0.0328809713692596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGA6,Integrin alpha-6,2477,100,0.95 [0.66-1.36],0.7668591778841063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGAL,Integrin alpha-L,2078,82,1.29 [0.78-2.15],0.3246978829679661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGAM,Integrin alpha-M,2490,100,1.14 [0.69-1.88],0.6063982352945951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGAV,Integrin alpha-V,2500,102,0.31 [0.13-0.73],0.0076738462289902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGAX,Integrin alpha-X,2114,81,0.66 [0.40-1.09],0.1080668637006561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB1,Integrin beta-1,2474,99,1.83 [0.91-3.69],0.089197956463943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB1BP1,Integrin beta-1-binding protein 1,2418,95,1.24 [0.82-1.89],0.3112225380240324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB1BP2,Integrin beta-1-binding protein 2,2437,97,1.03 [0.87-1.21],0.7571607403312169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB2,Integrin beta-2,2470,99,1.60 [0.95-2.72],0.0799114373530666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB5,Integrin beta-5,2489,101,0.91 [0.58-1.43],0.6818119580954621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB6,Integrin beta-6,2421,99,2.46 [1.43-4.22],0.0011438267318827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB7,Integrin beta-7,2500,102,1.34 [0.95-1.89],0.1004617593785276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGBL1,Integrin beta-like protein 1,2147,82,1.82 [1.32-2.51],0.0002378380900943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,2143,83,1.57 [0.53-4.68],0.415477951543002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,2486,99,2.49 [1.55-3.98],0.0001483662580659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,2143,83,1.78 [0.84-3.78],0.1308687279345679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,2133,83,1.21 [0.77-1.91],0.3987309779662659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITM2A,Integral membrane protein 2A,2477,100,1.28 [0.96-1.69],0.088200563717074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITPA,Inosine triphosphate pyrophosphatase,2068,81,1.08 [0.78-1.49],0.6632532842468819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",2096,83,1.09 [0.82-1.46],0.5386814332323091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",2071,82,0.99 [0.59-1.68],0.9810459556260304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",2414,94,1.03 [0.71-1.47],0.889129962023429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IZUMO1,Izumo sperm-egg fusion protein 1,2063,81,1.20 [0.78-1.83],0.4093655242599422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JAM2,Junctional adhesion molecule B,2505,102,5.60 [3.74-8.40],7.977101242703688e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JAM3,Junctional adhesion molecule C,2109,80,1.47 [1.05-2.05],0.0237461169034638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JCHAIN,Immunoglobulin J chain,2421,99,1.19 [0.89-1.58],0.2435455534827421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,2063,81,0.84 [0.54-1.31],0.4446032555081723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JPT2,Jupiter microtubule associated homolog 2,2130,82,1.21 [0.93-1.58],0.1628712221002455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JUN,Transcription factor AP-1,2421,99,1.37 [1.09-1.74],0.0083037404116201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,2475,101,2.09 [1.43-3.07],0.000152095244552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KAZN,Kazrin,2130,82,1.13 [0.91-1.40],0.2578223285484183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KCNC4,Potassium voltage-gated channel subfamily C member 4,2071,82,1.00 [0.66-1.50],0.986790582553866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KCNH2,Potassium voltage-gated channel subfamily H member 2,2095,81,0.71 [0.48-1.03],0.0742032706015734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KCNIP4,Kv channel-interacting protein 4,2414,94,0.85 [0.57-1.26],0.418905877998418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KCTD5,BTB/POZ domain-containing protein KCTD5,2097,82,1.36 [0.88-2.10],0.1604505137755362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KDM3A,Lysine-specific demethylase 3A,2078,82,1.19 [0.96-1.48],0.1114242893234816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KDR,Vascular endothelial growth factor receptor 2,2489,101,0.65 [0.32-1.31],0.2291970051910118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KEL,Kell blood group glycoprotein,2414,94,1.01 [0.62-1.64],0.9657754037728064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KHDC3L,KH domain-containing protein 3,2063,81,1.05 [0.80-1.38],0.7152943434713313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KHK,Ketohexokinase,2096,83,0.89 [0.64-1.24],0.4814688638495794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIAA0319,Dyslexia-associated protein KIAA0319,2140,84,2.16 [1.14-4.11],0.0185905059029195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIAA1549,UPF0606 protein KIAA1549,2114,81,1.37 [1.04-1.79],0.0243827481873706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIAA1549L,UPF0606 protein KIAA1549L,2114,81,1.28 [0.65-2.50],0.4713385231366611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIAA2013,Uncharacterized protein KIAA2013,2133,83,1.04 [0.67-1.63],0.8545123082105451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIF1C,Kinesin-like protein KIF1C,2068,81,2.33 [1.44-3.76],0.0005732641731049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIF20B,Kinesin-like protein KIF20B,2071,82,1.16 [0.92-1.47],0.2064117870241138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIF22,Kinesin-like protein KIF22,2068,81,1.01 [0.84-1.21],0.9472481462735952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIFBP,KIF-binding protein,2475,101,1.03 [0.83-1.28],0.7617057485215787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,2133,83,1.29 [1.03-1.60],0.0253098987801961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,2418,95,1.27 [1.02-1.57],0.0332474728799471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,2130,82,1.03 [0.92-1.16],0.6131589172291365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,2418,95,1.01 [0.88-1.17],0.83977160896068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,2063,81,1.16 [0.93-1.45],0.1894291247197603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIRREL1,Kin of IRRE-like protein 1,2071,82,1.09 [0.73-1.63],0.6723662237585635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIRREL2,Kin of IRRE-like protein 2,2414,94,1.39 [0.90-2.15],0.1358703780270965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIT,Mast/stem cell growth factor receptor Kit,2485,99,0.75 [0.42-1.34],0.3329397305797014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KITLG,Kit ligand,2483,101,1.07 [0.70-1.63],0.7478851908111052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLB,Beta-klotho,2414,94,1.15 [0.91-1.45],0.2547128015335624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLF4,Krueppel-like factor 4,2071,82,1.13 [0.66-1.93],0.6670900738712087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLHL41,Kelch-like protein 41,2136,83,1.25 [0.85-1.84],0.2620600933266377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK1,Kallikrein-1,2458,100,0.94 [0.81-1.08],0.3790052961190608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK10,Kallikrein-10,2481,101,1.72 [1.16-2.56],0.0071208369938786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK11,Kallikrein-11,2463,101,3.52 [2.24-5.54],4.8345719090192056e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK12,Kallikrein-12,2418,95,1.08 [0.95-1.24],0.2477138034277392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK13,Kallikrein-13,2432,100,1.05 [0.75-1.48],0.7581868540503258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK14,Kallikrein-14,2500,102,1.77 [1.22-2.57],0.0028269231428189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK15,Kallikrein-15,2128,83,1.34 [0.92-1.95],0.129902571387269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK3,Prostate-specific antigen,2147,82,0.88 [0.72-1.06],0.1768546614868334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK4,Kallikrein-4,2500,102,2.17 [1.81-2.61],7.80895694197881e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK6,Kallikrein-6,2485,101,2.64 [1.64-4.24],6.130571552967834e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK7,Kallikrein-7,2050,79,0.57 [0.32-1.01],0.0554968942397352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK8,Kallikrein-8,2397,98,1.50 [0.98-2.31],0.0623583422128629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLKB1,Plasma kallikrein,2100,83,0.70 [0.29-1.70],0.4316223913751922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,2506,101,2.98 [2.09-4.24],1.336185355226603e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,2071,82,1.10 [0.79-1.54],0.5561288444029358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRD1,Natural killer cells antigen CD94,2506,101,1.80 [1.25-2.58],0.0015472729019135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,2078,82,1.44 [1.09-1.91],0.0102343985302796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRK1,NKG2-D type II integral membrane protein,2140,84,1.51 [0.96-2.39],0.0768774133391327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT14,"Keratin, type I cytoskeletal 14",2347,92,1.22 [0.67-2.24],0.5188942239458392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT17,"Keratin, type I cytoskeletal 17",2068,81,0.96 [0.54-1.69],0.8845801602289638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT18,"Keratin, type I cytoskeletal 18",2475,101,1.06 [0.89-1.26],0.5312445118368043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT19,"Keratin, type I cytoskeletal 19",2473,100,1.58 [1.28-1.95],1.7540669314024663e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT5,"Keratin, type II cytoskeletal 5",2414,94,1.00 [0.71-1.40],0.9917158463089852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT6C,"Keratin, type II cytoskeletal 6C",2068,81,1.19 [0.72-1.97],0.485568793457517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT8,"Keratin, type II cytoskeletal 8",2071,82,1.12 [0.98-1.28],0.0869210439575665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KYAT1,Kynurenine--oxoglutarate transaminase 1,2480,101,0.76 [0.55-1.05],0.1003892690038394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KYNU,Kynureninase,2506,101,0.58 [0.40-0.83],0.00297691700245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,L1CAM,Neural cell adhesion molecule L1,2489,101,1.05 [0.60-1.83],0.8698975971524521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,2138,84,1.02 [0.80-1.30],0.8822208909418001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LACRT,Extracellular glycoprotein lacritin,2124,82,1.18 [0.82-1.71],0.3737111279349343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LACTB2,Endoribonuclease LACTB2,2483,101,0.94 [0.71-1.25],0.6797609573732841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAG3,Lymphocyte activation gene 3 protein,2475,101,2.72 [1.95-3.81],4.576566521496305e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,2481,99,2.58 [2.04-3.26],1.534579502557182e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,2463,98,1.13 [0.95-1.34],0.1768633719762986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMA1,Laminin subunit alpha-1,2068,81,0.77 [0.46-1.28],0.3139355400894927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMA4,Laminin subunit alpha-4,2496,99,1.55 [0.96-2.51],0.0739738507008517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMB1,Laminin subunit beta-1,2096,83,2.30 [1.19-4.45],0.0132175370560945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMP1,Lysosome-associated membrane glycoprotein 1,2091,80,1.09 [0.48-2.49],0.8332785991719113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMP2,Lysosome-associated membrane glycoprotein 2,2425,96,1.72 [0.69-4.26],0.2428174874441725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMP3,Lysosome-associated membrane glycoprotein 3,2501,101,1.46 [1.06-2.01],0.020572983720769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMTOR5,Ragulator complex protein LAMTOR5,2133,83,1.11 [0.66-1.90],0.6883993892291111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAP3,Cytosol aminopeptidase,2421,99,1.06 [0.75-1.50],0.7298405812044786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LARP1,La-related protein 1,2133,83,1.15 [0.82-1.60],0.411760728921672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAT,Linker for activation of T-cells family member 1,2506,101,1.05 [0.82-1.33],0.7019439149415183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAT2,Linker for activation of T-cells family member 2,2475,101,1.05 [0.91-1.21],0.5184610635413303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LATS1,Serine/threonine-protein kinase LATS1,2078,82,1.08 [0.83-1.40],0.5821370502817493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAYN,Layilin,2460,97,3.81 [2.79-5.21],4.895689928137638e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LBP,Lipopolysaccharide-binding protein,2486,99,1.49 [1.09-2.04],0.0114071683732014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LBR,Delta(14)-sterol reductase LBR,2505,102,1.12 [0.88-1.41],0.3586843780413186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCAT,Phosphatidylcholine-sterol acyltransferase,2148,83,0.73 [0.27-1.95],0.5312262325361999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCN15,Lipocalin-15,2136,83,1.57 [1.29-1.91],9.42893865214974e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCN2,Neutrophil gelatinase-associated lipocalin,2397,95,2.42 [1.82-3.22],1.432528714757969e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCP1,Plastin-2,2147,82,0.63 [0.39-1.02],0.0585093702525867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LDLR,Low-density lipoprotein receptor,2488,100,0.84 [0.60-1.19],0.3346898209925997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LDLRAP1,Low density lipoprotein receptor adapter protein 1,2136,83,1.04 [0.83-1.30],0.7092483604052153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LECT2,Leukocyte cell-derived chemotaxin-2,2138,84,1.26 [0.97-1.65],0.0837264288153634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEFTY2,Left-right determination factor 2,2495,102,1.40 [1.02-1.94],0.0397551482391184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEG1,Protein LEG1 homolog,2042,76,1.11 [0.82-1.50],0.5164948479161849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LELP1,Late cornified envelope-like proline-rich protein 1,2071,82,0.82 [0.58-1.17],0.2747350392176507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEO1,RNA polymerase-associated protein LEO1,2136,83,1.21 [0.72-2.03],0.4621095560159458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEP,Leptin,2483,101,1.16 [0.87-1.54],0.3022777246627606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEPR,Leptin receptor,2483,101,1.23 [0.72-2.12],0.4497193113143576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LETM1,Mitochondrial proton/calcium exchanger protein,2136,83,1.62 [1.12-2.36],0.0105711162670782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS1,Galectin-1,2483,101,2.35 [1.49-3.68],0.0002097050664238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS3,Galectin-3,2479,100,2.61 [1.50-4.53],0.000663013691486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS3BP,Galectin-3-binding protein,2143,83,1.58 [0.86-2.91],0.1381464452324995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS4,Galectin-4,2481,99,2.37 [1.82-3.09],1.4530653698354314e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS7_LGALS7B,Galectin-7,2471,101,1.72 [1.20-2.47],0.0029905658572873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS8,Galectin-8,2505,102,1.16 [0.86-1.57],0.3211857513132865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS9,Galectin-9,2484,99,4.46 [2.74-7.23],1.507353707680447e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGMN,Legumain,2496,99,1.45 [0.89-2.35],0.1325790788934195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LHB,Lutropin subunit beta,2418,95,1.03 [0.84-1.26],0.7593876084649157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,2488,99,0.85 [0.64-1.13],0.259904689998894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LIF,Leukemia inhibitory factor,2414,94,1.32 [0.92-1.90],0.132858184312142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LIFR,Leukemia inhibitory factor receptor,2477,100,5.60 [3.44-9.13],4.2890022163702004e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,2490,100,1.55 [0.94-2.56],0.0880899214924181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,2147,82,0.97 [0.85-1.12],0.6948354679055158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,2068,81,1.22 [0.83-1.80],0.3174320671923886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,2483,101,1.73 [1.01-2.96],0.0464306142691114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,2138,84,1.14 [0.86-1.50],0.3639138507643377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,2510,102,1.84 [1.00-3.38],0.0481842558718818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,2497,102,1.51 [0.92-2.48],0.1055664865255781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,2421,99,2.23 [1.59-3.14],3.684178627177938e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,2510,102,0.99 [0.77-1.27],0.9077153338338664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LIPF,Gastric triacylglycerol lipase,2096,83,1.00 [0.75-1.35],0.9890675696980537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMNB1,Lamin-B1,2128,82,0.96 [0.69-1.34],0.8199734328839898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMNB2,Lamin-B2,2140,84,3.23 [1.82-5.73],5.876524841938849e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMOD1,Leiomodin-1,2136,83,4.00 [2.56-6.23],9.931995548359726e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMOD2,Leiomodin-2,2071,82,0.86 [0.57-1.29],0.4546314070879795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LONP1,"Lon protease homolog, mitochondrial",2096,83,1.09 [0.85-1.40],0.5046167019718157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPA,Apolipoprotein(a),2091,82,0.92 [0.83-1.03],0.156852179079197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPCAT2,Lysophosphatidylcholine acyltransferase 2,2475,101,0.99 [0.68-1.45],0.9623092591310553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPL,Lipoprotein lipase,2483,101,0.96 [0.66-1.41],0.8439002640909584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPO,Lactoperoxidase,2397,96,1.43 [1.10-1.85],0.0068690819544078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPP,Lipoma-preferred partner,2068,81,1.15 [0.82-1.61],0.4300176542948365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,2068,81,1.10 [0.79-1.53],0.5823054833253715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,2095,81,1.18 [0.74-1.87],0.4915190965263364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRG1,Leucine-rich alpha-2-glycoprotein,2143,83,2.57 [1.15-5.76],0.0215262745162793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,2494,102,2.84 [1.97-4.12],2.9489244301168952e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,2074,82,1.52 [0.84-2.76],0.1707209990181837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP1,Prolow-density lipoprotein receptor-related protein 1,2475,101,1.89 [1.05-3.42],0.0339051556728375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP11,Low-density lipoprotein receptor-related protein 11,2483,101,2.39 [1.59-3.60],2.91703866558256e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP2,Low-density lipoprotein receptor-related protein 2,2095,81,0.90 [0.47-1.69],0.7353091985589241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP2BP,LRP2-binding protein,2095,81,1.00 [0.76-1.31],0.9871249963885578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,2505,102,1.07 [0.78-1.45],0.6883146099548538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRC25,Leucine-rich repeat-containing protein 25,2475,101,1.41 [1.03-1.93],0.0308040037606822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRC37A2,Leucine-rich repeat-containing protein 37A2,2130,82,1.63 [1.00-2.67],0.05000506132793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRC38,Leucine-rich repeat-containing protein 38,2095,81,1.34 [0.90-1.99],0.152297195745543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRC59,Leucine-rich repeat-containing protein 59,2138,84,1.36 [0.90-2.05],0.1421905270012201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,2133,83,1.23 [0.81-1.87],0.3387543260410685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRN1,Leucine-rich repeat neuronal protein 1,2421,99,0.63 [0.41-0.96],0.0328766646710238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,2095,81,1.53 [0.97-2.43],0.0702230553869949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,2136,83,1.20 [0.53-2.75],0.6602701210361427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LSM1,U6 snRNA-associated Sm-like protein LSm1,2418,95,1.03 [0.74-1.44],0.847522361168325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LSM8,U6 snRNA-associated Sm-like protein LSm8,2114,81,1.06 [0.85-1.32],0.5943583668297696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LSP1,Lymphocyte-specific protein 1,2477,100,1.01 [0.64-1.60],0.9667749081067482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTA,Lymphotoxin-alpha,2477,100,1.45 [0.93-2.25],0.097932844571241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTA4H,Leukotriene A-4 hydrolase,2500,102,0.95 [0.70-1.28],0.7276238647852276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTB,Lymphotoxin-beta,2133,83,1.23 [0.74-2.04],0.4276898091745608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,2510,102,3.58 [2.37-5.41],1.258417492266526e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,2418,95,1.45 [1.17-1.79],0.0005904868754934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBR,Tumor necrosis factor receptor superfamily member 3,2468,99,4.20 [2.83-6.22],8.630890726173369e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTO1,Protein LTO1 homolog,2421,99,1.03 [0.64-1.63],0.9113523781125958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LUZP2,Leucine zipper protein 2,2133,83,1.23 [0.86-1.76],0.2616186582489976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LXN,Latexin,2447,98,0.99 [0.77-1.28],0.9540475959926528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY6D,Lymphocyte antigen 6D,2473,98,2.34 [1.71-3.18],7.442325196399102e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY75,Lymphocyte antigen 75,2477,100,1.55 [0.99-2.41],0.0553768600253005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY9,T-lymphocyte surface antigen Ly-9,2452,98,2.16 [1.28-3.64],0.0039597680723946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY96,Lymphocyte antigen 96,2463,98,1.66 [1.04-2.67],0.0355072003881359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYAR,Cell growth-regulating nucleolar protein,2418,95,0.94 [0.64-1.39],0.7655149449226917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYN,Tyrosine-protein kinase Lyn,2475,101,1.02 [0.82-1.26],0.8829701990919757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYPD1,Ly6/PLAUR domain-containing protein 1,2414,94,0.94 [0.66-1.34],0.7359786634778528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYPD3,Ly6/PLAUR domain-containing protein 3,2463,100,1.40 [0.87-2.25],0.1649830702072153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYPD8,Ly6/PLAUR domain-containing protein 8,2418,95,1.19 [0.93-1.52],0.1573925154627036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYPLA2,Acyl-protein thioesterase 2,2071,82,0.89 [0.72-1.11],0.3128542811522928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,2095,81,0.98 [0.81-1.20],0.8514469246605008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,2143,83,2.26 [0.80-6.36],0.1237635158298464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYZL2,Lysozyme-like protein 2,2063,81,1.21 [0.66-2.23],0.5393223747282073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LZTFL1,Leucine zipper transcription factor-like protein 1,2109,80,0.89 [0.64-1.24],0.4860276335030054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,M6PR,Cation-dependent mannose-6-phosphate receptor,2096,83,0.88 [0.51-1.52],0.6357352433442296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,2451,97,1.33 [1.00-1.76],0.0490110944825767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAEA,E3 ubiquitin-protein transferase MAEA,2418,95,0.65 [0.39-1.09],0.1036384062956028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAG,Myelin-associated glycoprotein,2095,81,0.67 [0.42-1.05],0.0822256722007984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAGEA3,Melanoma-associated antigen 3,2114,81,1.03 [0.81-1.32],0.8017536189503224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAGED1,Melanoma-associated antigen D1,2418,95,1.20 [0.86-1.68],0.2825506385172578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAMDC2,MAM domain-containing protein 2,2138,84,3.21 [2.03-5.08],5.703676922400622e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAMDC4,Apical endosomal glycoprotein,2133,83,0.94 [0.65-1.36],0.7483425386239964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",2096,83,1.55 [0.67-3.57],0.3047421701130249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAN2B2,Epididymis-specific alpha-mannosidase,2138,84,1.03 [0.74-1.44],0.864479628570947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",2063,81,1.51 [1.01-2.27],0.0450509492874716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANF,Mesencephalic astrocyte-derived neurotrophic factor,2496,99,1.00 [0.86-1.17],0.9831492942922996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANSC1,MANSC domain-containing protein 1,2489,101,4.75 [2.80-8.08],8.258422043956367e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANSC4,MANSC domain-containing protein 4,2068,81,0.96 [0.71-1.28],0.7613486256309977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,2071,82,1.05 [0.53-2.08],0.8965531042749313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,2068,81,1.04 [0.76-1.42],0.821669884201915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP2,Microtubule-associated protein 2,2140,84,1.55 [1.04-2.32],0.0298749477861611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,2130,82,1.34 [0.95-1.90],0.0991300015075987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,2477,100,1.01 [0.84-1.22],0.8808633125302485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,2418,95,1.04 [0.86-1.26],0.6989086590737863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,2460,97,1.02 [0.86-1.20],0.8598143835563729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPK13,Mitogen-activated protein kinase 13,2063,81,1.13 [0.72-1.79],0.5885259593964522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPK9,Mitogen-activated protein kinase 9,2477,100,1.10 [0.72-1.68],0.6609956311135345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPKAPK2,MAP kinase-activated protein kinase 2,2114,81,1.04 [0.77-1.41],0.8020213069797573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPRE3,Microtubule-associated protein RP/EB family member 3,2063,81,0.95 [0.80-1.12],0.5155093276216798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPT,Microtubule-associated protein tau,2414,94,1.49 [1.05-2.11],0.0260133711328239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MARCO,Macrophage receptor MARCO,2483,101,1.27 [0.66-2.46],0.4727472819228426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MARS1,"Methionine--tRNA ligase, cytoplasmic",2108,80,1.03 [0.79-1.35],0.8081383699840181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MASP1,Mannan-binding lectin serine protease 1,2460,97,1.11 [0.52-2.36],0.7834499694542922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MATN2,Matrilin-2,2488,99,2.42 [1.35-4.32],0.0028950281912485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MATN3,Matrilin-3,2462,98,0.56 [0.33-0.96],0.0336181484779801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAVS,Mitochondrial antiviral-signaling protein,2418,95,1.11 [0.90-1.36],0.3397510192998529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAX,Protein max,2414,94,1.02 [0.85-1.22],0.8165258549723693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MB,Myoglobin,2510,102,1.84 [1.45-2.34],4.275041785605177e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MBL2,Mannose-binding protein C,2109,81,1.02 [0.84-1.22],0.8728775105788684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCAM,Cell surface glycoprotein MUC18,2486,99,1.83 [1.20-2.78],0.0050464447047906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",2136,83,0.68 [0.38-1.21],0.1915676402555577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCEMP1,Mast cell-expressed membrane protein 1,2078,82,0.93 [0.72-1.22],0.6111186358946658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCFD2,Multiple coagulation factor deficiency protein 2,2473,99,1.53 [1.02-2.28],0.0387745806258741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCTS1,Malignant T-cell-amplified sequence 1,2130,82,1.58 [0.83-3.03],0.1642204600545907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,2463,98,1.15 [0.90-1.47],0.2637243159717012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDH1,"Malate dehydrogenase, cytoplasmic",2137,83,0.94 [0.53-1.66],0.8215117767637647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDK,Midkine,2481,100,1.78 [1.42-2.21],3.2654064043465226e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDM1,Nuclear protein MDM1,2095,81,1.07 [0.51-2.22],0.8626606368618466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",2096,83,1.07 [0.84-1.36],0.5829039946188227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MED18,Mediator of RNA polymerase II transcription subunit 18,2418,95,1.04 [0.81-1.34],0.7681192635467575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MED21,Mediator of RNA polymerase II transcription subunit 21,2068,81,0.99 [0.62-1.59],0.9695062859550782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEGF10,Multiple epidermal growth factor-like domains protein 10,2481,99,1.49 [0.97-2.28],0.0714874580277387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEGF11,Multiple epidermal growth factor-like domains protein 11,2068,81,1.15 [0.57-2.29],0.6983860323697946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEGF9,Multiple epidermal growth factor-like domains protein 9,2502,102,2.08 [0.89-4.87],0.0917805278944905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MELTF,Melanotransferrin,2138,84,2.38 [1.21-4.64],0.011463380575624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MENT,Protein MENT,2109,80,0.34 [0.15-0.77],0.0095877205211422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEP1A,Meprin A subunit alpha,2130,82,0.77 [0.57-1.03],0.0764513812061059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEP1B,Meprin A subunit beta,2483,101,0.85 [0.74-0.98],0.0272834284779138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEPE,Matrix extracellular phosphoglycoprotein,2481,99,0.99 [0.52-1.88],0.9711286252290352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MERTK,Tyrosine-protein kinase Mer,2506,101,2.36 [1.27-4.37],0.0066191273000837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MESD,LRP chaperone MESD,2490,100,1.02 [0.87-1.18],0.8427687205941877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MET,Hepatocyte growth factor receptor,2490,99,2.17 [0.97-4.83],0.0588548164328503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,METAP1,Methionine aminopeptidase 1,2414,94,1.02 [0.55-1.89],0.9556462846612164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",2477,100,1.05 [0.84-1.33],0.6521279819143159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,METAP2,Methionine aminopeptidase 2,2495,102,1.01 [0.72-1.41],0.9750791569904386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP3,Microfibril-associated glycoprotein 3,2437,97,1.05 [0.74-1.49],0.772292828569648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP3L,Microfibrillar-associated protein 3-like,2095,81,0.75 [0.50-1.12],0.1561411428730272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP4,Microfibril-associated glycoprotein 4,2109,80,2.97 [1.62-5.44],0.0004091905929307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP5,Microfibrillar-associated protein 5,2510,102,2.15 [1.45-3.20],0.0001561105234439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFGE8,Lactadherin,2490,100,1.34 [0.94-1.91],0.1094286301346062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MGLL,Monoglyceride lipase,2492,99,0.98 [0.80-1.21],0.8565429957998474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MGMT,Methylated-DNA--protein-cysteine methyltransferase,2477,100,1.05 [0.89-1.23],0.5566879495500503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MIA,Melanoma-derived growth regulatory protein,2489,101,1.72 [1.14-2.61],0.0102695718368212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MICALL2,MICAL-like protein 2,2095,81,1.20 [0.88-1.65],0.2511495522323118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,2477,100,1.13 [0.98-1.29],0.0860897218586141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MIF,Macrophage migration inhibitory factor,2486,100,1.03 [0.78-1.35],0.8591259541643752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MILR1,Allergin-1,2421,99,1.58 [1.15-2.18],0.0046208053462747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,2133,83,0.99 [0.81-1.22],0.9542845894589732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MINK1,Misshapen-like kinase 1,2140,84,1.01 [0.79-1.29],0.91647959188907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MITD1,MIT domain-containing protein 1,2463,98,1.03 [0.84-1.25],0.799781392703028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MKI67,Proliferation marker protein Ki-67,2078,82,1.14 [0.65-1.98],0.6532185479815757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MLLT1,Protein ENL,2063,81,1.01 [0.72-1.40],0.9628593685209544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MLN,Promotilin,2477,100,1.32 [1.07-1.63],0.009903451543278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MME,Neprilysin,2475,101,1.09 [0.89-1.33],0.4148397740742112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP1,Interstitial collagenase,2383,92,1.20 [0.97-1.49],0.0897924560213549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP10,Stromelysin-2,2480,99,1.83 [1.39-2.43],2.1768359715164392e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP12,Macrophage metalloelastase,2485,102,1.58 [1.18-2.12],0.0021278586036969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP13,Collagenase 3,2414,94,1.76 [1.02-3.03],0.0431871257010591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP15,Matrix metalloproteinase-15,2138,84,1.22 [0.86-1.73],0.255413203754233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP3,Stromelysin-1,2490,100,1.50 [1.10-2.05],0.0097208196640792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP7,Matrilysin,2433,97,2.20 [1.52-3.17],2.6739120941582665e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP8,Neutrophil collagenase,2502,102,1.28 [1.02-1.59],0.0318935738012941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP9,Matrix metalloproteinase-9,2488,100,1.29 [0.97-1.73],0.0823894129298795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",2068,81,0.97 [0.61-1.54],0.8904422148457362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MN1,Transcriptional activator MN1,2095,81,1.27 [0.95-1.71],0.1079677624623721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MNAT1,CDK-activating kinase assembly factor MAT1,2114,81,0.80 [0.46-1.40],0.429429567003995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MNDA,Myeloid cell nuclear differentiation antigen,2480,101,0.94 [0.78-1.13],0.5170145741105099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MOCS2,Molybdopterin synthase catalytic subunit,2109,80,1.07 [0.76-1.51],0.6869991266705266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MOG,Myelin-oligodendrocyte glycoprotein,2500,102,2.47 [1.59-3.83],5.284312962857356e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MORC3,MORC family CW-type zinc finger protein 3,2140,84,1.00 [0.45-2.20],0.9976649950474034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MORF4L1,Mortality factor 4-like protein 1,2114,81,0.61 [0.31-1.17],0.1369396458850888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MORF4L2,Mortality factor 4-like protein 2,2063,81,0.84 [0.43-1.62],0.5929792747513141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MORN4,MORN repeat-containing protein 4,2063,81,1.01 [0.78-1.29],0.9597764285942204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPHOSPH8,M-phase phosphoprotein 8,2437,97,0.94 [0.73-1.20],0.6059397035362568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPI,Mannose-6-phosphate isomerase,2475,101,1.16 [0.94-1.44],0.1720829257442265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,2492,99,0.95 [0.76-1.20],0.6764205534668959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPO,Myeloperoxidase,2490,100,1.13 [0.78-1.63],0.5178460445506619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPRIP,Myosin phosphatase Rho-interacting protein,2129,83,0.77 [0.47-1.27],0.3074550619616805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRC1,Macrophage mannose receptor 1,2148,83,2.19 [1.12-4.25],0.0213479984993398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRI1,Methylthioribose-1-phosphate isomerase,2095,81,1.19 [0.87-1.63],0.2729181395842923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL24,"39S ribosomal protein L24, mitochondrial",2068,81,1.47 [1.01-2.14],0.0438312009969971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL28,"39S ribosomal protein L28, mitochondrial",2136,83,1.22 [0.73-2.04],0.4562847588992581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL46,"39S ribosomal protein L46, mitochondrial",2414,94,0.90 [0.46-1.74],0.7448766435268934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL52,"39S ribosomal protein L52, mitochondrial",2058,80,0.82 [0.36-1.85],0.6273613947205707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",2136,83,1.06 [0.80-1.41],0.6697483257282504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPS16,"28S ribosomal protein S16, mitochondrial",2078,82,0.81 [0.36-1.81],0.5994159672924022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSLN,Mesothelin,2466,100,1.44 [1.11-1.88],0.0066616291200845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSLNL,Mesothelin-like protein,2095,81,1.01 [0.56-1.84],0.973541755338066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSMB,Beta-microseminoprotein,2480,102,1.37 [1.08-1.73],0.0097145320277458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSR1,Macrophage scavenger receptor types I and II,2505,102,1.70 [1.18-2.44],0.0045870549416494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSRA,Mitochondrial peptide methionine sulfoxide reductase,2489,101,0.97 [0.75-1.25],0.8185407098246862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MST1,Hepatocyte growth factor-like protein,2115,82,1.17 [0.80-1.70],0.4217490279005579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSTN,Growth/differentiation factor 8,2437,97,0.78 [0.56-1.09],0.1481235815713864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTDH,Protein LYRIC,2078,82,1.22 [0.97-1.53],0.091094748718761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",2140,84,1.33 [0.64-2.76],0.4403106463856441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,2114,81,1.00 [0.82-1.21],0.9645952112449632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTIF3,"Translation initiation factor IF-3, mitochondrial",2130,82,1.02 [0.79-1.32],0.8742612053726606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTPN,Myotrophin,2437,97,0.71 [0.37-1.37],0.3120158114025076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTR,Methionine synthase,2068,81,1.02 [0.75-1.38],0.921813956676478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTSS1,Protein MTSS 1,2130,82,1.17 [0.97-1.42],0.1090794371746588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTSS2,Protein MTSS 2,2133,83,1.13 [0.90-1.41],0.288336661192881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTUS1,Microtubule-associated tumor suppressor 1,2114,81,0.69 [0.46-1.04],0.0796979082503733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUC13,Mucin-13,2414,94,2.02 [1.60-2.55],2.649973946033518e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUC16,Mucin-16,2475,101,0.98 [0.89-1.07],0.613615632796843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUC2,Mucin-2,2147,82,1.06 [0.85-1.32],0.6194210100782598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUCL3,Mucin-like protein 3,2063,81,0.76 [0.42-1.38],0.3710430321843652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MVK,Mevalonate kinase,2421,99,0.99 [0.81-1.22],0.9552944528310948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MXRA8,Matrix remodeling-associated protein 8,2109,80,0.49 [0.24-0.98],0.0439886912093978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYBPC1,"Myosin-binding protein C, slow-type",2138,84,1.40 [1.09-1.79],0.0080600308071615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYBPC2,"Myosin-binding protein C, fast-type",2096,83,1.36 [1.13-1.63],0.0009522214027596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,2136,83,0.97 [0.70-1.35],0.8717615024308333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYDGF,Myeloid-derived growth factor,2138,84,1.10 [0.87-1.38],0.4353525982506808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYH4,Myosin-4,2068,81,1.22 [0.81-1.82],0.3370199519696945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYH7B,Myosin-7B,2063,81,0.79 [0.43-1.46],0.4510352462389299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYH9,Myosin-9,2147,82,0.96 [0.79-1.16],0.6494297970962815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",2068,81,1.36 [1.03-1.79],0.0285437294544992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYL3,Myosin light chain 3,2096,83,1.20 [0.91-1.59],0.1968821243071802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYL4,Myosin light chain 4,2096,83,1.36 [0.96-1.92],0.083265062885957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYL6B,Myosin light chain 6B,2095,81,0.98 [0.76-1.25],0.844221564046159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",2095,81,1.83 [1.46-2.30],2.127988410239116e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYO6,Unconventional myosin-VI,2136,83,1.40 [0.81-2.40],0.2263052835623642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYO9B,Unconventional myosin-IXb,2421,99,1.04 [0.79-1.38],0.7752491929646577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYOC,Myocilin,2490,100,0.79 [0.54-1.15],0.2133730328548854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYOM1,Myomesin-1,2071,82,1.13 [0.75-1.71],0.5522246537941071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYOM2,Myomesin-2,2068,81,1.65 [1.16-2.34],0.0052914743337715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYOM3,Myomesin-3,2109,80,1.09 [0.86-1.37],0.4791298153918144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MZB1,Marginal zone B- and B1-cell-specific protein,2492,99,1.31 [0.94-1.82],0.1085911654669513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MZT1,Mitotic-spindle organizing protein 1,2418,95,1.02 [0.71-1.46],0.9049732843386388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAA10,N-alpha-acetyltransferase 10,2068,81,1.32 [0.89-1.97],0.1658011191339293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAA80,N-alpha-acetyltransferase 80,2095,81,1.00 [0.83-1.20],0.9647467514299412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAAA,N-acylethanolamine-hydrolyzing acid amidase,2449,97,1.29 [0.95-1.74],0.0995426400930806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NACC1,Nucleus accumbens-associated protein 1,2133,83,1.00 [0.67-1.48],0.992991023203115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NADK,NAD kinase,2483,101,0.93 [0.67-1.30],0.6746789836025049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAGA,Alpha-N-acetylgalactosaminidase,2073,82,1.40 [1.03-1.92],0.0328381363225959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAGK,N-acetyl-D-glucosamine kinase,2089,83,0.67 [0.45-0.99],0.0470225032298456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,2109,80,1.51 [0.61-3.75],0.3755838000799116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAMPT,Nicotinamide phosphoribosyltransferase,2418,95,0.82 [0.56-1.18],0.2861413828282619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAP1L4,Nucleosome assembly protein 1-like 4,2125,81,1.15 [0.67-1.97],0.6206728959024121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAPRT,Nicotinate phosphoribosyltransferase,2140,84,0.82 [0.42-1.60],0.569069210929658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NARS1,"Asparagine--tRNA ligase, cytoplasmic",2136,83,1.14 [0.71-1.82],0.595769175184296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,2489,101,5.22 [3.16-8.61],1.0049306349163136e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NBN,Nibrin,2421,99,0.84 [0.56-1.26],0.4100544545051872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCAM1,Neural cell adhesion molecule 1,2486,99,1.17 [0.70-1.94],0.5515370352937488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCAM2,Neural cell adhesion molecule 2,2490,100,1.31 [0.70-2.45],0.3899219524388766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCAN,Neurocan core protein,2505,102,0.77 [0.51-1.17],0.2251493443220577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCF2,Neutrophil cytosol factor 2,2473,100,0.87 [0.70-1.08],0.2136362821987714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCK2,Cytoplasmic protein NCK2,2496,99,1.02 [0.86-1.22],0.7977119951647031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCLN,Nicalin,2421,99,1.23 [0.92-1.63],0.1576371246013183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCR1,Natural cytotoxicity triggering receptor 1,2474,100,3.21 [2.23-4.63],4.3526021740223975e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,2130,82,4.35 [2.68-7.05],2.5718406935194277e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCS1,Neuronal calcium sensor 1,2500,102,6.08 [3.58-10.32],2.4890042091152488e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDRG1,Protein NDRG1,2414,94,1.03 [0.79-1.34],0.8255045963191368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,2133,83,1.08 [0.77-1.49],0.6662086591919318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,2074,82,1.06 [0.56-2.00],0.8530097621545393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,2130,82,1.07 [0.83-1.38],0.583180420535953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",2418,95,1.23 [1.01-1.49],0.034814568272359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEB,Nebulin,2068,81,1.49 [0.96-2.31],0.0767459031613489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECAP2,Adaptin ear-binding coat-associated protein 2,2068,81,1.09 [0.79-1.50],0.595254331835388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN1,Nectin-1,2078,82,0.95 [0.49-1.85],0.8908797189140546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN2,Nectin-2,2483,101,3.64 [2.43-5.45],3.5072393099707435e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN4,Nectin-4,2489,101,2.83 [2.11-3.79],3.422588484284227e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,2078,82,0.85 [0.56-1.27],0.4211438532026483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEDD9,Enhancer of filamentation 1,2078,82,1.65 [1.01-2.72],0.0475483988800916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEFL,Neurofilament light polypeptide,2408,94,3.12 [2.44-4.01],2.630610413993516e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEK7,Serine/threonine-protein kinase Nek7,2114,81,0.85 [0.61-1.17],0.3159232296308878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NELL1,Protein kinase C-binding protein NELL1,2489,101,0.33 [0.24-0.47],7.47793083750749e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NELL2,Protein kinase C-binding protein NELL2,2496,99,0.94 [0.53-1.68],0.8355506995965473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NENF,Neudesin,2133,83,1.10 [0.93-1.30],0.2638038256323288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEO1,Neogenin,2136,83,1.27 [0.60-2.68],0.5326021620378221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEXN,Nexilin,2148,83,1.09 [0.81-1.48],0.5596371559292663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFASC,Neurofascin,2506,101,3.84 [2.36-6.26],6.217723137269192e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFAT5,Nuclear factor of activated T-cells 5,2078,82,1.11 [0.86-1.41],0.4233742502923009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",2477,100,1.02 [0.85-1.22],0.8567672952370659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",2421,99,0.88 [0.66-1.18],0.3905238774343067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFE2,Transcription factor NF-E2 45 kDa subunit,2096,83,1.11 [0.83-1.50],0.4766862823256402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFIC,Nuclear factor 1 C-type,2136,83,1.22 [0.81-1.82],0.3383165467134602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFKB1,Nuclear factor NF-kappa-B p105 subunit,2068,81,1.08 [0.79-1.48],0.6223389337189688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFKB2,Nuclear factor NF-kappa-B p100 subunit,2114,81,1.07 [0.71-1.59],0.752318866040599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFKBIE,NF-kappa-B inhibitor epsilon,2418,95,1.04 [0.71-1.53],0.8303397999304426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",2130,82,1.09 [0.88-1.36],0.4395322671082795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFX1,Transcriptional repressor NF-X1,2068,81,1.12 [0.86-1.47],0.4043532931818218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFYA,Nuclear transcription factor Y subunit alpha,2068,81,1.57 [0.97-2.52],0.0643955707124158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NGF,Beta-nerve growth factor,2463,98,3.23 [1.03-10.12],0.0446787831389989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NGFR,Tumor necrosis factor receptor superfamily member 16,2138,84,1.33 [0.84-2.10],0.2204157078634349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NGRN,Neugrin,2140,84,2.71 [1.18-6.22],0.018931337475567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NHLRC3,NHL repeat-containing protein 3,2054,78,1.77 [0.87-3.59],0.1167444391346508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NID1,Nidogen-1,2484,99,1.35 [0.84-2.16],0.2109911993841087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NID2,Nidogen-2,2490,100,0.97 [0.77-1.23],0.8114783977724092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NINJ1,Ninjurin-1,2418,95,1.27 [0.98-1.64],0.072006683995939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NIT1,Deaminated glutathione amidase,2096,83,0.89 [0.55-1.44],0.6410852010486514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NIT2,Omega-amidase NIT2,2123,84,0.93 [0.68-1.27],0.6367568336904618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NLGN1,Neuroligin-1,2095,81,0.83 [0.55-1.24],0.3628028093955164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NLGN2,Neuroligin-2,2071,82,1.11 [0.68-1.81],0.6853937738420111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NME1,Nucleoside diphosphate kinase A,2078,82,0.90 [0.32-2.59],0.8518116630325364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NME3,Nucleoside diphosphate kinase 3,2488,99,1.02 [0.48-2.16],0.9668990893699216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NMI,N-myc-interactor,2127,83,1.10 [0.80-1.50],0.5578682331100107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,2463,98,0.90 [0.71-1.14],0.389907343930847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NMRK2,Nicotinamide riboside kinase 2,2063,81,0.87 [0.47-1.63],0.6724787877007437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,2136,83,0.95 [0.66-1.36],0.7690387427847811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOMO1,Nodal modulator 1,2490,100,1.86 [0.90-3.83],0.0922767929124986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOP56,Nucleolar protein 56,2068,81,1.12 [0.93-1.34],0.2256336653051655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOS1,"Nitric oxide synthase, brain",2414,94,1.86 [1.44-2.40],2.212215277769604e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOS2,"Nitric oxide synthase, inducible",2068,81,0.90 [0.50-1.64],0.738255518552968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOS3,"Nitric oxide synthase, endothelial",2414,94,1.40 [1.08-1.82],0.011462554016933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH1,Neurogenic locus notch homolog protein 1,2510,102,10.74 [4.18-27.63],8.399335984479011e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH2,Neurogenic locus notch homolog protein 2,2147,82,3.50 [1.64-7.48],0.0011966586818666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH3,Neurogenic locus notch homolog protein 3,2510,102,2.09 [1.31-3.36],0.0021409869588239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPC2,NPC intracellular cholesterol transporter 2,2112,82,5.40 [3.31-8.80],1.3982775566296088e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPDC1,Neural proliferation differentiation and control protein 1,2483,101,3.21 [2.31-4.46],3.983518867917253e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPHS1,Nephrin,2078,82,1.01 [0.53-1.93],0.980563121086386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPHS2,Podocin,2078,82,1.05 [0.86-1.28],0.6377379800598615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPL,N-acetylneuraminate lyase,2138,84,1.17 [0.77-1.79],0.4632104224997151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPPB,Natriuretic peptides B,2437,97,1.23 [1.09-1.38],0.0005982628557096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPPC,C-type natriuretic peptide,2477,100,1.20 [0.91-1.58],0.1977738989936492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPR1,Atrial natriuretic peptide receptor 1,2068,81,1.07 [0.62-1.84],0.811698883739111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPTN,Neuroplastin,2418,95,1.07 [0.85-1.34],0.5761651262002556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPTX1,Neuronal pentraxin-1,2490,100,1.03 [0.68-1.56],0.8818144837853867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPTX2,Neuronal pentraxin-2,2147,82,2.14 [1.17-3.92],0.0140212053720499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPTXR,Neuronal pentraxin receptor,2483,101,1.00 [0.63-1.58],0.9984107733217646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPY,Pro-neuropeptide Y,2500,102,1.83 [1.39-2.42],1.975631864517716e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRCAM,Neuronal cell adhesion molecule,2483,101,2.34 [1.45-3.77],0.0005002420113465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRGN,Neurogranin,2148,83,1.03 [0.81-1.32],0.8000918116275836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRN1,Neuritin,2136,83,0.76 [0.36-1.59],0.466452047802695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRP1,Neuropilin-1,2486,99,3.61 [2.04-6.38],1.0182838553234171e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRP2,Neuropilin-2,2490,100,1.56 [0.88-2.76],0.1252937072172806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRTN,Neurturin,2421,99,1.23 [0.88-1.71],0.2206200511055008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRXN3,Neurexin-3,2095,81,0.93 [0.47-1.84],0.838560171280568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NSFL1C,NSFL1 cofactor p47,2505,102,1.06 [0.81-1.39],0.6728590785281645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",2138,84,1.17 [0.86-1.60],0.3163568781169693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,2140,84,2.56 [1.69-3.86],7.705731983003775e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5C3A,Cytosolic 5'-nucleotidase 3A,2474,100,0.94 [0.76-1.17],0.5875393201923806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5E,5'-nucleotidase,2489,101,1.01 [0.73-1.41],0.9398349032243348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTF3,Neurotrophin-3,2477,100,1.39 [0.93-2.09],0.1083747760749719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTF4,Neurotrophin-4,2418,95,1.16 [0.75-1.80],0.5064047780550455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTRK2,BDNF/NT-3 growth factors receptor,2483,101,1.56 [0.83-2.94],0.1705278294029778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTRK3,NT-3 growth factor receptor,2505,102,1.23 [0.57-2.64],0.5945785350945907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,2483,101,1.35 [1.19-1.51],1.010165656846337e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUB1,NEDD8 ultimate buster 1,2477,100,0.97 [0.77-1.22],0.7915650999651338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,2133,83,0.92 [0.72-1.17],0.4827330930563096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUCB2,Nucleobindin-2,2498,102,2.56 [1.65-3.96],2.6789249078470787e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDC,Nuclear migration protein nudC,2506,101,1.03 [0.77-1.40],0.8256510426276567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,2096,83,0.73 [0.27-1.98],0.5410509772947065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,2068,81,0.98 [0.66-1.46],0.927452561325182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT16,U8 snoRNA-decapping enzyme,2127,81,1.14 [0.88-1.47],0.3349074848744936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],2475,101,0.81 [0.58-1.14],0.2352203751322316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT5,ADP-sugar pyrophosphatase,2490,100,1.11 [0.76-1.62],0.5799663026192562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUMB,Protein numb homolog,2078,82,1.08 [0.82-1.42],0.5741006422380494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUP50,Nuclear pore complex protein Nup50,2068,81,2.21 [1.40-3.49],0.0006429019759444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NXPE4,NXPE family member 4,2068,81,0.92 [0.45-1.87],0.8124791462973886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NXPH1,Neurexophilin-1,2414,94,1.64 [1.09-2.45],0.0164545212307706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NXPH3,Neurexophilin-3,2078,82,2.54 [1.24-5.22],0.0112118104103456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OBP2B,Odorant-binding protein 2b,2459,98,1.27 [0.95-1.71],0.1032159425142226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OCLN,Occludin,2136,83,2.38 [1.59-3.57],2.8379059890386183e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ODAM,Odontogenic ameloblast-associated protein,2410,94,1.22 [0.89-1.66],0.2157591622689127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OFD1,Oral-facial-digital syndrome 1 protein,2114,81,1.05 [0.76-1.45],0.7730196539639125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGA,Protein O-GlcNAcase,2130,82,1.30 [0.95-1.78],0.1051134953755853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGFR,Opioid growth factor receptor,2475,101,1.18 [0.68-2.05],0.56574422789868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGN,Mimecan,2490,100,3.04 [2.26-4.08],1.6263275963877172e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,2114,81,0.66 [0.42-1.04],0.0722616110656694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OLFM4,Olfactomedin-4,2033,78,1.26 [1.06-1.50],0.0080935091548742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OLR1,Oxidized low-density lipoprotein receptor 1,2461,101,1.28 [0.98-1.67],0.0677590756242702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OMD,Osteomodulin,2496,99,0.79 [0.54-1.15],0.2173492061314339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OMG,Oligodendrocyte-myelin glycoprotein,2475,101,0.82 [0.64-1.05],0.1205818264769348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OMP,Olfactory marker protein,2071,82,1.25 [0.88-1.78],0.2149569205139607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OPHN1,Oligophrenin-1,2140,84,1.05 [0.86-1.28],0.6487166993548235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OPLAH,5-oxoprolinase,2096,83,1.32 [0.97-1.79],0.0824532097508502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OPTC,Opticin,2475,101,1.66 [1.22-2.25],0.0012509687460109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ORM1,Alpha-1-acid glycoprotein 1,2137,82,1.69 [0.59-4.82],0.3304174132572643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSBPL2,Oxysterol-binding protein-related protein 2,2140,84,0.95 [0.54-1.66],0.8574868064154969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,2488,99,2.56 [1.54-4.26],0.0002775384033361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSM,Oncostatin-M,2466,100,1.16 [0.91-1.49],0.2369439601912795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSMR,Oncostatin-M-specific receptor subunit beta,2486,99,1.35 [0.61-2.98],0.4592218346029038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSTN,Osteocrin,2095,81,1.06 [0.65-1.71],0.8225570829775621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OTOA,Otoancorin,2071,82,1.01 [0.69-1.46],0.9657128232366552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OTUD6B,Deubiquitinase OTUD6B,2130,82,1.18 [0.81-1.73],0.3900646929523306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OTUD7B,OTU domain-containing protein 7B,2136,83,1.38 [0.97-1.97],0.0760835051024409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",2096,83,0.92 [0.68-1.26],0.6195271063521313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OXT,Oxytocin-neurophysin 1,2505,102,1.02 [0.90-1.15],0.8079547450783625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,P4HB,Protein disulfide-isomerase,2466,100,1.69 [1.07-2.69],0.0252132066217388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PACS2,Phosphofurin acidic cluster sorting protein 2,2068,81,1.10 [0.77-1.58],0.6019134455583759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PADI2,Protein-arginine deiminase type-2,2421,99,1.06 [0.79-1.41],0.7008556212762902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PADI4,Protein-arginine deiminase type-4,2410,94,0.81 [0.63-1.06],0.1219076596488486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAEP,Glycodelin,2463,98,1.09 [0.92-1.29],0.3349447872057644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,2136,83,0.94 [0.76-1.15],0.5303932543336902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",2114,81,0.86 [0.54-1.38],0.5332290568139679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,2437,97,1.35 [0.99-1.85],0.0565900404804223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAGR1,PAXIP1-associated glutamate-rich protein 1,2096,83,1.11 [0.67-1.85],0.676369010459176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,2061,81,0.92 [0.60-1.39],0.6768297790178004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAK4,Serine/threonine-protein kinase PAK 4,2414,94,1.08 [0.81-1.44],0.5993055645954113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALLD,Palladin,2078,82,0.90 [0.53-1.55],0.71532565966944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM,Paralemmin-1,2120,81,2.91 [1.76-4.82],3.0654405603506987e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM2,Paralemmin-2,2140,84,3.08 [1.99-4.77],4.565427241740052e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM3,Paralemmin-3,2068,81,0.92 [0.65-1.31],0.6541419744147596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAM,Peptidyl-glycine alpha-amidating monooxygenase,2500,101,1.97 [1.03-3.74],0.0395232159992931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAMR1,Inactive serine protease PAMR1,2490,100,1.17 [0.62-2.20],0.6299042075160801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAPPA,Pappalysin-1,2421,99,0.68 [0.47-0.99],0.042713192688728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PARD3,Partitioning defective 3 homolog,2114,81,1.08 [0.80-1.45],0.632073174167907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PARK7,Parkinson disease protein 7,2490,100,1.07 [0.75-1.53],0.7080348443931183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PARP1,Poly [ADP-ribose] polymerase 1,2477,100,0.88 [0.62-1.26],0.483786125560627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAXX,Protein PAXX,2109,80,1.22 [0.74-2.00],0.4425049085926904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PBK,Lymphokine-activated killer T-cell-originated protein kinase,2063,81,1.22 [0.60-2.49],0.5754612571649134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PBLD,Phenazine biosynthesis-like domain-containing protein,2414,94,0.63 [0.44-0.90],0.0110321834029107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,2130,82,2.19 [1.22-3.93],0.0085522226232712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCARE,Photoreceptor cilium actin regulator,2071,82,1.02 [0.78-1.33],0.9096350397346278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,2106,80,0.81 [0.54-1.21],0.3029693723200952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCBP2,Poly(rC)-binding protein 2,2136,83,1.08 [0.80-1.46],0.6247066913108714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH1,Protocadherin-1,2494,101,2.63 [1.44-4.80],0.0016164721044062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH12,Protocadherin-12,2136,83,1.84 [0.82-4.14],0.1387314411841073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH17,Protocadherin-17,2483,101,1.71 [1.17-2.51],0.0053386138476941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH7,Protocadherin-7,2130,82,2.74 [1.90-3.93],5.182037009175732e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH9,Protocadherin-9,2130,82,1.25 [0.70-2.23],0.4469202476255806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDHB15,Protocadherin beta-15,2133,83,1.82 [1.22-2.70],0.0030593788286208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCNA,Proliferating cell nuclear antigen,2063,81,0.85 [0.56-1.28],0.4323932893326137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCSK7,Proprotein convertase subtilisin/kexin type 7,2133,83,1.01 [0.68-1.49],0.9743154188919684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,2510,102,1.87 [1.21-2.88],0.0044975256647252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCYT2,Ethanolamine-phosphate cytidylyltransferase,2130,82,1.11 [0.81-1.52],0.5105187245365588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDAP1,28 kDa heat- and acid-stable phosphoprotein,2138,84,1.07 [0.85-1.35],0.5694887406132547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD1,Programmed cell death protein 1,2497,101,1.97 [1.45-2.69],1.6607528945828193e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD1LG2,Programmed cell death 1 ligand 2,2475,101,3.83 [2.61-5.61],6.309113596669788e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD5,Programmed cell death protein 5,2505,102,1.18 [0.86-1.62],0.3101035933634676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD6,Programmed cell death protein 6,2483,101,1.38 [1.00-1.91],0.0478534759894232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCL2,Phosducin-like protein 2,2063,81,0.67 [0.40-1.11],0.1211744335469792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",2063,81,0.63 [0.36-1.11],0.1078465586911939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",2068,81,0.82 [0.53-1.26],0.3579368790397219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",2109,80,1.01 [0.81-1.25],0.945364914529922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFA,Platelet-derived growth factor subunit A,2510,102,0.86 [0.68-1.09],0.2162623964386899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFB,Platelet-derived growth factor subunit B,2496,99,0.95 [0.77-1.17],0.6287006912688862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFC,Platelet-derived growth factor C,2418,95,1.17 [0.65-2.10],0.6023673151872772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFRA,Platelet-derived growth factor receptor alpha,2483,101,3.37 [2.10-5.43],5.29956680248281e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFRB,Platelet-derived growth factor receptor beta,2510,102,1.10 [0.67-1.82],0.70031942412457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDIA2,Protein disulfide-isomerase A2,2063,81,0.52 [0.27-0.98],0.0442424171357271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDIA3,Protein disulfide-isomerase A3,2109,80,1.90 [0.86-4.17],0.1118082630630464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDIA4,Protein disulfide-isomerase A4,2147,82,1.14 [0.79-1.64],0.4798737111099709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDIA5,Protein disulfide-isomerase A5,2063,81,1.07 [0.78-1.47],0.6767375848797257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDLIM5,PDZ and LIM domain protein 5,2136,83,1.04 [0.87-1.26],0.6465001262419239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDLIM7,PDZ and LIM domain protein 7,2496,99,1.07 [0.93-1.25],0.3395491493250645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",2418,95,1.03 [0.72-1.48],0.8733806320969564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDRG1,p53 and DNA damage-regulated protein 1,2095,81,0.88 [0.56-1.37],0.5647095139926726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,2063,81,0.79 [0.48-1.28],0.336419288759173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDZD2,PDZ domain-containing protein 2,2068,81,1.17 [0.84-1.65],0.354580380637143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,2078,82,1.43 [0.99-2.05],0.0548066667197458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PEAR1,Platelet endothelial aggregation receptor 1,2510,102,3.98 [1.91-8.33],0.0002378471668427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PEBP1,Phosphatidylethanolamine-binding protein 1,2490,100,1.09 [0.79-1.49],0.6019404418157576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PECAM1,Platelet endothelial cell adhesion molecule,2490,100,1.06 [0.60-1.88],0.8298567757408324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PECR,Peroxisomal trans-2-enoyl-CoA reductase,2096,83,1.02 [0.45-2.35],0.9558840176230172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PENK,Proenkephalin-A,2109,80,2.28 [1.33-3.92],0.0028160419546885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PEPD,Xaa-Pro dipeptidase,2148,83,0.85 [0.40-1.81],0.6728595051348298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PER3,Period circadian protein homolog 3,2078,82,0.98 [0.83-1.17],0.8360822803605878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PF4,Platelet factor 4,2127,83,0.90 [0.72-1.14],0.3874610008239251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PFDN2,Prefoldin subunit 2,2414,94,1.51 [1.09-2.08],0.0137070097214539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PFDN4,Prefoldin subunit 4,2063,81,0.98 [0.63-1.52],0.9118076876773826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PFDN6,Prefoldin subunit 6,2095,81,0.58 [0.36-0.93],0.0252926315756206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",2474,101,0.90 [0.72-1.14],0.3831548466975067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGA4,Pepsin A-4,2148,83,1.31 [1.06-1.64],0.0146921241181386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",2138,84,1.18 [0.80-1.74],0.4143670040247614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGF,Placenta growth factor,2506,101,5.74 [3.68-8.96],1.4754305559189876e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGLYRP1,Peptidoglycan recognition protein 1,2497,102,2.14 [1.54-2.98],6.488853887278492e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,2118,82,0.73 [0.35-1.50],0.3912660721342312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGLYRP4,Peptidoglycan recognition protein 4,2068,81,1.15 [0.79-1.68],0.4574754306189996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGM2,Phosphoglucomutase-2,2095,81,0.74 [0.46-1.21],0.228502572817944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGR,Progesterone receptor,2078,82,1.26 [1.09-1.46],0.0020298499811101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHACTR2,Phosphatase and actin regulator 2,2136,83,1.04 [0.86-1.26],0.6972520605556731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHLDB1,Pleckstrin homology-like domain family B member 1,2130,82,2.25 [1.54-3.31],3.3132019017622506e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHLDB2,Pleckstrin homology-like domain family B member 2,2063,81,0.97 [0.77-1.22],0.807369155137691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,2463,98,3.18 [1.89-5.35],1.2436514726256912e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,2109,80,0.90 [0.55-1.47],0.6682285112690649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PI16,Peptidase inhibitor 16,2148,83,3.05 [1.31-7.09],0.0094421423015247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PI3,Elafin,2447,100,1.74 [1.43-2.12],4.97677189624818e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",2136,83,1.04 [0.78-1.38],0.7940466778171692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIGR,Polymeric immunoglobulin receptor,2458,99,3.05 [2.01-4.62],1.3887522763839098e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,2477,100,0.76 [0.56-1.03],0.0733427360267493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,2490,100,5.12 [3.55-7.38],1.9587721788426817e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,2078,82,1.16 [0.78-1.71],0.4603444439516488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,2490,100,2.68 [1.78-4.03],2.5992656368876225e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,2483,101,1.86 [1.34-2.58],0.00022799305809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,2109,80,0.75 [0.56-1.01],0.0618189946624193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PITHD1,PITH domain-containing protein 1,2061,81,1.00 [0.79-1.27],0.9842907351317975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKD1,Polycystin-1,2138,84,3.40 [1.68-6.90],0.0006974566673888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKD2,Polycystin-2,2068,81,1.30 [0.89-1.91],0.173126469550091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKLR,Pyruvate kinase PKLR,2487,99,0.87 [0.66-1.15],0.3382782798172948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKN3,Serine/threonine-protein kinase N3,2114,81,0.97 [0.72-1.31],0.8498927126811298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G10,Group 10 secretory phospholipase A2,2463,98,1.67 [1.23-2.25],0.0008668063765855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G15,Phospholipase A2 group XV,2489,101,2.04 [1.15-3.61],0.0142784376730956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G1B,Phospholipase A2,2509,102,1.03 [0.75-1.43],0.8474154485812789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G2A,"Phospholipase A2, membrane associated",2474,101,1.28 [0.98-1.67],0.0684288018398489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G4A,Cytosolic phospholipase A2,2496,99,1.04 [0.84-1.28],0.7349633965699991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G7,Platelet-activating factor acetylhydrolase,2490,100,0.36 [0.23-0.56],7.508605868476162e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLAT,Tissue-type plasminogen activator,2502,102,0.89 [0.64-1.22],0.4550275201633329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLAU,Urokinase-type plasminogen activator,2490,100,0.87 [0.49-1.53],0.6310288011857753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLAUR,Urokinase plasminogen activator surface receptor,2468,99,5.13 [3.10-8.50],2.2265602574899644e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLB1,"Phospholipase B1, membrane-associated",2140,84,0.55 [0.39-0.78],0.0008456089744848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",2078,82,1.10 [0.63-1.91],0.7439449574943799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",2140,84,1.08 [0.86-1.35],0.5252574674092538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLEKHO1,Pleckstrin homology domain-containing family O member 1,2140,84,1.18 [0.87-1.58],0.2842058067532637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLG,Plasminogen,2080,81,1.34 [0.49-3.66],0.56519656511079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLIN1,Perilipin-1,2414,94,1.35 [0.87-2.10],0.1773274430683736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLIN3,Perilipin-3,2483,101,1.38 [0.92-2.07],0.119755686043926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLPBP,Pyridoxal phosphate homeostasis protein,2483,101,0.91 [0.69-1.20],0.499736619311911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLSCR3,Phospholipid scramblase 3,2134,83,1.32 [0.88-1.96],0.1753257088686527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLTP,Phospholipid transfer protein,2502,101,0.97 [0.63-1.49],0.8788838388232453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXDC1,Plexin domain-containing protein 1,2418,95,1.37 [0.85-2.19],0.1942786005933172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXDC2,Plexin domain-containing protein 2,2140,84,1.84 [1.06-3.21],0.0305037667462263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXNA4,Plexin-A4,2477,100,1.03 [0.83-1.29],0.7625788123747811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXNB2,Plexin-B2,2496,101,4.05 [2.55-6.43],2.965554243994787e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXNB3,Plexin-B3,2472,100,0.97 [0.65-1.44],0.8744172228266357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,2475,101,0.97 [0.89-1.06],0.4599436070711139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PMCH,Pro-MCH,2068,81,1.01 [0.77-1.33],0.9419072287166756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PMM2,Phosphomannomutase 2,2068,81,1.03 [0.70-1.52],0.8783432249650684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PMS1,PMS1 protein homolog 1,2095,81,1.19 [0.83-1.70],0.335408766962972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PMVK,Phosphomevalonate kinase,2412,94,1.00 [0.84-1.19],0.9900709471670692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNLIP,Pancreatic triacylglycerol lipase,2148,83,0.86 [0.66-1.13],0.2870565715709874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,2140,84,1.05 [0.85-1.32],0.6394249559201157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNLIPRP2,Pancreatic lipase-related protein 2,2481,99,1.00 [0.94-1.06],0.9824880006539272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNMA1,Paraneoplastic antigen Ma1,2096,83,1.02 [0.70-1.51],0.9005777754647575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNMA2,Paraneoplastic antigen Ma2,2071,82,1.07 [0.66-1.72],0.7901707378540745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",2421,99,1.09 [0.95-1.25],0.2192226763781683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PODXL,Podocalyxin,2475,101,1.27 [0.44-3.72],0.6593714555340466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PODXL2,Podocalyxin-like protein 2,2489,101,2.28 [1.30-4.02],0.004264014236524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POF1B,Protein POF1B,2078,82,1.78 [1.21-2.63],0.0035383495007585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POLR2A,DNA-directed RNA polymerase II subunit RPB1,2078,82,1.00 [0.46-2.19],0.9992015467841812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",2475,101,1.79 [1.24-2.57],0.0016973590496334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POMC,Pro-opiomelanocortin,2096,83,0.90 [0.68-1.21],0.4915067337466354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PON1,Serum paraoxonase/arylesterase 1,2148,83,0.51 [0.25-1.03],0.0620813004935564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PON2,Serum paraoxonase/arylesterase 2,2437,97,0.78 [0.47-1.27],0.3153821330021803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PON3,Serum paraoxonase/lactonase 3,2496,99,0.69 [0.42-1.12],0.1330474731138192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POSTN,Periostin,2147,82,1.10 [0.65-1.85],0.7209268140392197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPBP,Platelet basic protein,2126,83,0.95 [0.74-1.24],0.7238157244792311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPCDC,Phosphopantothenoylcysteine decarboxylase,2505,102,0.93 [0.64-1.36],0.6985378745930824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPIB,Peptidyl-prolyl cis-trans isomerase B,2478,100,1.01 [0.83-1.22],0.9436675627307632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPIE,Peptidyl-prolyl cis-trans isomerase E,2114,81,1.38 [1.08-1.75],0.0091393991751689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",2147,82,0.76 [0.51-1.12],0.1694143131374545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPL,Periplakin,2078,82,1.42 [0.81-2.48],0.2223294353609068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPM1A,Protein phosphatase 1A,2418,95,0.88 [0.49-1.59],0.6701179336608647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPM1B,Protein phosphatase 1B,2078,82,1.07 [0.74-1.54],0.7101193279537961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPM1F,Protein phosphatase 1F,2138,84,1.16 [0.77-1.76],0.4818637700931631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPME1,Protein phosphatase methylesterase 1,2475,101,0.94 [0.70-1.25],0.6551904538230704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,2133,83,1.00 [0.76-1.31],0.9783675455253948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,2489,101,1.00 [0.83-1.20],0.9741298749348174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,2114,81,1.17 [0.91-1.51],0.2218682416437204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,2136,83,0.90 [0.68-1.20],0.4720410578889766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,2136,83,1.82 [1.25-2.65],0.0016502860189464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R2,Protein phosphatase inhibitor 2,2483,101,0.99 [0.78-1.25],0.929173584583036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R9B,Neurabin-2,2506,101,1.10 [0.91-1.34],0.3024927185214098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,2130,82,1.03 [0.85-1.24],0.7952918110264748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP3R1,Calcineurin subunit B type 1,2463,98,1.49 [0.96-2.31],0.0761250069384753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPT1,Palmitoyl-protein thioesterase 1,2095,81,1.18 [0.94-1.48],0.1615370402776091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPY,Pancreatic prohormone,2479,101,1.21 [1.04-1.41],0.0151796498431346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PQBP1,Polyglutamine-binding protein 1,2418,95,1.01 [0.73-1.40],0.952396719625527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRAME,Melanoma antigen preferentially expressed in tumors,2063,81,0.98 [0.42-2.31],0.970893483298181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRAP1,Proline-rich acidic protein 1,2147,82,6.49 [3.67-11.48],1.3079632425565216e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRC1,Protein regulator of cytokinesis 1,2133,83,0.77 [0.43-1.38],0.3831085484430667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRCP,Lysosomal Pro-X carboxypeptidase,2498,102,1.90 [1.22-2.95],0.0046648082631302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX1,Peroxiredoxin-1,2403,94,0.97 [0.79-1.19],0.7702684770851145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX2,Peroxiredoxin-2,2112,83,1.00 [0.72-1.41],0.9821488472603824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",2421,99,1.32 [1.04-1.68],0.0244203759824455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX5,"Peroxiredoxin-5, mitochondrial",2506,101,0.92 [0.70-1.21],0.5529118242010301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX6,Peroxiredoxin-6,2500,102,0.94 [0.70-1.26],0.6964730850046559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PREB,Prolactin regulatory element-binding protein,2421,99,1.93 [1.26-2.97],0.0027321234452741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRELP,Prolargin,2481,99,4.75 [2.81-8.06],6.790749622715221e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRG2,Bone marrow proteoglycan,2147,82,1.91 [1.35-2.71],0.0002835108824332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRG3,Proteoglycan 3,2147,82,1.37 [0.89-2.09],0.1501621146532028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,2421,99,1.29 [0.94-1.77],0.1169920525076838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,2095,81,0.84 [0.45-1.60],0.6034481748415124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,2483,101,0.91 [0.73-1.13],0.3790290237513718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,2138,84,1.15 [0.86-1.53],0.3472394155386714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKCQ,Protein kinase C theta type,2421,99,1.07 [0.72-1.60],0.7331551230816888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKD2,Serine/threonine-protein kinase D2,2068,81,0.95 [0.51-1.74],0.857871985466741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKG1,cGMP-dependent protein kinase 1,2109,80,0.99 [0.82-1.18],0.8871834262943006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,2418,95,1.05 [0.80-1.39],0.7049613762384299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRL,Prolactin,2505,102,1.36 [1.12-1.66],0.0023616442638752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRND,Prion-like protein doppel,2140,84,1.46 [1.02-2.10],0.0390919231993407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PROC,Vitamin K-dependent protein C,2485,99,0.69 [0.35-1.34],0.2678098295559112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PROCR,Endothelial protein C receptor,2068,81,1.29 [0.72-2.31],0.3953865120837287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PROK1,Prokineticin-1,2477,100,1.17 [0.85-1.59],0.3350726047032688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PROS1,Vitamin K-dependent protein S,2143,83,0.48 [0.24-0.98],0.0431142445940749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRR4,Proline-rich protein 4,2085,79,1.17 [0.88-1.56],0.2682508888543632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRR5,Proline-rich protein 5,2078,82,0.94 [0.61-1.42],0.7554239099731473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRRT3,Proline-rich transmembrane protein 3,2096,83,2.17 [1.42-3.32],0.0003670716494211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS2,Trypsin-2,2486,99,1.25 [0.99-1.58],0.0553153596700565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS22,Brain-specific serine protease 4,2078,82,1.70 [1.18-2.47],0.0046219971691722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS27,Serine protease 27,2476,101,1.89 [1.24-2.87],0.0030213921119869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS53,Serine protease 53,2140,84,0.65 [0.38-1.12],0.1216199656484456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS8,Prostasin,2478,99,2.86 [1.93-4.24],1.6691595720435166e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,2414,94,0.99 [0.84-1.17],0.9047046759199148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRTG,Protogenin,2500,102,3.25 [1.75-6.03],0.0001981745801474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRTN3,Myeloblastin,2419,99,1.46 [1.05-2.02],0.0239939640145714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRUNE2,Protein prune homolog 2,2114,81,0.52 [0.24-1.15],0.1044930599605016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSAP,Prosaposin,2128,82,5.53 [2.93-10.43],1.2556210282369e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSAPL1,Proactivator polypeptide-like 1,2130,82,1.17 [0.81-1.70],0.4056365490278255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSCA,Prostate stem cell antigen,2130,82,1.11 [1.02-1.21],0.0155709938131975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,2463,98,1.44 [1.21-1.71],3.70653721859472e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSIP1,PC4 and SFRS1-interacting protein,2477,100,1.04 [0.79-1.37],0.7910925471372838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMA1,Proteasome subunit alpha type-1,2418,95,0.79 [0.50-1.23],0.2975006380586431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMC3,26S proteasome regulatory subunit 6A,2063,81,0.46 [0.22-0.96],0.0377286888293666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMD1,26S proteasome non-ATPase regulatory subunit 1,2136,83,1.33 [0.94-1.88],0.1108261222437506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMD5,26S proteasome non-ATPase regulatory subunit 5,2095,81,1.29 [0.93-1.79],0.1293093609286134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMD9,26S proteasome non-ATPase regulatory subunit 9,2475,101,0.88 [0.64-1.20],0.4029439559378193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSME1,Proteasome activator complex subunit 1,2461,98,1.21 [0.74-1.99],0.4475881790764877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSME2,Proteasome activator complex subunit 2,2449,94,1.19 [0.71-1.98],0.5093306175270411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMG3,Proteasome assembly chaperone 3,2477,100,0.98 [0.70-1.39],0.9258169991447164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMG4,Proteasome assembly chaperone 4,2078,82,1.10 [0.76-1.59],0.6253584412012185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSPN,Persephin,2477,100,0.95 [0.79-1.15],0.606017592133206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSRC1,Proline/serine-rich coiled-coil protein 1,2418,95,1.11 [0.85-1.46],0.4326782294616172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,2036,77,0.98 [0.79-1.21],0.8311380282139287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",2414,94,1.18 [0.66-2.10],0.5835030584774226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTGDS,Prostaglandin-H2 D-isomerase,2457,99,3.19 [2.32-4.39],7.487008127487494e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTGES2,Prostaglandin E synthase 2,2062,81,0.99 [0.65-1.51],0.9615633380543382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTGR1,Prostaglandin reductase 1,2138,84,0.78 [0.62-0.98],0.0312243385437189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTH,Parathyroid hormone,2095,81,1.05 [0.82-1.34],0.7243273397169594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,2477,100,1.69 [1.26-2.27],0.0005197989059303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTK7,Inactive tyrosine-protein kinase 7,2414,94,2.48 [1.61-3.82],3.4517199579352206e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTN,Pleiotrophin,2437,97,1.27 [0.92-1.73],0.1418094962528885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,2078,82,1.05 [0.69-1.58],0.8247052046665385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,2463,98,1.07 [0.84-1.36],0.588865259230583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,2492,99,0.99 [0.81-1.22],0.9353634031793564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,2077,82,1.25 [0.75-2.09],0.3848297968969535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,2138,84,0.89 [0.46-1.75],0.7411184814920423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,2147,82,2.05 [0.84-5.05],0.1170819162205926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,2510,102,2.19 [1.25-3.83],0.0061656421639588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,2130,82,1.69 [1.14-2.49],0.0085043749564565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,2130,82,2.62 [1.25-5.49],0.0107459272342375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,2473,100,1.08 [0.55-2.12],0.8325599052473278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,2457,97,3.05 [2.02-4.63],1.381420167832164e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRR,Receptor-type tyrosine-protein phosphatase R,2140,84,1.39 [0.85-2.28],0.1881980418727657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,2510,102,2.25 [1.22-4.14],0.0091544801301513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,2138,84,1.10 [0.58-2.08],0.7734210769060264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,2109,80,0.93 [0.63-1.37],0.7247070666163611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,2400,93,0.78 [0.58-1.06],0.1080583127045972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTTG1,Securin,2114,81,0.46 [0.25-0.85],0.0124901668987468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTX3,Pentraxin-related protein PTX3,2477,100,1.96 [1.25-3.08],0.0031852584262548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PVALB,Parvalbumin alpha,2489,102,1.20 [1.01-1.42],0.0348323051190014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PVR,Poliovirus receptor,2505,102,1.94 [1.30-2.89],0.0010961858929139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PXDNL,Peroxidasin-like protein,2133,83,1.02 [0.68-1.54],0.9079870856901592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PXN,Paxillin,2414,94,1.27 [0.91-1.78],0.1581483241315297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PYDC1,Pyrin domain-containing protein 1,2096,83,0.97 [0.58-1.62],0.8999522289544687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PYY,Peptide YY,2068,81,1.38 [1.18-1.62],7.894691296057557e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PZP,Pregnancy zone protein,2143,83,0.73 [0.45-1.19],0.2078732723967072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,QDPR,Dihydropteridine reductase,2474,101,0.90 [0.58-1.39],0.636536636419635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,QPCT,Glutaminyl-peptide cyclotransferase,2484,102,5.49 [3.05-9.88],1.36202785235834e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,QSOX1,Sulfhydryl oxidase 1,2100,83,1.26 [0.80-2.01],0.3208940117831458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB10,Ras-related protein Rab-10,2138,84,0.97 [0.64-1.46],0.8780205470512606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB11FIP3,Rab11 family-interacting protein 3,2138,84,1.06 [0.87-1.29],0.577215872569179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB27B,Ras-related protein Rab-27B,2138,84,1.02 [0.78-1.33],0.8949504600760156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB2B,Ras-related protein Rab-2B,2133,83,1.09 [0.75-1.58],0.643283936729727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB33A,Ras-related protein Rab-33A,2068,81,0.91 [0.64-1.29],0.6014515136251273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB37,Ras-related protein Rab-37,2421,99,1.06 [0.87-1.29],0.5588821591666575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB39B,Ras-related protein Rab-39B,2068,81,0.80 [0.59-1.09],0.151014768663651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,2071,82,1.23 [0.91-1.65],0.1741463826388097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB44,Ras-related protein Rab-44,2133,83,1.02 [0.65-1.59],0.9398376647772092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB6A,Ras-related protein Rab-6A,2477,100,0.69 [0.48-0.98],0.0398006768084134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB6B,Ras-related protein Rab-6B,2414,94,1.02 [0.70-1.47],0.91983146135996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RABEP1,Rab GTPase-binding effector protein 1,2109,80,1.00 [0.74-1.33],0.9762265027352314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RABEPK,Rab9 effector protein with kelch motifs,2418,95,0.94 [0.69-1.29],0.7161767252385278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RABGAP1L,Rab GTPase-activating protein 1-like,2421,99,1.09 [0.81-1.45],0.5778341488156178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAC3,Ras-related C3 botulinum toxin substrate 3,2095,81,0.99 [0.73-1.35],0.9546812895900634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAD23B,UV excision repair protein RAD23 homolog B,2418,95,1.30 [0.90-1.87],0.1573650466276508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAD51,DNA repair protein RAD51 homolog 1,2114,81,1.09 [0.69-1.74],0.7020565296838184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RALB,Ras-related protein Ral-B,2078,82,1.34 [0.66-2.71],0.4144323691116266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RALY,RNA-binding protein Raly,2133,83,0.99 [0.62-1.56],0.949561291125804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RANBP1,Ran-specific GTPase-activating protein,2096,83,0.99 [0.65-1.48],0.9442522162519208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RANBP2,E3 SUMO-protein ligase RanBP2,2071,82,0.85 [0.43-1.70],0.6517952759713546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RANGAP1,Ran GTPase-activating protein 1,2418,95,1.17 [0.84-1.64],0.3477456221326781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAP1A,Ras-related protein Rap-1A,2078,82,1.03 [0.75-1.41],0.8782557857866549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAPGEF2,Rap guanine nucleotide exchange factor 2,2114,81,1.08 [0.73-1.61],0.702868404195271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RARRES1,Retinoic acid receptor responder protein 1,2418,95,1.34 [0.74-2.41],0.3329258438911607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RARRES2,Retinoic acid receptor responder protein 2,2486,99,1.85 [1.35-2.53],0.0001204336127165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RASA1,Ras GTPase-activating protein 1,2414,94,0.75 [0.43-1.32],0.3242884507514016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,2063,81,0.68 [0.41-1.11],0.1202762825723672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RASSF2,Ras association domain-containing protein 2,2418,95,1.10 [0.83-1.47],0.5033837580067799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBFOX3,RNA binding protein fox-1 homolog 3,2136,83,2.24 [1.70-2.94],7.222023011167627e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBKS,Ribokinase,2430,96,0.68 [0.49-0.93],0.0164417226931615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBM17,Splicing factor 45,2136,83,1.20 [0.92-1.58],0.1836627511089695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBM19,Probable RNA-binding protein 19,2068,81,1.33 [0.82-2.17],0.2534657579750403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBM25,RNA-binding protein 25,2063,81,0.97 [0.59-1.60],0.9184057684698592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP1,Retinol-binding protein 1,2095,81,1.08 [0.81-1.43],0.6164427293446988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP2,Retinol-binding protein 2,2475,101,1.63 [1.35-1.96],2.688439049496691e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP5,Retinol-binding protein 5,2475,101,1.32 [1.01-1.73],0.0450493314376879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP7,Retinoid-binding protein 7,2130,82,1.38 [1.04-1.82],0.0239380229748054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBPMS,RNA-binding protein with multiple splicing,2078,82,0.97 [0.66-1.43],0.8874415452947271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBPMS2,RNA-binding protein with multiple splicing 2,2096,83,1.08 [0.87-1.34],0.4712996773941511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RCC1,Regulator of chromosome condensation,2133,83,1.03 [0.68-1.56],0.8806636043185936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RCOR1,REST corepressor 1,2437,97,0.80 [0.49-1.32],0.3814597950925873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,2096,83,2.10 [0.75-5.87],0.1596789376253462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REEP4,Receptor expression-enhancing protein 4,2136,83,1.24 [0.88-1.73],0.2134877705444866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG1A,Lithostathine-1-alpha,2463,99,2.36 [1.85-3.01],3.431662817752349e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG1B,Lithostathine-1-beta,2510,102,1.77 [1.39-2.25],2.9368954441234222e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG3A,Regenerating islet-derived protein 3-alpha,2510,102,1.61 [1.28-2.01],3.251161423970329e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG3G,Regenerating islet-derived protein 3-gamma,2133,83,0.99 [0.57-1.74],0.978202436709614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG4,Regenerating islet-derived protein 4,2488,99,2.84 [2.20-3.66],8.770312406300712e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RELB,Transcription factor RelB,2078,82,1.01 [0.65-1.57],0.9703796399283572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RELT,Tumor necrosis factor receptor superfamily member 19L,2490,100,4.04 [2.62-6.24],2.781631997024436e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REN,Renin,2483,101,1.89 [1.63-2.19],3.7467063169499163e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REPS1,RalBP1-associated Eps domain-containing protein 1,2078,82,0.82 [0.43-1.56],0.5435615381353878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REST,RE1-silencing transcription factor,2063,81,1.09 [0.58-2.05],0.7814206820376031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,2475,101,0.94 [0.61-1.46],0.7909624192121711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RETN,Resistin,2479,101,1.98 [1.45-2.69],1.581543113926424e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REXO2,"Oligoribonuclease, mitochondrial",2068,81,1.08 [0.71-1.65],0.7094988746242892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RFC4,Replication factor C subunit 4,2133,83,1.03 [0.38-2.79],0.9490661416982464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGCC,Regulator of cell cycle RGCC,2136,83,1.03 [0.77-1.38],0.8314654954518685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,2114,81,1.16 [0.86-1.56],0.3437961388466143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGMA,Repulsive guidance molecule A,2505,102,2.01 [1.22-3.32],0.0065127718771122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGMB,RGM domain family member B,2505,102,3.56 [2.19-5.79],2.8103511836630105e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGS10,Regulator of G-protein signaling 10,2136,83,1.07 [0.73-1.57],0.7358316976034551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGS8,Regulator of G-protein signaling 8,2421,99,0.98 [0.73-1.31],0.9020985612431196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RHOC,Rho-related GTP-binding protein RhoC,2453,98,1.07 [0.91-1.26],0.4022875850055296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RICTOR,Rapamycin-insensitive companion of mTOR,2078,82,0.84 [0.52-1.37],0.4851108820693507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,2109,80,1.08 [0.74-1.57],0.6905768693141091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RILP,Rab-interacting lysosomal protein,2494,102,1.04 [0.78-1.40],0.7880561940217654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RILPL2,RILP-like protein 2,2138,84,1.01 [0.80-1.26],0.9620402756225854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,2068,81,1.09 [0.81-1.46],0.5757040870935767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RLN1,Prorelaxin H1,2136,83,1.33 [0.95-1.87],0.1003281900719339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RLN2,Prorelaxin H2,2101,80,1.20 [0.81-1.77],0.3714994575657516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE1,Ribonuclease pancreatic,2148,83,4.89 [2.75-8.70],6.745504377034923e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE10,Inactive ribonuclease-like protein 10,2096,83,1.66 [1.12-2.46],0.0121387801722133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE3,Eosinophil cationic protein,2473,101,1.02 [0.87-1.19],0.7991658223903242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE4,Ribonuclease 4,2069,79,4.56 [2.76-7.53],2.97405906721629e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE6,Ribonuclease K6,2134,83,0.74 [0.35-1.53],0.4107072372432276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASEH2A,Ribonuclease H2 subunit A,2136,83,1.09 [0.69-1.72],0.7196966386122505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASET2,Ribonuclease T2,2502,102,3.56 [2.65-4.80],5.773733719973436e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF149,E3 ubiquitin-protein ligase RNF149,2096,83,4.88 [2.88-8.27],3.6812159697948636e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF168,E3 ubiquitin-protein ligase RNF168,2078,82,0.88 [0.48-1.60],0.6728153368303575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF31,E3 ubiquitin-protein ligase RNF31,2078,82,1.34 [0.92-1.95],0.1291897643966885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF4,E3 ubiquitin-protein ligase RNF4,2114,81,1.22 [0.93-1.62],0.1567798526356337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF41,E3 ubiquitin-protein ligase NRDP1,2418,95,1.01 [0.76-1.33],0.9652190626883198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF43,E3 ubiquitin-protein ligase RNF43,2114,81,0.93 [0.63-1.38],0.7351730106142038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF5,E3 ubiquitin-protein ligase RNF5,2096,83,0.91 [0.67-1.24],0.562400627746354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ROBO1,Roundabout homolog 1,2488,99,1.63 [0.90-2.95],0.1094832430400685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ROBO2,Roundabout homolog 2,2505,102,2.34 [1.19-4.61],0.0138701609758711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ROBO4,Roundabout homolog 4,2096,83,3.22 [1.03-10.13],0.0451810446163243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,2483,101,2.30 [1.41-3.77],0.000900140556718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RP2,Protein XRP2,2475,101,0.93 [0.62-1.40],0.7327564642752147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPA2,Replication protein A 32 kDa subunit,2078,82,0.80 [0.38-1.67],0.5455660812117586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPE,Ribulose-phosphate 3-epimerase,2114,81,0.95 [0.69-1.30],0.7466798267023531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPGR,X-linked retinitis pigmentosa GTPase regulator,2095,81,0.79 [0.46-1.36],0.3920707651006641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPL14,60S ribosomal protein L14,2096,83,0.91 [0.49-1.67],0.75253787605728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPS10,40S ribosomal protein S10,2068,81,1.01 [0.57-1.80],0.9673048751502684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RRAS,Ras-related protein R-Ras,2095,81,1.05 [0.88-1.24],0.5970181399988497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RRM2,Ribonucleoside-diphosphate reductase subunit M2,2418,95,1.07 [0.76-1.49],0.7023944716610946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,2418,95,1.10 [0.84-1.44],0.4981382349465478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RRP15,RRP15-like protein,2071,82,0.99 [0.79-1.24],0.9458594139855372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RSPO1,R-spondin-1,2463,98,2.32 [1.41-3.82],0.0009856742804453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RSPO3,R-spondin-3,2500,102,3.67 [2.37-5.69],5.214388412858444e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTBDN,Retbindin,2475,101,3.18 [1.87-5.42],2.1447741600010063e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTKN2,Rhotekin-2,2068,81,1.00 [0.67-1.49],0.9915205950962132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",2136,83,1.06 [0.83-1.34],0.6378944032395715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTN4R,Reticulon-4 receptor,2500,102,3.99 [2.60-6.13],2.5021598923622616e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RUVBL1,RuvB-like 1,2418,95,1.03 [0.87-1.22],0.7222248602979751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RWDD1,RWD domain-containing protein 1,2505,102,1.03 [0.77-1.38],0.8278848701492835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RYR1,Ryanodine receptor 1,2068,81,1.44 [0.89-2.32],0.1368604567705687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A11,Protein S100-A11,2460,99,0.79 [0.52-1.21],0.2790849305295624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A12,Protein S100-A12,2451,100,0.95 [0.74-1.20],0.6472093164565356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A13,Protein S100-A13,2078,82,1.22 [0.70-2.14],0.4809169211104354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A14,Protein S100-A14,2136,83,0.67 [0.44-1.03],0.0668475134866697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A16,Protein S100-A16,2410,94,0.92 [0.67-1.25],0.5821134762130863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A3,Protein S100-A3,2133,83,1.25 [0.94-1.67],0.1235124914043102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A4,Protein S100-A4,2489,101,0.73 [0.53-1.00],0.0500177165844226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100G,Protein S100-G,2136,83,1.41 [0.98-2.02],0.0622625551344806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100P,Protein S100-P,2437,97,1.35 [1.06-1.72],0.016221674149811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAA4,Serum amyloid A-4 protein,2143,83,0.54 [0.19-1.49],0.2327846180682861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAFB2,Scaffold attachment factor B2,2136,83,0.97 [0.41-2.27],0.942849219944009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAG,S-arrestin,2071,82,1.40 [0.99-1.98],0.0599305635187045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAMD9L,Sterile alpha motif domain-containing protein 9-like,2477,100,1.05 [0.80-1.36],0.7343000496958061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAP18,Histone deacetylase complex subunit SAP18,2114,81,1.05 [0.80-1.38],0.7040659467978403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SARG,Specifically androgen-regulated gene protein,2132,84,1.10 [0.91-1.34],0.3165628449141999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SART1,U4/U6.U5 tri-snRNP-associated protein 1,2068,81,1.60 [1.01-2.54],0.0447142212417238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAT1,Diamine acetyltransferase 1,2068,81,0.84 [0.51-1.40],0.502892740257981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAT2,Thialysine N-epsilon-acetyltransferase,2114,81,0.74 [0.52-1.06],0.1028241988290753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SATB1,DNA-binding protein SATB1,2136,83,1.22 [0.60-2.48],0.5741726548154307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SBSN,Suprabasin,2140,82,1.61 [0.96-2.72],0.0714504270598111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCAMP3,Secretory carrier-associated membrane protein 3,2475,101,1.14 [0.93-1.41],0.2138211421813635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARA5,Scavenger receptor class A member 5,2505,102,5.74 [3.83-8.60],2.3435142472356722e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARB1,Scavenger receptor class B member 1,2414,94,1.38 [1.10-1.74],0.0058537139902409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARB2,Lysosome membrane protein 2,2409,96,3.92 [2.86-5.39],2.653715048556311e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARF1,Scavenger receptor class F member 1,2510,102,2.11 [1.43-3.10],0.0001632225375306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARF2,Scavenger receptor class F member 2,2505,102,4.85 [3.40-6.92],2.9888693269950645e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCG2,Secretogranin-2,2492,102,4.69 [3.15-6.99],2.909070741910921e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCG3,Secretogranin-3,2488,99,2.29 [1.38-3.79],0.0012552713636664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB1A1,Uteroglobin,2488,99,2.06 [1.47-2.89],2.7030946007254524e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB2A2,Mammaglobin-A,2068,81,0.83 [0.38-1.84],0.6511077339286442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB3A1,Secretoglobin family 3A member 1,2109,80,1.89 [0.86-4.15],0.1126585494828214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB3A2,Secretoglobin family 3A member 2,2492,99,1.10 [0.94-1.29],0.2442150537942055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGN,Secretagogin,2421,99,2.42 [1.77-3.32],3.8091538446921575e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCIN,Adseverin,2071,82,0.85 [0.60-1.20],0.3627018061097182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCLY,Selenocysteine lyase,2494,102,0.74 [0.52-1.05],0.0950556247775214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN2A,Sodium channel protein type 2 subunit alpha,2071,82,1.48 [1.03-2.13],0.0359861073441662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN2B,Sodium channel subunit beta-2,2095,81,0.75 [0.33-1.67],0.4783268459039588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN3A,Sodium channel protein type 3 subunit alpha,2095,81,0.80 [0.41-1.56],0.5204785058553176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN3B,Sodium channel subunit beta-3,2071,82,1.11 [0.72-1.70],0.647016959449427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN4B,Sodium channel subunit beta-4,2096,83,1.88 [1.26-2.82],0.0022187712578791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCP2,Non-specific lipid-transfer protein,2418,95,0.99 [0.78-1.26],0.9453836873404654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,2088,83,1.41 [0.92-2.15],0.1123969182812251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCRG1,Scrapie-responsive protein 1,2138,84,2.44 [1.32-4.52],0.0044932366931259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCRIB,Protein scribble homolog,2096,83,1.12 [0.90-1.40],0.2931782701120166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCRN1,Secernin-1,2477,100,0.99 [0.71-1.38],0.941829245265626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCT,Secretin,2095,81,1.54 [1.05-2.27],0.0283369001158592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDC1,Syndecan-1,2483,101,1.55 [1.07-2.24],0.0203716613274757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDC4,Syndecan-4,2483,101,0.51 [0.36-0.73],0.0001931546373312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDCCAG8,Serologically defined colon cancer antigen 8,2133,83,1.12 [0.92-1.36],0.2513390880343348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDHB,Succinate dehydrogenase,2130,82,1.02 [0.72-1.45],0.9030740945984586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDK2,Protein sidekick-2,2109,80,1.39 [0.88-2.20],0.1565880484006732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEC31A,Protein transport protein Sec31A,2096,83,0.94 [0.70-1.25],0.6558302776604448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEL1L,Protein sel-1 homolog 1,2096,83,2.51 [1.61-3.90],4.314267054203604e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELE,E-selectin,2510,102,1.30 [0.95-1.79],0.0994167956982896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELENOP,Selenoprotein P,2143,83,0.72 [0.31-1.66],0.4354322775110075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELL,L-selectin,2143,83,0.75 [0.29-1.95],0.5520470487924101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELP,P-selectin,2486,99,1.11 [0.80-1.52],0.5383333570792228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELPLG,P-selectin glycoprotein ligand 1,2477,100,1.31 [0.71-2.43],0.3880827667482155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA3F,Semaphorin-3F,2483,101,2.67 [1.47-4.86],0.0012914158585467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA3G,Semaphorin-3G,2109,80,1.35 [0.89-2.07],0.1605778163924605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA4C,Semaphorin-4C,2475,101,1.33 [0.92-1.94],0.1299386902687033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA4D,Semaphorin-4D,2505,102,1.33 [0.73-2.44],0.3567946750139746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA6C,Semaphorin-6C,2078,82,1.62 [0.91-2.90],0.1020433931199415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA7A,Semaphorin-7A,2502,102,2.38 [1.53-3.71],0.0001159742990026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN3,Neuronal-specific septin-3,2136,83,0.82 [0.62-1.08],0.1628630951777093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN7,Septin-7,2114,81,1.37 [1.06-1.77],0.0160372839354564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN8,Septin-8,2137,84,3.42 [2.11-5.55],5.864358174181848e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN9,Septin-9,2475,101,0.78 [0.41-1.46],0.4288847759063796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA1,Alpha-1-antitrypsin,2109,83,5.49 [0.40-75.80],0.2037443969574003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA11,Serpin A11,2510,102,1.46 [0.96-2.21],0.0771890383867572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA12,Serpin A12,2423,100,0.77 [0.62-0.94],0.011589157201676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA3,Alpha-1-antichymotrypsin,2136,83,2.13 [0.58-7.82],0.2526815395862256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA4,Kallistatin,2097,82,1.33 [0.56-3.19],0.5171994523930216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA5,Plasma serine protease inhibitor,2113,83,1.34 [0.69-2.59],0.3820653818894991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA6,Corticosteroid-binding globulin,2143,83,2.64 [0.76-9.14],0.1263163269887468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA7,Thyroxine-binding globulin,2143,83,0.88 [0.27-2.80],0.8243350166988023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA9,Serpin A9,2467,101,0.94 [0.75-1.18],0.6023031751492187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB1,Leukocyte elastase inhibitor,2484,100,1.01 [0.83-1.24],0.8838004642916404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB5,Serpin B5,2437,97,1.23 [0.84-1.79],0.2868120446421632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB6,Serpin B6,2498,102,1.27 [0.93-1.72],0.1330458310217111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB8,Serpin B8,2506,101,1.14 [0.87-1.48],0.3447006186113899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB9,Serpin B9,2463,98,1.29 [0.72-2.29],0.3889120868236994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINC1,Antithrombin-III,2139,83,1.76 [0.46-6.78],0.4112526290218362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPIND1,Heparin cofactor 2,2139,83,2.31 [1.10-4.86],0.0265018586964321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINE1,Plasminogen activator inhibitor 1,2510,102,0.84 [0.65-1.10],0.206032772048649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINE2,Glia-derived nexin,2138,84,0.78 [0.55-1.09],0.147439799552587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINF1,Pigment epithelium-derived factor,2110,83,3.25 [1.59-6.64],0.0012322664955815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINF2,Alpha-2-antiplasmin,2103,83,1.05 [0.23-4.82],0.9460870626457508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPING1,Plasma protease C1 inhibitor,2139,83,2.73 [0.91-8.17],0.0729516195838623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINH1,Serpin H1,2114,81,1.04 [0.87-1.23],0.687777715898239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINI1,Neuroserpin,2108,80,0.84 [0.40-1.75],0.6414149532802372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINI2,Serpin I2,2130,82,1.01 [0.70-1.45],0.9705931911115482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,2414,94,1.07 [0.81-1.42],0.6337372836986239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,2456,98,0.77 [0.41-1.44],0.4095001138935515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEZ6,Seizure protein 6 homolog,2095,81,1.17 [0.63-2.19],0.623342060289281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEZ6L,Seizure 6-like protein,2489,101,2.66 [1.55-4.57],0.0004086548174641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEZ6L2,Seizure 6-like protein 2,2475,101,2.71 [1.33-5.51],0.0058813776325019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SF3B4,Splicing factor 3B subunit 4,2475,101,0.99 [0.78-1.27],0.9566139084399028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFRP1,Secreted frizzled-related protein 1,2459,98,1.91 [1.43-2.56],1.1717133867662e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFRP4,Secreted frizzled-related protein 4,2109,80,0.83 [0.50-1.38],0.4775563810148361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFTPA1,Pulmonary surfactant-associated protein A1,2418,95,1.10 [0.81-1.50],0.5258007550462223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFTPA2,Pulmonary surfactant-associated protein A2,2418,95,1.35 [0.97-1.87],0.0742536035458732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFTPD,Pulmonary surfactant-associated protein D,2483,101,1.22 [0.95-1.57],0.115744940068008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SGSH,N-sulphoglucosamine sulphohydrolase,2105,83,1.35 [0.95-1.91],0.0900178600378621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH2B3,SH2B adapter protein 3,2418,95,1.11 [0.92-1.34],0.282796293119831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH2D1A,SH2 domain-containing protein 1A,2477,100,1.10 [0.81-1.50],0.537735380899425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,2071,82,1.15 [0.85-1.56],0.3592703883511855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH3BP1,SH3 domain-binding protein 1,2130,82,0.99 [0.64-1.54],0.9734931936691624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH3GL3,Endophilin-A3,2103,81,1.17 [0.90-1.53],0.2329714980318423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH3GLB2,Endophilin-B2,2140,84,1.17 [0.86-1.59],0.3209080298150693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHBG,Sex hormone-binding globulin,2148,83,0.96 [0.64-1.43],0.8378027770158627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHC1,SHC-transforming protein 1,2063,81,1.09 [0.91-1.30],0.364425374846517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHD,SH2 domain-containing adapter protein D,2063,81,1.22 [1.00-1.50],0.049720411867484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHH,Sonic hedgehog protein,2078,82,0.93 [0.55-1.59],0.8026801447857663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHISA5,Protein shisa-5,2147,82,4.51 [2.89-7.06],3.7480736902424704e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHMT1,"Serine hydroxymethyltransferase, cytosolic",2492,99,0.91 [0.73-1.14],0.4151857884579017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHPK,Sedoheptulokinase,2114,81,0.69 [0.37-1.30],0.2506841968799196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIAE,Sialate O-acetylesterase,2488,101,1.44 [0.99-2.09],0.0570312937544848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC1,Sialoadhesin,2496,99,2.57 [1.76-3.75],9.71419476322679e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,2477,100,2.31 [1.57-3.42],2.391331353880101e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC15,Sialic acid-binding Ig-like lectin 15,2414,94,1.26 [1.05-1.50],0.0122099100767358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,2490,100,1.06 [0.91-1.25],0.4548465822093508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,2500,102,2.41 [1.50-3.87],0.0002646404731708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,2483,101,1.93 [1.07-3.48],0.0278741627439326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,2096,83,1.44 [0.95-2.17],0.0860317969900448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,2499,102,1.20 [0.68-2.12],0.5299632900395095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIL1,Nucleotide exchange factor SIL1,2096,83,1.20 [0.70-2.03],0.5086725825531004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,2481,100,1.26 [0.90-1.75],0.1744092969972202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRPB1,Signal-regulatory protein beta-1,2476,99,2.12 [1.52-2.94],8.251332932948176e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRT1,NAD-dependent protein deacetylase sirtuin-1,2078,82,1.25 [1.02-1.53],0.0320331554991871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRT2,NAD-dependent protein deacetylase sirtuin-2,2475,101,1.03 [0.83-1.27],0.782469780269929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",2414,94,1.00 [0.73-1.38],0.9828609654851322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,2421,99,1.44 [1.06-1.96],0.019386401952188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SKAP1,Src kinase-associated phosphoprotein 1,2460,97,1.02 [0.80-1.32],0.8514567365416466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SKAP2,Src kinase-associated phosphoprotein 2,2496,99,0.97 [0.81-1.16],0.7590502339958477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SKIV2L,Helicase SKI2W,2068,81,1.06 [0.59-1.90],0.8564734546843209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLA2,Src-like-adapter 2,2136,83,1.01 [0.82-1.25],0.9149597970070832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF1,Signaling lymphocytic activation molecule,2421,99,1.68 [1.25-2.25],0.0005208210877239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF6,SLAM family member 6,2418,95,1.21 [0.76-1.92],0.4191258321575029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF7,SLAM family member 7,2477,100,1.29 [0.96-1.72],0.0872798871038182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF8,SLAM family member 8,2418,95,1.71 [1.23-2.37],0.0014560525384512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC12A2,Solute carrier family 12 member 2,2068,81,2.27 [0.99-5.18],0.0523082673238792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC13A1,Solute carrier family 13 member 1,2133,83,1.21 [0.87-1.68],0.2635954416898487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC16A1,Monocarboxylate transporter 1,2414,94,1.34 [1.01-1.78],0.0408862697482061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC1A4,Neutral amino acid transporter A,2095,81,0.74 [0.43-1.26],0.2712770157573737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC27A4,Long-chain fatty acid transport protein 4,2414,94,1.11 [0.83-1.49],0.4701978897629884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC28A1,Sodium/nucleoside cotransporter 1,2063,81,1.04 [0.72-1.50],0.8418585211143271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC34A3,Sodium-dependent phosphate transport protein 2C,2063,81,0.60 [0.33-1.09],0.0918617014712611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC39A14,Zinc transporter ZIP14,2414,94,1.52 [1.08-2.15],0.017412117801738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC39A5,Zinc transporter ZIP5,2477,100,1.69 [1.21-2.37],0.0021099384985913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC44A4,Choline transporter-like protein 4,2095,81,1.02 [0.74-1.40],0.9165793759357862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC4A1,Band 3 anion transport protein,2147,82,0.86 [0.54-1.37],0.5226685996785445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC51B,Organic solute transporter subunit beta,2068,81,0.95 [0.70-1.28],0.7165827578996338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,2109,80,0.99 [0.76-1.31],0.9600805573997392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,2130,82,1.16 [0.80-1.67],0.4438028840310787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",2063,81,0.98 [0.66-1.45],0.9103950828471348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLIT2,Slit homolog 2 protein,2414,94,1.27 [0.91-1.77],0.1661956518470967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLITRK1,SLIT and NTRK-like protein 1,2078,82,0.97 [0.51-1.82],0.9133924278057196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLITRK2,SLIT and NTRK-like protein 2,2500,102,2.41 [1.57-3.69],5.376303250135061e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLITRK6,SLIT and NTRK-like protein 6,2437,97,1.88 [1.20-2.95],0.0057577622737041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLK,STE20-like serine/threonine-protein kinase,2114,81,0.93 [0.68-1.27],0.6489127541646214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLMAP,Sarcolemmal membrane-associated protein,2130,82,1.38 [1.07-1.77],0.0121342525791329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,2129,82,1.97 [1.27-3.05],0.0023090276771511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMAD1,Mothers against decapentaplegic homolog 1,2418,95,1.01 [0.81-1.26],0.951772400153562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMAD2,Mothers against decapentaplegic homolog 2,2133,83,1.15 [0.85-1.55],0.3569973019699329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMAD3,Mothers against decapentaplegic homolog 3,2133,83,1.02 [0.66-1.57],0.9361387939230318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMAD5,Mothers against decapentaplegic homolog 5,2475,101,0.53 [0.21-1.30],0.1667926667247902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMARCA2,Probable global transcription activator SNF2L2,2414,94,1.15 [0.90-1.47],0.2751427574031628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMC3,Structural maintenance of chromosomes protein 3,2063,81,0.89 [0.57-1.39],0.608082347890713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMNDC1,Survival of motor neuron-related-splicing factor 30,2130,82,0.85 [0.58-1.27],0.4325379164550275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMOC1,SPARC-related modular calcium-binding protein 1,2500,102,2.51 [1.63-3.88],3.135300466506086e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMOC2,SPARC-related modular calcium-binding protein 2,2496,99,3.07 [2.23-4.22],5.8453344038836455e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMPD1,Sphingomyelin phosphodiesterase,2499,101,1.42 [1.04-1.95],0.027245486503998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMPD3,Sphingomyelin phosphodiesterase 3,2078,82,1.35 [1.00-1.83],0.0481198022751516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,2491,99,1.05 [0.81-1.37],0.705039700967772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,2133,83,0.74 [0.50-1.09],0.1253133496731817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMS,Spermine synthase,2071,82,1.06 [0.75-1.50],0.7316315965493709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMTN,Smoothelin,2136,84,1.28 [1.03-1.58],0.0242105846825098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNAP23,Synaptosomal-associated protein 23,2483,101,0.97 [0.79-1.18],0.7381896130210199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNAP25,Synaptosomal-associated protein 25,2071,82,1.18 [0.77-1.81],0.4410140671728436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNAP29,Synaptosomal-associated protein 29,2489,101,0.98 [0.80-1.19],0.8311881811557489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNAPIN,SNARE-associated protein Snapin,2136,83,0.87 [0.60-1.26],0.4694949866673552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNCA,Alpha-synuclein,2109,80,1.01 [0.84-1.22],0.9186964218857356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNCG,Gamma-synuclein,2463,98,2.09 [1.62-2.69],1.1044675029343588e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",2096,83,1.60 [0.88-2.92],0.1239275784023413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',2140,84,1.19 [0.83-1.71],0.3503174254479054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNU13,NHP2-like protein 1,2068,81,1.03 [0.69-1.55],0.8693314076106251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX15,Sorting nexin-15,2109,80,0.95 [0.63-1.41],0.7841176007741185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX18,Sorting nexin-18,2130,82,0.77 [0.45-1.33],0.3557981476855922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX2,Sorting nexin-2,2133,83,1.01 [0.80-1.27],0.9222643284404552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX5,Sorting nexin-5,2096,83,1.04 [0.48-2.27],0.9149722803962116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX9,Sorting nexin-9,2483,101,1.11 [0.85-1.46],0.4233975809790103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOD1,Superoxide dismutase [Cu-Zn],2426,93,1.07 [0.73-1.56],0.7395281317698115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOD2,"Superoxide dismutase [Mn], mitochondrial",2490,100,0.63 [0.41-0.97],0.0368108637177743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOD3,Extracellular superoxide dismutase,2148,83,0.75 [0.49-1.16],0.1925742621382005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORBS1,Sorbin and SH3 domain-containing protein 1,2136,83,1.58 [1.16-2.16],0.0038052932915133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORCS2,VPS10 domain-containing receptor SorCS2,2418,95,2.87 [1.98-4.16],2.6954474490221053e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORD,Sorbitol dehydrogenase,2490,102,0.85 [0.67-1.08],0.1743677692857389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORT1,Sortilin,2483,101,1.14 [0.73-1.80],0.5674173227052519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOST,Sclerostin,2483,101,1.75 [1.13-2.69],0.0114327612134151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,2095,81,0.52 [0.28-0.96],0.0355511858526907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOX2,Transcription factor SOX-2,2131,82,1.44 [0.65-3.16],0.3687701730162581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOX9,Transcription factor SOX-9,2095,81,1.60 [0.72-3.55],0.2491474457428139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,2136,83,2.00 [1.21-3.32],0.0072971460018499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPAG1,Sperm-associated antigen 1,2136,83,1.03 [0.69-1.54],0.8834847107431858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPARC,SPARC,2489,101,0.87 [0.68-1.11],0.2703559015645452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPARCL1,SPARC-like protein 1,2474,98,1.87 [1.05-3.36],0.0345258911011729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPART,Spartin,2109,80,1.09 [0.80-1.47],0.5880495535624678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPESP1,Sperm equatorial segment protein 1,2138,84,2.23 [1.34-3.71],0.0020504322393726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK1,Serine protease inhibitor Kazal-type 1,2490,100,2.78 [2.16-3.58],1.849312349093146e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK2,Serine protease inhibitor Kazal-type 2,2109,80,1.60 [0.95-2.70],0.0799002913268816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK4,Serine protease inhibitor Kazal-type 4,2477,100,2.33 [1.92-2.84],1.852400252853853e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK5,Serine protease inhibitor Kazal-type 5,2490,100,2.05 [1.28-3.27],0.0027817857131205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK6,Serine protease inhibitor Kazal-type 6,2500,102,1.07 [0.76-1.50],0.6893396517631559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK8,Serine protease inhibitor Kazal-type 8,2068,81,1.00 [0.51-1.98],0.9973388630296548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINT1,Kunitz-type protease inhibitor 1,2484,100,1.81 [1.01-3.23],0.0444670340617309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINT2,Kunitz-type protease inhibitor 2,2496,99,2.16 [1.45-3.21],0.000140885137056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINT3,Kunitz-type protease inhibitor 3,2130,82,1.00 [0.87-1.15],0.996889522098636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPOCK1,Testican-1,2463,98,0.69 [0.37-1.29],0.2441178228335891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPON1,Spondin-1,2488,99,2.90 [1.98-4.25],4.795486076272823e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPON2,Spondin-2,2475,100,3.74 [2.47-5.67],4.695857080410242e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPP1,Osteopontin,2505,102,1.58 [1.12-2.23],0.0093686739468215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",2078,82,1.33 [0.82-2.17],0.2470637159011475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRING1,SREBP regulating gene protein,2063,81,0.96 [0.65-1.43],0.8564961727435356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRR1B,Cornifin-B,2114,81,0.99 [0.79-1.25],0.9482473961356565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRR3,Small proline-rich protein 3,2140,84,1.47 [1.13-1.91],0.0042960649909038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRY2,Protein sprouty homolog 2,2421,99,1.03 [0.84-1.25],0.7868991536774231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",2071,82,1.02 [0.55-1.91],0.9474448671969068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPTLC1,Serine palmitoyltransferase 1,2140,84,1.13 [0.69-1.84],0.636526302042212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SRC,Proto-oncogene tyrosine-protein kinase Src,2485,101,1.01 [0.87-1.18],0.8955493360349087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SRP14,Signal recognition particle 14 kDa protein,2475,101,1.03 [0.76-1.41],0.8495107482207938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SRPK2,SRSF protein kinase 2,2477,100,1.02 [0.82-1.27],0.8538317989083246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SRPX,Sushi repeat-containing protein SRPX,2138,84,3.60 [2.14-6.04],1.3414081239119996e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSB,Lupus La protein,2414,94,0.76 [0.52-1.12],0.1653927861833342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",2078,82,0.72 [0.37-1.42],0.3451360355655511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,2483,101,0.82 [0.72-0.95],0.0058832213559174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,2486,99,1.19 [0.79-1.79],0.4032952169653991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSH3,Protein phosphatase Slingshot homolog 3,2063,81,0.78 [0.35-1.70],0.5277240288764478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSNA1,Sjoegren syndrome nuclear autoantigen 1,2130,82,1.26 [0.84-1.89],0.2658761388244786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST13,Hsc70-interacting protein,2109,80,0.93 [0.63-1.37],0.7005412422537345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",2475,101,1.82 [1.36-2.44],6.066172366495765e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",2510,102,2.22 [1.29-3.85],0.0042014859360491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",2078,82,1.33 [0.98-1.80],0.0650088074034777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAB2,Stabilin-2,2147,82,1.46 [0.68-3.16],0.3349367716498628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAM,Signal transducing adapter molecule 1,2133,83,1.42 [0.80-2.51],0.2349436604630326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAMBP,STAM-binding protein,2460,97,1.11 [0.83-1.48],0.50068781348373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAT2,Signal transducer and activator of transcription 2,2078,82,1.16 [0.87-1.55],0.3256010736877976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAT5B,Signal transducer and activator of transcription 5B,2475,101,0.98 [0.86-1.12],0.7906011115554309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,2063,81,0.92 [0.65-1.31],0.6497859501005261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STC1,Stanniocalcin-1,2505,102,1.99 [1.45-2.73],2.027392991784096e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STC2,Stanniocalcin-2,2484,98,2.68 [1.30-5.52],0.0075422018620593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STEAP4,Metalloreductase STEAP4,2071,82,1.02 [0.75-1.37],0.9146189366401872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STIP1,Stress-induced-phosphoprotein 1,2486,100,0.95 [0.72-1.26],0.7403726046217388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STK11,Serine/threonine-protein kinase STK11,2437,97,1.12 [0.87-1.44],0.380898427366419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STK24,Serine/threonine-protein kinase 24,2414,94,1.00 [0.73-1.36],0.9770694638719092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STK4,Serine/threonine-protein kinase 4,2483,101,0.86 [0.70-1.07],0.1737926083817409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STOML2,"Stomatin-like protein 2, mitochondrial",2063,81,0.93 [0.72-1.18],0.5385506634563694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX16,Syntaxin-16,2418,95,1.16 [0.84-1.60],0.3584412616038556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX1B,Syntaxin-1B,2095,81,1.31 [0.87-1.99],0.1965835919809236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX3,Syntaxin-3,2140,84,0.86 [0.47-1.56],0.6177485602670834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX4,Syntaxin-4,2475,101,1.31 [1.00-1.72],0.0459025138093917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX5,Syntaxin-5,2078,82,1.17 [0.71-1.91],0.543381187960633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX6,Syntaxin-6,2418,95,1.17 [0.90-1.52],0.2481333309522906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX7,Syntaxin-7,2078,82,1.39 [0.89-2.18],0.1473718029522676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX8,Syntaxin-8,2477,100,1.37 [0.95-2.00],0.0951752352670972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STXBP1,Syntaxin-binding protein 1,2136,83,0.95 [0.71-1.26],0.6999274512663911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STXBP3,Syntaxin-binding protein 3,2418,95,1.05 [0.67-1.64],0.8409840543627596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUGP1,SURP and G-patch domain-containing protein 1,2130,82,0.89 [0.50-1.61],0.7068792304630533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUGT1,Protein SGT1 homolog,2418,95,1.12 [0.88-1.42],0.3530646122701735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SULT1A1,Sulfotransferase 1A1,2505,102,1.01 [0.88-1.16],0.8784119870664959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SULT2A1,Bile salt sulfotransferase,2477,100,0.97 [0.74-1.26],0.8025773375403225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUMF1,Formylglycine-generating enzyme,2078,82,0.88 [0.60-1.27],0.488608131616388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,2505,102,1.19 [0.82-1.71],0.3569319093048745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUOX,"Sulfite oxidase, mitochondrial",2136,83,1.08 [0.80-1.45],0.6076208478877857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUSD1,Sushi domain-containing protein 1,2437,97,0.87 [0.60-1.25],0.4440285571416895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUSD2,Sushi domain-containing protein 2,2490,100,2.12 [1.18-3.81],0.0119523146179213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUSD4,Sushi domain-containing protein 4,2133,83,1.31 [0.86-2.00],0.2121590295824049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUSD5,Sushi domain-containing protein 5,2100,80,1.80 [1.00-3.24],0.0484542460459254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SV2A,Synaptic vesicle glycoprotein 2A,2095,81,1.02 [0.72-1.45],0.9171952600778696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SWAP70,Switch-associated protein 70,2130,82,0.92 [0.48-1.75],0.7921741305691399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SYAP1,Synapse-associated protein 1,2109,80,0.98 [0.67-1.45],0.9317964298081473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,2071,82,0.83 [0.55-1.26],0.3856450225177346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SYT1,Synaptotagmin-1,2140,84,1.32 [0.85-2.05],0.2120081806190785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SYTL4,Synaptotagmin-like protein 4,2138,84,1.08 [0.81-1.44],0.5967382820380879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,2114,81,1.09 [0.87-1.35],0.4536748489754212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TACC3,Transforming acidic coiled-coil-containing protein 3,2475,101,1.01 [0.86-1.18],0.919245324451642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TACSTD2,Tumor-associated calcium signal transducer 2,2194,90,2.72 [1.56-4.76],0.0004397681434932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TADA3,Transcriptional adapter 3,2133,83,1.33 [0.78-2.28],0.2938738371081164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAFA5,Chemokine-like protein TAFA-5,2475,101,3.33 [2.39-4.64],1.3339492170974245e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAGLN3,Transgelin-3,2063,81,1.25 [0.90-1.72],0.1841878719781579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TALDO1,Transaldolase,2143,82,1.34 [0.82-2.19],0.2461981921194792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TANK,TRAF family member-associated NF-kappa-B activator,2421,99,1.03 [0.79-1.35],0.8202356548791347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAP1,Antigen peptide transporter 1,2114,81,0.85 [0.56-1.29],0.437097710613915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TARBP2,RISC-loading complex subunit TARBP2,2414,94,1.25 [0.98-1.59],0.0722039046976298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",2095,81,1.07 [0.79-1.43],0.6705849178192079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",2133,83,0.93 [0.52-1.65],0.7964553212092966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAX1BP1,Tax1-binding protein 1,2140,84,1.23 [0.89-1.70],0.2188635977820119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBC1D17,TBC1 domain family member 17,2414,94,0.99 [0.67-1.47],0.9789845278648106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBC1D23,TBC1 domain family member 23,2475,101,0.98 [0.80-1.19],0.8240981378480606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBC1D5,TBC1 domain family member 5,2477,100,1.04 [0.83-1.31],0.7133347750134487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBCA,Tubulin-specific chaperone A,2109,80,1.04 [0.79-1.37],0.7921445454516254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBCB,Tubulin-folding cofactor B,2463,98,1.06 [0.88-1.29],0.52908022111868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBCC,Tubulin-specific chaperone C,2463,98,1.08 [0.85-1.36],0.5212270699617239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBL1X,F-box-like/WD repeat-containing protein TBL1X,2418,95,1.05 [0.84-1.31],0.6942980254414681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBR1,T-box brain protein 1,2095,81,0.83 [0.51-1.37],0.4723523660718032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCL1A,T-cell leukemia/lymphoma protein 1A,2461,97,0.82 [0.69-0.97],0.0186523243136835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCL1B,T-cell leukemia/lymphoma protein 1B,2437,97,0.83 [0.63-1.09],0.1864741797732659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCN1,Transcobalamin-1,2097,82,1.42 [0.80-2.53],0.2339508010818543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCN2,Transcobalamin-2,2505,102,3.23 [2.12-4.92],4.7306557782732184e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCOF1,Treacle protein,2138,84,1.88 [1.03-3.42],0.0404466573389226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCP11,T-complex protein 11 homolog,2114,81,0.91 [0.60-1.37],0.6543488047970483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCTN3,Tectonic-3,2138,84,1.24 [0.66-2.33],0.507989649429374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TDGF1,Teratocarcinoma-derived growth factor 1,2414,94,1.01 [0.89-1.14],0.9190771455216044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TDO2,"Tryptophan 2,3-dioxygenase",2095,81,0.42 [0.21-0.85],0.0149469356898585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TDP1,Tyrosyl-DNA phosphodiesterase 1,2133,83,1.00 [0.73-1.37],0.993768667545765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TDRKH,Tudor and KH domain-containing protein,2414,94,1.24 [0.99-1.54],0.0555762912877644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TEF,Thyrotroph embryonic factor,2068,81,1.39 [0.82-2.37],0.2227100870855277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TEK,Angiopoietin-1 receptor,2489,101,2.19 [1.03-4.63],0.0407014228422759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TERF1,Telomeric repeat-binding factor 1,2078,82,1.37 [0.66-2.84],0.3914170766145062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TET2,Methylcytosine dioxygenase TET2,2107,81,1.01 [0.82-1.23],0.960544511963247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TEX101,Testis-expressed protein 101,2095,81,1.36 [0.97-1.92],0.0788493686898111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TEX33,Testis-expressed protein 33,2114,81,0.63 [0.30-1.30],0.2102287950325748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TF,Serotransferrin,2143,83,3.09 [1.18-8.13],0.0222025907777379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFAP2A,Transcription factor AP-2-alpha,2071,82,0.91 [0.62-1.35],0.6479118426687622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF1,Trefoil factor 1,2479,100,1.69 [1.43-2.00],5.563030460188415e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF2,Trefoil factor 2,2492,99,1.98 [1.60-2.45],4.768154424731095e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF3,Trefoil factor 3,2462,98,2.24 [1.84-2.73],8.347723508614945e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFPI,Tissue factor pathway inhibitor,2476,99,1.05 [0.63-1.75],0.8434352751441989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFPI2,Tissue factor pathway inhibitor 2,2483,101,1.51 [1.05-2.18],0.0272046972764742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFRC,Transferrin receptor protein 1,2483,98,1.50 [1.01-2.25],0.0466579371225016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TG,Thyroglobulin,2133,83,1.16 [0.98-1.38],0.0893031003471852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFA,Protransforming growth factor alpha,2477,100,2.07 [1.51-2.83],5.294266721803689e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFB1,Transforming growth factor beta-1 proprotein,2501,101,1.83 [1.27-2.65],0.0012828971376018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFB2,Transforming growth factor beta-2 proprotein,2133,83,0.96 [0.62-1.48],0.8468846003673873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,2465,99,0.37 [0.20-0.69],0.0018047500683597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR1,TGF-beta receptor type-1,2078,82,2.22 [1.11-4.44],0.0242932261123446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR2,TGF-beta receptor type-2,2489,101,3.11 [2.31-4.19],7.472494159333477e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR3,Transforming growth factor beta receptor type 3,2510,102,2.75 [1.75-4.33],1.1674882412273766e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGM2,Protein-glutamine gamma-glutamyltransferase 2,2476,100,0.99 [0.79-1.24],0.9098405241879418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGOLN2,Trans-Golgi network integral membrane protein 2,2148,83,4.27 [2.24-8.13],1.0058137151598071e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THAP12,52 kDa repressor of the inhibitor of the protein kinase,2061,81,0.83 [0.63-1.10],0.1958927298218725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THBD,Thrombomodulin,2483,101,2.41 [1.57-3.72],6.488617482052091e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THBS2,Thrombospondin-2,2490,100,1.54 [1.12-2.11],0.0083010062936519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THBS4,Thrombospondin-4,2484,99,1.30 [0.91-1.84],0.1460277177706412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THOP1,Thimet oligopeptidase,2477,101,0.51 [0.32-0.81],0.0039169825278835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THPO,Thrombopoietin,2437,97,0.93 [0.60-1.45],0.7525689061029371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THRAP3,Thyroid hormone receptor-associated protein 3,2068,81,1.00 [0.82-1.22],0.9977879796796556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THSD1,Thrombospondin type-1 domain-containing protein 1,2061,80,0.78 [0.41-1.50],0.4576555510882109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THTPA,Thiamine-triphosphatase,2129,83,1.01 [0.78-1.31],0.9117076399905653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THY1,Thy-1 membrane glycoprotein,2505,102,4.15 [2.56-6.72],7.095988403046714e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIA1,Nucleolysin TIA-1 isoform p40,2413,95,1.06 [0.90-1.23],0.4962883442369493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIE1,Tyrosine-protein kinase receptor Tie-1,2510,102,1.14 [0.72-1.81],0.5617978762167884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",2411,93,0.97 [0.64-1.47],0.8857936885683428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,2114,81,1.25 [0.88-1.79],0.2130038925065786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,2486,99,1.12 [0.76-1.64],0.5605824198762916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,2138,84,1.39 [0.83-2.32],0.2053855928689741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,2140,84,1.00 [0.77-1.29],0.9781611664202318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP1,Metalloproteinase inhibitor 1,2444,98,2.75 [1.71-4.42],2.9687187583915315e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP2,Metalloproteinase inhibitor 2,2138,84,1.79 [1.13-2.84],0.0124685001580382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP3,Metalloproteinase inhibitor 3,2496,99,1.04 [0.91-1.19],0.5990697524622035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP4,Metalloproteinase inhibitor 4,2490,100,1.54 [1.04-2.30],0.0319145559725985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TINAGL1,Tubulointerstitial nephritis antigen-like,2480,101,2.75 [1.32-5.71],0.0069168374163096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TJAP1,Tight junction-associated protein 1,2489,101,1.02 [0.82-1.27],0.8673745922320772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TJP3,Tight junction protein ZO-3,2071,82,1.00 [0.60-1.67],0.9947539784983416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TK1,"Thymidine kinase, cytosolic",2114,81,1.28 [0.81-2.01],0.2908401784546128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TLR1,Toll-like receptor 1,2078,82,1.99 [1.04-3.80],0.0371717949075999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TLR2,Toll-like receptor 2,2114,81,1.68 [0.66-4.26],0.2737669552986851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TLR3,Toll-like receptor 3,2506,101,0.96 [0.73-1.26],0.7644382062428254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TLR4,Toll-like receptor 4,2078,82,1.12 [0.53-2.38],0.7587339673541202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,2095,81,1.01 [0.67-1.53],0.9438540716719744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMED1,Transmembrane emp24 domain-containing protein 1,2114,81,1.38 [0.97-1.96],0.0757993832285915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMED10,Transmembrane emp24 domain-containing protein 10,2068,81,1.09 [0.71-1.68],0.687638227878479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMED4,Transmembrane emp24 domain-containing protein 4,2068,81,1.03 [0.72-1.49],0.853718585567936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMED8,Protein TMED8,2130,82,1.06 [0.85-1.32],0.595134797008226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMEM106A,Transmembrane protein 106A,2133,83,0.89 [0.64-1.23],0.4800698149415139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMEM132A,Transmembrane protein 132A,2096,83,0.68 [0.48-0.95],0.0241134349753342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMEM25,Transmembrane protein 25,2136,83,1.79 [1.24-2.59],0.001844720995246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMOD4,Tropomodulin-4,2063,81,0.98 [0.58-1.66],0.9401215134511652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS11B,Transmembrane protease serine 11B,2071,82,0.64 [0.43-0.95],0.027539803679304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS11D,Transmembrane protease serine 11D,2137,84,1.69 [1.09-2.62],0.0197765973026291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS15,Enteropeptidase,2475,101,1.39 [1.15-1.68],0.0007170319992736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS5,Transmembrane protease serine 5,2456,97,1.62 [1.01-2.59],0.0442617349342818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMSB10,Thymosin beta-10,2490,100,1.33 [1.04-1.70],0.0254010741386495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNC,Tenascin,2486,99,1.35 [0.96-1.90],0.0830480383527241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNF,Tumor necrosis factor,2435,96,1.61 [1.13-2.29],0.0087248055532442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,2130,82,1.20 [0.80-1.82],0.3804907687767141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,2421,99,0.82 [0.50-1.34],0.4204641444714687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,2109,80,0.76 [0.52-1.12],0.1728621535234648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,2463,98,2.54 [1.94-3.34],1.9220906343533697e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,2463,98,1.73 [1.51-1.97],5.802451848648285e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,2488,101,1.64 [1.12-2.39],0.0112258374544047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,2506,101,3.11 [2.28-4.24],7.799895495729134e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,2481,99,2.83 [1.72-4.66],4.531176567416721e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,2489,101,4.25 [3.00-6.02],4.2287866529557965e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,2488,99,2.02 [1.41-2.89],0.0001241535624772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,2421,99,1.25 [0.84-1.86],0.2632686365341566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,2488,99,3.87 [2.78-5.38],8.612866718796688e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,2109,80,1.04 [0.63-1.71],0.878082569380533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,2500,102,3.35 [2.43-4.62],1.3895383617908068e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,2490,100,4.63 [3.15-6.79],5.0032263806266046e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,2490,100,2.00 [1.63-2.45],3.9824614707050334e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,2505,102,3.98 [2.37-6.69],1.907211047187461e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,2501,101,3.64 [2.64-5.02],3.836412800164639e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,2463,98,1.56 [1.20-2.04],0.0010962953781603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,2505,102,1.95 [1.39-2.74],0.0001009014132525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,2463,98,2.24 [1.76-2.86],8.475409369202396e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,2506,101,0.97 [0.49-1.91],0.922343209038266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,2477,100,0.92 [0.68-1.25],0.6118052653081321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,2506,101,0.84 [0.45-1.55],0.5787299579174344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,2496,99,7.05 [4.08-12.18],2.665758048741583e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,2507,102,2.08 [1.23-3.49],0.0060160180235654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF14,Tumor necrosis factor ligand superfamily member 14,2463,98,0.95 [0.69-1.33],0.7848687507399581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,2147,82,2.15 [1.32-3.51],0.0022226278448245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNIP1,TNFAIP3-interacting protein 1,2140,84,1.07 [0.84-1.37],0.5858418447039002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNN,Tenascin-N,2147,82,1.79 [1.11-2.91],0.0179238085161643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNNI3,"Troponin I, cardiac muscle",2437,97,1.13 [0.91-1.41],0.2795326188100143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNPO1,Transportin-1,2114,81,0.90 [0.48-1.67],0.7332912075871364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNR,Tenascin-R,2463,98,1.80 [1.21-2.68],0.0035335121482009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNXB,Tenascin-X,2490,100,0.47 [0.25-0.89],0.0200947508680342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,2138,84,1.18 [0.90-1.55],0.2417311458717975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOP1,DNA topoisomerase 1,2130,82,1.00 [0.84-1.19],0.99844770538604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOP1MT,"DNA topoisomerase I, mitochondrial",2063,81,0.93 [0.58-1.51],0.7826793616426042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOP2B,DNA topoisomerase 2-beta,2078,82,1.14 [0.87-1.50],0.3481921736039189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOR1AIP1,Torsin-1A-interacting protein 1,2096,83,1.12 [0.76-1.67],0.5602595922967505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP53,Cellular tumor antigen p53,2418,95,1.07 [0.71-1.59],0.7543971247973003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP53BP1,TP53-binding protein 1,2078,82,1.15 [0.90-1.47],0.2731423865969719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP53I3,Quinone oxidoreductase PIG3,2056,79,1.15 [0.76-1.77],0.5057738784822069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP53INP1,Tumor protein p53-inducible nuclear protein 1,2437,97,0.79 [0.39-1.60],0.5073233601650677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP73,Tumor protein p73,2095,81,0.69 [0.37-1.30],0.2534112155856903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPBGL,Trophoblast glycoprotein-like,2095,81,0.72 [0.39-1.33],0.291170236130341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPD52L2,Tumor protein D54,2109,80,0.95 [0.77-1.17],0.6258182176982992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPK1,Thiamin pyrophosphokinase 1,2138,84,0.66 [0.31-1.39],0.2728255340388088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPM3,Tropomyosin alpha-3 chain,2068,81,1.26 [0.87-1.83],0.2127804624681469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPMT,Thiopurine S-methyltransferase,2418,95,0.75 [0.57-0.98],0.0336361601996381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPP1,Tripeptidyl-peptidase 1,2468,99,1.21 [0.84-1.74],0.3065424625019362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPPP2,Tubulin polymerization-promoting protein family member 2,2114,81,1.11 [0.85-1.43],0.450202466414095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPPP3,Tubulin polymerization-promoting protein family member 3,2414,94,1.49 [1.04-2.14],0.0287766871485172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPR,Nucleoprotein TPR,2068,81,1.18 [0.80-1.74],0.4071910456956134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPRKB,EKC/KEOPS complex subunit TPRKB,2063,81,1.17 [0.87-1.57],0.2976281829500809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPSAB1,Tryptase alpha/beta-1,2504,101,1.63 [1.14-2.34],0.0080397877159246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPSD1,Tryptase delta,2136,83,1.73 [1.10-2.72],0.017849387411366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPSG1,Tryptase gamma,2078,82,0.74 [0.33-1.67],0.474549339760001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPT1,Translationally-controlled tumor protein,2421,99,0.89 [0.63-1.25],0.5070879269787176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRAF2,TNF receptor-associated factor 2,2477,100,0.97 [0.75-1.27],0.8452302710098917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRAF3,"TNF receptor-associated factor 3, Isoform 2",2078,82,0.57 [0.29-1.10],0.0955381322273446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,2068,81,1.00 [0.67-1.50],0.9835258794975206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,2114,81,1.00 [0.79-1.27],0.974061910803329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TREH,Trehalase,2147,82,1.07 [0.80-1.43],0.6408837222007326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TREM2,Triggering receptor expressed on myeloid cells 2,2481,99,1.13 [0.83-1.52],0.445181808783591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TREML1,Trem-like transcript 1 protein,2148,83,1.01 [0.66-1.53],0.9772157075481788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TREML2,Trem-like transcript 2 protein,2490,100,1.56 [0.96-2.54],0.0721445856803357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIAP1,TP53-regulated inhibitor of apoptosis 1,2500,102,1.40 [1.04-1.88],0.0251661767767538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM21,E3 ubiquitin-protein ligase TRIM21,2477,100,0.84 [0.67-1.06],0.1489723826891949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM24,Transcription intermediary factor 1-alpha,2112,81,1.02 [0.73-1.43],0.8971888967077273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,2130,82,1.11 [0.91-1.37],0.2983900509891584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM26,Tripartite motif-containing protein 26,2063,81,1.18 [0.90-1.57],0.2343445213710506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM40,E3 ubiquitin ligase TRIM40,2095,81,0.92 [0.70-1.22],0.5810855390029049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM5,Tripartite motif-containing protein 5,2477,100,1.05 [0.85-1.29],0.6789695293761506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM58,E3 ubiquitin-protein ligase TRIM58,2133,83,1.01 [0.79-1.30],0.9109372702527836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRPV3,Transient receptor potential cation channel subfamily V member 3,2068,81,1.02 [0.67-1.54],0.93863669594266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSC1,Hamartin,2078,82,1.11 [0.86-1.44],0.4295604602318505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSC22D1,TSC22 domain family protein 1,2136,83,1.30 [0.95-1.79],0.1049716135256168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSHB,Thyrotropin subunit beta,2483,101,0.83 [0.67-1.04],0.1117066635857718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSLP,Thymic stromal lymphopoietin,2437,97,1.17 [0.91-1.51],0.222334193566102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSNAX,Translin-associated protein X,2068,81,1.02 [0.57-1.83],0.938633988042297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPAN1,Tetraspanin-1,2437,97,0.76 [0.58-1.00],0.0487216726138227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPAN15,Tetraspanin-15,2068,81,1.30 [0.94-1.81],0.1173677721876072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPAN7,Tetraspanin-7,2071,82,0.90 [0.69-1.17],0.432596421250082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPAN8,Tetraspanin-8,2130,82,0.96 [0.79-1.18],0.722598739868155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPYL1,Testis-specific Y-encoded-like protein 1,2078,82,1.16 [0.68-1.98],0.5958925015555325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TST,Thiosulfate sulfurtransferase,2412,93,1.01 [0.78-1.32],0.9266051641164424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TTF2,Transcription termination factor 2,2095,81,1.17 [0.75-1.82],0.4913154562909166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TTN,Titin,2068,81,1.21 [0.89-1.63],0.2187419686183183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TTR,Transthyretin,2122,82,0.79 [0.35-1.77],0.5710845508151093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TUBB3,Tubulin beta-3 chain,2071,82,1.99 [0.90-4.40],0.0884953196857289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TWF2,Twinfilin-2,2147,82,1.09 [0.83-1.41],0.5401948772009957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXK,Tyrosine-protein kinase TXK,2114,81,0.95 [0.72-1.26],0.7284802580359577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXLNA,Alpha-taxilin,2463,98,1.08 [0.87-1.33],0.497359500229344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXN,Thioredoxin,2114,83,1.17 [0.70-1.94],0.5540504332585718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNDC15,Thioredoxin domain-containing protein 15,2489,101,1.30 [0.71-2.39],0.4013096998174489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNDC5,Thioredoxin domain-containing protein 5,2505,102,1.45 [1.12-1.87],0.0049651918540982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNDC9,Thioredoxin domain-containing protein 9,2140,84,1.08 [0.72-1.63],0.7080844591161417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNL1,Thioredoxin-like protein 1,2068,82,0.94 [0.75-1.19],0.6159173888071627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",2490,100,0.80 [0.54-1.18],0.2550086194674569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TYMP,Thymidine phosphorylase,2464,98,0.91 [0.67-1.23],0.5383062789710473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TYRO3,Tyrosine-protein kinase receptor TYRO3,2483,101,2.43 [1.33-4.45],0.003911574860683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",2078,82,1.54 [1.08-2.20],0.0174571813929813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBAC1,Ubiquitin-associated domain-containing protein 1,2475,101,1.12 [0.68-1.86],0.6484116249784726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBE2B,Ubiquitin-conjugating enzyme E2 B,2133,83,0.88 [0.41-1.90],0.7446217098311907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,2138,84,1.40 [0.98-2.00],0.0660649018770533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,2078,82,1.15 [0.79-1.67],0.4715431045861921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBQLN3,Ubiquilin-3,2068,81,1.24 [0.97-1.59],0.0800381507170239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBXN1,UBX domain-containing protein 1,2109,80,1.02 [0.73-1.42],0.9106120723140034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,2130,82,1.06 [0.90-1.25],0.5000885028041098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UGDH,UDP-glucose 6-dehydrogenase,2068,81,1.09 [0.87-1.35],0.4574409385911457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UHRF2,E3 ubiquitin-protein ligase UHRF2,2068,81,0.93 [0.43-1.99],0.8473899477686729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ULBP2,UL16-binding protein 2,2463,98,3.53 [2.42-5.14],5.299419857585641e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UMOD,Uromodulin,2500,102,0.44 [0.33-0.57],2.1584975426146966e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UNC5D,Netrin receptor UNC5D,2078,82,1.73 [0.93-3.22],0.0819505243027378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UNC79,Protein unc-79 homolog,2063,81,0.98 [0.66-1.47],0.9333496938560863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UNG,Uracil-DNA glycosylase,2133,83,1.62 [0.87-2.99],0.1265215603541429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UPB1,Beta-ureidopropionase,2138,84,0.87 [0.70-1.08],0.1998752429342565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UPK3A,Uroplakin-3a,2071,82,0.88 [0.57-1.37],0.5816255739539141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UPK3BL1,Uroplakin-3b-like protein 1,2109,80,1.19 [0.85-1.66],0.3021168436425385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UROD,Uroporphyrinogen decarboxylase,2109,80,1.12 [0.81-1.56],0.4994826309870284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UROS,Uroporphyrinogen-III synthase,2095,81,0.83 [0.59-1.18],0.3058654172949057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USO1,General vesicular transport factor p115,2475,101,1.04 [0.85-1.27],0.7295861309783811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USP25,Ubiquitin carboxyl-terminal hydrolase 25,2133,83,1.19 [0.87-1.61],0.2794985751099829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,2140,84,1.67 [1.09-2.55],0.0190154350422495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USP47,Ubiquitin carboxyl-terminal hydrolase 47,2068,81,1.06 [0.84-1.35],0.6063450396322808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USP8,Ubiquitin carboxyl-terminal hydrolase 8,2437,97,1.05 [0.86-1.28],0.6205552318974965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UXS1,UDP-glucuronic acid decarboxylase 1,2418,95,1.01 [0.72-1.42],0.9354112569809394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VAMP5,Vesicle-associated membrane protein 5,2437,97,1.26 [0.96-1.65],0.1026113875112591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VAMP8,Vesicle-associated membrane protein 8,2078,82,0.99 [0.75-1.30],0.9370890248473804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VASH1,Tubulinyl-Tyr carboxypeptidase 1,2477,100,0.98 [0.78-1.23],0.8596410004298103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VASN,Vasorin,2440,97,2.89 [1.72-4.84],5.8003143408896046e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VASP,Vasodilator-stimulated phosphoprotein,2148,83,1.04 [0.77-1.41],0.7909893617908728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,2475,101,0.52 [0.22-1.23],0.1354256682986589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VAV3,Guanine nucleotide exchange factor VAV3,2071,82,1.11 [0.89-1.39],0.3638887547696439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VCAM1,Vascular cell adhesion protein 1,2485,99,3.57 [2.17-5.88],5.921700830175052e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VCAN,Versican core protein,2505,102,1.84 [1.05-3.23],0.0331261523486805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VCPKMT,Protein-lysine methyltransferase METTL21D,2063,81,1.02 [0.79-1.32],0.8771450747688441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFA,Vascular endothelial growth factor A,2498,101,1.38 [1.03-1.85],0.0311717693142469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFB,Vascular endothelial growth factor B,2078,82,2.84 [1.43-5.65],0.0028893933050566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFC,Vascular endothelial growth factor C,2489,101,0.86 [0.63-1.18],0.3470469712888961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFD,Vascular endothelial growth factor D,2503,101,2.56 [1.72-3.81],3.838005977187137e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VGF,Neurosecretory protein VGF,2136,83,1.64 [0.94-2.89],0.0837842104443809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VIM,Vimentin,2437,97,0.93 [0.80-1.08],0.3552744583978869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VIPR1,Vasoactive intestinal polypeptide receptor 1,2096,83,1.09 [0.41-2.89],0.8602255192899313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VIT,Vitrin,2138,84,1.47 [0.88-2.45],0.1408076996868357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VMO1,Vitelline membrane outer layer protein 1 homolog,2475,101,1.71 [1.28-2.27],0.0002544789486182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VNN1,Pantetheinase,2148,83,1.22 [0.91-1.63],0.1938209163907878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VNN2,Vascular non-inflammatory molecule 2,2475,101,1.36 [0.92-2.00],0.1246604890462503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VPS28,Vacuolar protein sorting-associated protein 28 homolog,2114,81,1.19 [0.86-1.65],0.2993100837715535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VPS37A,Vacuolar protein sorting-associated protein 37A,2475,101,1.13 [0.90-1.41],0.2853115406577692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VPS4B,Vacuolar protein sorting-associated protein 4B,2133,83,0.99 [0.78-1.26],0.9482127367107462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VPS53,Vacuolar protein sorting-associated protein 53 homolog,2475,101,1.00 [0.80-1.25],0.9921256203933568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG10,V-set and immunoglobulin domain-containing protein 10,2133,83,1.25 [0.68-2.28],0.4770332784663654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,2068,81,1.64 [0.95-2.84],0.0757315767118194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,2133,83,1.84 [1.47-2.29],6.19824756243548e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,2484,98,2.83 [2.04-3.93],5.207141440437653e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,2480,101,0.97 [0.72-1.29],0.8156033605992112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSNL1,Visinin-like protein 1,2140,84,0.58 [0.35-0.97],0.0376384940176347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSTM1,V-set and transmembrane domain-containing protein 1,2414,94,1.60 [1.15-2.25],0.0058821716332423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSTM2B,V-set and transmembrane domain-containing protein 2B,2114,81,0.93 [0.53-1.64],0.8047029144171065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,2437,97,1.27 [0.99-1.62],0.0620068877853126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,2505,102,1.06 [0.83-1.37],0.6307975925277389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,2418,95,1.10 [0.64-1.89],0.7401155481066395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,2109,80,1.10 [0.75-1.63],0.619257686334398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWA1,von Willebrand factor A domain-containing protein 1,2495,102,1.44 [0.94-2.20],0.0913315070697127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWA5A,von Willebrand factor A domain-containing protein 5A,2063,81,1.10 [0.86-1.41],0.4442030768516773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWC2,Brorin,2459,97,3.10 [2.10-4.58],1.3017697412193998e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWC2L,von Willebrand factor C domain-containing protein 2-like,2136,83,1.15 [0.73-1.80],0.5533706307655004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWF,von Willebrand factor,2510,102,1.27 [1.01-1.60],0.0374624253972041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WARS,"Tryptophan--tRNA ligase, cytoplasmic",2490,100,1.11 [0.70-1.75],0.6687562117253129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WAS,Wiskott-Aldrich syndrome protein,2421,99,1.09 [0.83-1.42],0.533616471772898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WASF1,Wiskott-Aldrich syndrome protein family member 1,2437,97,1.07 [0.88-1.31],0.4895016749399532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WASF3,Wiskott-Aldrich syndrome protein family member 3,2414,94,1.02 [0.81-1.28],0.8519529685370879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WASHC3,WASH complex subunit 3,2140,84,1.10 [0.83-1.47],0.5038059008460858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WASL,Neural Wiskott-Aldrich syndrome protein,2078,82,1.12 [0.78-1.60],0.5357411882126648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WDR46,WD repeat-containing protein 46,2133,83,1.00 [0.55-1.81],0.997498068603361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC1,WAP four-disulfide core domain protein 1,2091,80,1.35 [0.98-1.86],0.0677735856589239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC12,WAP four-disulfide core domain protein 12,2497,102,1.35 [1.06-1.72],0.0157209448545749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC2,WAP four-disulfide core domain protein 2,2358,93,3.11 [2.33-4.16],1.4702407797028145e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",2456,98,0.79 [0.53-1.18],0.2526196091330318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",2488,99,1.86 [1.12-3.09],0.0164114646109781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WIF1,Wnt inhibitory factor 1,2500,102,0.71 [0.43-1.19],0.192472550292599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WNT9A,Protein Wnt-9a,2421,99,2.33 [1.71-3.18],9.390214038118058e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,2463,98,0.86 [0.61-1.23],0.4127673865327154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XCL1,Lymphotactin,2500,102,1.46 [1.10-1.95],0.0095623120655274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XG,Glycoprotein Xg,2497,101,3.85 [2.73-5.44],1.918695939902932e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XIAP,E3 ubiquitin-protein ligase XIAP,2078,82,1.33 [0.91-1.96],0.141189486651993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XPNPEP2,Xaa-Pro aminopeptidase 2,2489,101,0.87 [0.74-1.03],0.1014735128007243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XRCC4,DNA repair protein XRCC4,2414,94,0.76 [0.45-1.28],0.2997861282113147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YAP1,Transcriptional coactivator YAP1,2140,84,5.55 [3.24-9.49],4.3136120824927183e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",2130,82,1.03 [0.88-1.21],0.6768595373510131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YES1,Tyrosine-protein kinase Yes,2475,101,1.10 [0.94-1.28],0.2177580895559803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YJU2,Splicing factor YJU2,2133,83,1.35 [0.67-2.69],0.3994769880582636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YOD1,Ubiquitin thioesterase OTU1,2068,81,0.92 [0.66-1.29],0.6313298980383765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YTHDF3,YTH domain-containing family protein 3,2421,99,1.02 [0.82-1.26],0.8575571844416485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YWHAQ,14-3-3 protein theta,2109,80,1.10 [0.81-1.49],0.5491759778091709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YY1,Transcriptional repressor protein YY1,2078,82,0.85 [0.38-1.88],0.6795777734038049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZBP1,Z-DNA-binding protein 1,2078,82,1.15 [0.64-2.06],0.6381654412258151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZBTB16,Zinc finger and BTB domain-containing protein 16,2418,95,1.13 [0.88-1.45],0.3364427659324542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,2437,97,1.30 [0.87-1.94],0.2053453820603593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZCCHC8,Zinc finger CCHC domain-containing protein 8,2068,81,0.96 [0.68-1.37],0.8313133067585916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZFYVE19,Abscission/NoCut checkpoint regulator,2130,82,1.03 [0.80-1.32],0.8380779032484595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZHX2,Zinc fingers and homeoboxes protein 2,2140,84,0.98 [0.50-1.92],0.9551843712393632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNF174,Zinc finger protein 174,2078,82,1.28 [0.76-2.17],0.3573595935425546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNF75D,Zinc finger protein 75D,2114,81,1.20 [0.94-1.54],0.1500802709955628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNF830,Zinc finger protein 830,2133,83,0.91 [0.66-1.26],0.5779880605934377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNRD2,Protein ZNRD2,2130,82,1.35 [1.02-1.77],0.0340214862268014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,2133,83,0.91 [0.60-1.37],0.639655056890249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZP3,Zona pellucida sperm-binding protein 3,2096,83,1.12 [1.03-1.22],0.0112811353201433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZP4,Zona pellucida sperm-binding protein 4,2063,81,0.44 [0.18-1.09],0.0749510321368194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZPR1,Zinc finger protein ZPR1,2071,82,0.92 [0.72-1.19],0.5371853046135623
